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Chapter A 
 
Introduction 
 
General Introduction 
Carbohydrates represent the third class of bio-informative macromolecules, together with 
nucleic acids and proteins. This concept has strongly emerged only recently, although sugars 
have already been considered for very long time as one of the most important class of bio-
molecules, because of their essential role in metabolism and as important structural 
components of biological systems.1 
The idea of carbohydrates, one of the most abundant macromolecules in nature, “just“ as 
energy source or building block for cell walls, is pretty limiting.  
Abundant and diverse glycans cover all the cells of all living organisms. Carbohydrate chains 
are prominent components at the surfaces of mammalian cells, occurring as N- and O-glycans 
on glycoproteins, glycosaminoglycan chains on proteoglycans, and oligosaccharides of 
glycolipids. Carbohydrate chains also occur on many secreted and extra cellular 
glycoproteins. Some carbohydrate sequences are widely distributed in different cell types, 
while others, such as the blood group antigens,2 are genetically determined. Still others have a 
regulated expression at different stages of embryonic development and cellular 
differentiation.3 
A very different portrait of sugars has been emerging due to new rising fields of research 
gathered under the very general name of glycoscience. The study of the structure-function 
relation of carbohydrates and of oligosaccharide chains of carbohydrate-decorated molecules 
(also known as glycoconjugates) evidenced that the saccharidic moieties are very often 
involved in cell communication, signaling and trafficking processes, playing key roles in 
immune response, viral replication, cell-cell adhesion, fertilisation, parasitic infection, cell 
growth and differentiation, and inflammation.4 Cancer is another area where carbohydrates 
turn out to play a pivotal role, helping to transmit the signals that trigger unchecked cell 
growth.5 Obviously the involvement of carbohydrates in so many crucial biological processes 
suggested their use in medicinal chemistry. Several carbohydrate-based drugs have been 
developed in several different fields.6 
The multiplicity of signal trasduction processes involving specific oligosaccharide sequences 
put strongly in evidence the bio-informative nature of carbohydrates. But, in contrast to the 
two major classes of bio-informative macromolecules, in the case of sugars, scientists haven’t 
cracked the code yet. The pivotal, but still not well understood, role of sugars in so many and 
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different cellular processes has been driving the scientific community to investigate the 
glycome -all the glycan molecules synthesized by an organism- in the same systematic way as 
for DNA and proteins. A new field of research has been opened named glycomics, in analogy 
with genomics and proteomics, with the aim of creating a cell-by-cell catalogue of glycan 
structures and glycosyltransferases involved in their bio-synthesis. 
In 1958 F. Crick referred to the “central dogma” as a universally accepted rule for the 
direction of genetic information (DNA to mRNA, and mRNA to protein). Almost fifty years 
ago the central dogma ended with proteins, nowadays we should reconsider it, including the 
post-translational modifications of the proteins, terminating the cascade of the genetic 
information with glycans. Post-translational glycosylation of proteins is a non-template-driven 
synthesis, a glycan structure does not mimic the sequences of the proteins that produced it, 
this means that at the sugars point nature gives a new challenge to scientists: a code-break. 
The task of the glycoscientists is to decipher the “sweet-code”. From this point of view, 
glycomics is far behind genomics and proteomics, not only because the youngest subject, but 
also for the great structural complexity carbohydrates exhibit. While DNA and proteins have 
essentially linear sequences, sugars branch; DNA has just four basic building blocks and 
proteins have 20, but sugars have more than 30. The number of all linear and branched 
isomers of an hexasaccharide is calculated to be over 1x1012. Because of this great structural 
diversity between carbohydrates and the others bioinformative molecules glyco-scientists 
have to face a completely different scenario, “the  languages of both nucleic acids and 
proteins can be compared to the Western phonogram (alphabet); and that of glycans, to the 
Eastern ideogram (kanji)”.7 
Clearly, for unravelling the mysteries of sugars, elucidating their biological functions, pure 
oligosaccharides of defined structure are required in sufficient amounts for biophysical and 
biochemical studies. But these biomolecules are often found in nature in low concentrations 
and in microheterogeneous forms. Most glycoproteins are not uniform, but consist of various 
“glycoforms” differing in type, length, branching and terminal decoration of oligosaccharides, 
and number or site of glycosylation. The isolation of oligosaccharides in a pure form from 
natural sources is therefore extremely challenging, when at all possible. 
Access to pure carbohydrates for biological studies relies on chemical or enzymatic synthesis. 
No amplification methods analogous to the polymerase chain reaction (PCR) for DNA are 
available for carbohydrates, nor a fully developed automated synthesis technology as in the 
case of oligopeptides and oligonucleotides. Recently automated8 and computer-assisted9 
synthetic approaches have been developed to boost the raising field of glycomics. To date 
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these technologies are not yet diffused and the synthesis of target molecules is still mainly 
practised by chemical synthesis. Enzymatic or chemoenzymatic approaches are certainly 
promising, but of the vast array of glycosyltranferases involved in biosynthetic pathways of 
carbohydrates, only a small fraction has been overexpressed and few of these are 
commercially available.10 Additionally, glycosyltranferases have narrow substrate 
specificities, being able to catalyse the formation of single types of glycosidic linkages. The 
extreme specificity exhibited by enzymes is the dream of every synthetic chemist, 
guaranteeing the desired glycosylation outcomes in terms of regio- and stereo-selectivity, 
without any previous chemical modification of the substrates. But, since every type of linkage 
requires a specific enzyme, the synthesis of target oligosaccharides via enzymatic catalysis is 
still expensive. 
In conclusion, although lots of promising approaches for the synthesis of oligosaccharide have 
been emerging as the future, unfortunately we are still in the present and the chemical 
approach is still more reliable and cheap. 
 
Glycosylation Reaction 
The key step in oligosaccharide synthesis is the glycosylation reaction. The majority of 
glycosylations are performed by nucleophilic substitution reaction at the anomeric carbon 
(Scheme 1). 
 
Scheme 1 Glycoside Synthesis by Nucleophilic Substitution at the Anomeric Carbon. 
 
The glycosylating agent is called glycosyl donor. Generally it carries a leaving group at the 
anomeric position, that can be activated by an appropriate promoter. Several different 
glycosylation methods exist whose classification relies on the nature of the leaving groups. 
Every class of leaving groups requires specific promoting systems. Since a universal 
glycosylation method – generally applicable - hasn’t been developed yet, several different 
methods are used and the choice depends on the specific reaction to be performed and on the 
planned synthetic strategy.  
The nucleophile species is generally called glycosyl acceptor (Scheme 2). 
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Scheme 2 Glycosylation Reaction. 
 
An ideal glycosylation reaction should be fast, high yielding, experimentally simple and 
completely regio- and stereo-selective. 
The regioselectivity of glycosidation is generally controlled by the use of protection 
strategies. Both glycosyl donor and acceptor have several nuclephilic functionalities (mostly 
hydroxyl and amino groups) that are able to compete each other in the reaction with the 
glycosylating agent. The regioselective protection of all the potentially reactive moieties, but 
the one desired, allows the regiochemical outcome to be perfectly controlled. 
Stereoselectivity is one of the major challenge in glycosylation reactions. The anomeric 
carbon on the glycosyl donor is a chiral centre, thus the nucleophilic attack on it generates two 
diasteroisomers that are referred to as anomers, designated α or β (Figure 1) according to the 
configurational relationship between the anomeric centre and a specified anomeric reference 
atom. The anomeric reference atom is the configurational atom of the parent. In the α anomer, 
the exocyclic oxygen atom at the anomeric centre is formally cis, in the Fischer projection, to 
the oxygen attached to the anomeric reference atom; in the β anomer these oxygen atoms are 
formally trans. 
 
Figure 1 Anomeric Configurations of D-Glucopyranose. 
 
Several approaches are used to achieve the desired stereoselectivity. The most effective 
method involves the use of neighboring group participation. Installation of an acyl protecting 
group at the donor O-2 generally results in excellent stereoselectivities for 1,2-trans-glycoside 
syntheses. When formation of 1,2-cis-glycosides is required, different strategies have to be 
used. Very common is the use of solvent effect: coordinating solvents such as ethers or 
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nitriles influence the stereochemical outcome of the reaction via the formation of intermediate 
carbocation-solvent adducts. 
Further aspects have to be considered when approaching to the synthesis of structures longer 
than a disaccharide. The synthesis of oligosaccharides requires a careful planning of the 
protection strategy and differentiation between permanent and temporary protecting groups is 
crucial. Thus, the building blocks synthesis becomes more complicate and time consuming. 
Also the synthetic strategy is a matter of choice, often driven by the intrinsic nature of the 
target molecules. The oligosaccharide chain can be elongated following stepwise or 
convergent approaches, or more straightforwardly in one-pot fashion. 
Insights in all these aspects of the glycosylation reactions are the object of next paragraphs 
and represent the topic of several excellent works.11 
 
Glycosylation Methods 
As anticipated in the previous paragraph, glycosylations are mostly carried out by 
nucleophilic substitution at the anomeric carbon of the glycosyl donor. Other approaches are 
used such as the nucleophilic substitution at the aglycone carbon or addition reactions to 1,2-
unsaturated sugars. 
Most of the methods belong to the first class, they are classified on the nature of the leaving 
group on the glycosyl donor and can be grouped according to the heteroatom attached to the 
anomeric center (Figure 2). 
 
Figure 2 Types of Glycosyl Donors. 
 
The departure of the leaving group is generally activated by the use of specific promoters. The 
choice of the glycosylation method implies the use of a specific promoter, which means that 
also the synthetic strategy has to be planned considering the compatibility of all protecting 
groups to the glycosylation conditions. 
Glycosyl halides (especially bromides and chlorides) were the first type of glycosyl donors 
used for the synthesis of complex oligosaccharides. Glycosylations with glycosyl bromides 
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and chlorides in the presence of stoichiometric amounts of silver salts (Ag2O, Ag2CO3), 
known as the Koenigs-Knorr reaction,12 is one of the oldest glycosylation methods. Over the 
years a wide variety of promoters to activate glycosyl halides in glycosylation reactions have 
been developed. The heavy metal salts frequently used as promoters include silver salts of 
hydroxyl carboxylic acids, such as silver salicylate,12b silver imidazolate,13 Hg(CN)2 and 
HgBr2,14 HgO and HgBr2,15 HgI216 and CdCO3.17 AgClO418 and AgOTf 19 are the most 
efficient among the heavy metal promoters, and the latter is the most frequently used. 
Heterogeneous catalysts such as silver silicate,20 silver zeolite21 and silver silica-alumina22 
were developed particularly for the synthesis of otherwise hard to synthesize β-mannosidic 
and β-rhamnosidic linkages. Besides heavy metal salts, Lewis acids such as SnCl4, BF3·Et2O, 
23 or ZnCl224 have also been introduced as promoters. 
The use of acid scavengers and drying agents in the reaction mixture in combination with the 
promoters is advantageous, and often necessary. Metal carbonates and oxides (Ag2O, 
Ag2CO3, HgO, CdCO3) not only do serve as promoters, but they also neutralize the acid 
released in the reaction. 
It should be noted that glycosylation reactions of glycosyl halides bearing participating groups 
at O-2 in the presence of excess base lead to 1,2-orthoesters instead of glycosides. Therefore 
the amount of base in the reaction mixture should be limited. 
A different type of activation was introduced by Lemieux converting α-glycosyl bromides 
into glycosides via their highly reactive β-anomers.25 In these cases, promoters such as 
Bu4NBr or Et4NBr in combination with DIPEA (Hünig’s base) are used. These halide ion-
catalyzed glycosylations give 1,2-cis-glycosides in excellent stereoselectivity. Unfortunately, 
the scope of the method is limited to reactive glycosyl halides and acceptors. 
Glycosyl halides, for a long time pratically the only type of glycosyl donors, have now lost 
their predominant role in glycosylations. This is due to attempts to avoid the use of 
stoichiometric amounts of toxic, expensive and often light- and moisture-sensitive heavy 
metal salts for their activation. Additionally, glycosyl halides are moderately stable. In the 
synthesis of glycosyl halides with non trivial protecting group patterns, the introduction of the 
halide is usually the last step of the synthetic pathway. The chemical elaboration of the non-
anomeric carbinols can be hardly performed without damaging the highly reactive halide at 
the anomeric position. Furthermore, purification of the halides from these reactions is often 
problematic. 
Installation of the halogen at the anomeric centers is generally performed by treatment of 1-O-
Ac-sugars with the desired hydrogen halide in acetic acid. Of course, this procedure is not 
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compatible with acid-labile protecting groups and several different approaches have been 
developed; however for the synthesis of peracetylated glycosyl halides this still represents one 
of the easiest and most reliable procedures. 
Glycosyl fluorides are more stable than glycosyl bromides and chlorides, but this has an 
effect also on their reactivity. Infact they are too unreactive to be activated under standard 
Koenigs-Knorr conditions, and, for this reason, their use as glycosyl donors was explored 
relatively late. Their use was introduced in 1981 by Mukaiyama and coworkers,26 and 
glycosyl fluorides are currently among the most frequently used glycosyl donors. Several 
methods for the preparation of glycosyl fluorides are known.27 They are commonly 
synthesized by the reaction of a protected sugar with a free anomeric hydroxyl group with 
diethylaminosulfur trifluoride (DAST) (Scheme 3).28 
 
Scheme 3 Synthesis of Glycosyl Fluorides. 
 
Most importantly, glycosyl fluorides can be activated under specific conditions compatible 
with the stability of most protecting groups. The first useful activation of glycosyl fluorides 
for glycosylation was introduced by Mukaiyama27 using a combination of SnCl2 with AgClO4 
(often replaced by AgOTf).29 Noyori and coworkers introduced the use of SiF4 and 
TMSOTf,30 whereas BF3·Et2O was introduced independently by Nicolau and Kunz.31 
Additionally, Wessel et al. introduced Tf2O as a powerful glycosylaton promoter for glycosyl 
fluoride donors.32 The sequence TMSOTf < SnCl2-AgOTf <Tf2O was suggested for the 
relative reactivity of different promoters, all used in stoichiometric amounts. Catalytic 
amounts of the protic acid TfOH were recently used by Mukaiyama and coworkers.33 
Glycosyl fluorides have found use in the synthesis of a wide range of complex natural 
products. In Scheme 4 is reported the Nicolaou’s synthesis of avermectin B1a, where glycosyl 
fluorides are prepared from thioglycosides by reaction with NBS and DAST.34 Although 
emphasis is placed on the donor properties of glycosyl fluorides, it should be mentioned that, 
in contrast to glycosyl bromides, partially unprotected glycosyl fluorides could also serve as 
glycosyl acceptors in oligosaccharides synthesis, acting as latent glycosylating agents. They 
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can be glycosylated by a variety of methods including thioglycoside and trichloroacetimidate 
donors.35 
 
Scheme 4 Synthesis of Avermectin B1a. 
 
Glycosyl iodides have been known for a long time.36 However, because of their instability, 
they have been used only occasionally as glycosyl donors. Since the introduction of the halide 
ion-catalysed glycosylation method,25 a number of glycosylations actually proceeded through 
in situ generated glycosyl iodides intermediates by activating glycosyl bromides with 
tetraalkylammonium iodides. Recently improved methods for the preparation of glycosyl 
iodides have been developed, and several glycosyl iodides were prepared and isolated. 
Although benzylated glycosyl iodides are very unstable and should be used directly, acyl 
protected derivatives are considerably less labile, and stable crystalline glycosyl iodides can 
be prepared.37 
Thioglycosides are the most used class of donors in oligosaccharide synthesis. The first 
thioglycoside was synthesized in 1909,38 but it is only recently that their excellent glycosyl 
donor qualities have been recognized. The strength of thioglycosides as glycosylating agents 
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lies in their easy synthesis combined with their stability, and, at the same time, their effective 
activation using chemoselective thiophilic promoters. 
Thioglycosides show remarkable stability: not only they do have long shelf lives, but they 
also tolerate very diverse chemical manipulations leaving the thioglycoside function intact. 
Importantly, most of the common carbohydrate protecting group manipulations can be 
performed on thioglycosides, a feature making the preparation of highly functionalized 
thioglycoside donors possible. Moreover, they are inert under several glycosylation 
conditions, so thioglycosides can serve as glycosyl acceptor in the assembly of 
oligosaccharide blocks. In addition, thioglycosides can also be directly converted into other 
types of donors, making them a very versatile class of compounds (Figure 3). 
 
Figure 3 Conversion of Thioglycosides into Other Types of Donors. 
 
The synthesis of the most used types of thioglycoside donors, mainly simple alkyl and aryl 
glycosides, is straightforward and can be performed on a large scale using cheap chemicals. 
Often the product is crystalline and can be purified without chromatography. Numerous ways 
to prepare thioglycosides have been described,39 but for the easy production of thioglycosides 
mainly two synthetic methods are commonly employed, namely the reaction of peracetylated 
glycosides with a thiol in the presence of a Lewis acid40 and the reaction of an acylated 
glycosyl halide with a thiolate (Scheme 5).38 
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Scheme 5 Synthesis of Thioglycosides. 
 
Indirect formation of thioglycosides can also be performed from glycosyl halides. Reaction 
with thiourea yields a pseudothiouronium salt, which can be hydrolyzed under mild, selective 
conditions to give the anomeric thiol, which then can be alkylated in an efficient, non-
smelling procedure to produce thioglycosides (Scheme 6).41 
 
 
Scheme 6 Alternative non-Smelling Procedure for Thioglycosides Generation. 
 
All common protecting groups such as esters, ethers, acetals and orthoesters can effectively be 
introduced, manipulated and removed. Problems encountered are the removal of benzyl 
groups using catalytic hydrogenolysis, since the sulfur generally contaminates the catalyst. 
Despite their stability, thioglycosides can be easily activated with thiophilic reagents, 
typically soft electrophilic reagents, under mild conditions (Scheme 7). Treatment of a 
thioglycoside with a thiophilic electrophile leads to the formation of a sulfonium ion species, 
that, with the assistance of the ring oxygen or a neighbouring group, evolves to the common 
intermediate of glycosylation reactions, the oxycarbenium ion depicted in the scheme, which 
then reacts with the nucleophile to afford the desired glycoside. 
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Scheme 7 Activation of Thioglycosides for Glycosylations by Electrophilic Reagents. 
 
The first efforts to use thioglycosides directly as donors were performed mainly with mercury 
(II) salts as promoters. It was early recognised that mercury had high affinity for the sulfur 
functionality. In the first successful attempt HgSO4 was employed.42 Other mercury salts, 
such as Hg(OAc)2, HgCl2, Hg(OBz)2, and PhHgOTf, were tried later.43 These activations gave 
moderate yields, and were not powerful enough to be of general use. 
Starting from the mid-1980s, however, a series of highly powerful activation methods of 
thioglicosides was developed. Starting with NBS,44 and especially with MeOTf45 and 
dimethyl(methylthio)sulfonium triflate (DMTST)46 a seemingly never-ending spectrum of 
new promoters has been reported, but also electrochemical and radical activation have been 
described.47 
Iodine-containing compounds are also used as promoters. Iodonium dicollidine perchlorate 
(IDCP) was introduced first as iodonium source,48 later on the corresponding triflate (IDCT) 
started to be effectively used.49 A very efficient promoter system, N-iodosuccinimide in the 
presence of a catalytic amount of triflic acid, was introduced independently by van Boom50 
and Fraser-Reid.51 Glycosylations promoted by NIS-TfOH are frequently used as they 
proceed at low temperatures within a short time, and are capable of activating a wide variety 
of glycosyl donors with various acceptors. Triflic acid is frequently replaced by different 
Lewis acids such as TMSOTf, TESOTf, AgOTf or BF3·Et2O. 
N-iodosaccharin (NISac) (Figure 4) was recently proposed as a replacement of NIS to reduce 
occasional by-products caused by the nucleophilicity of succinimide generally obtained as by-
product in NIS promoted reactions.52 
 
Figure 4 N-iodosaccharin. 
 
 
 15
Numerous highly complex structures have been synthesized using the here cited promoting 
systems, verifying the impressive utility of the method. These promoters also nicely 
complement each other regarding reactivity, from the least reactive IDCP and MeOTf through 
the intermediate DMTST up to the most reactive NIS/TfOH. This promoter reactivity 
difference, in combination with the different reactivity of donors and acceptors, allows many 
practical orthogonal couplings between thioglycosides. Furthermore, thioglycosides reactivity 
can also be tuned by the choice of the aglycone.53 Bulky or electron withdrawing groups on 
the sulphur decrease the reactivity of thioglycoside donors. Furthermore, several heterocyclic 
aglycones, such as benzothiazol-2-yl,54 pyridine-2-yl,44a pyrimidin-2-yl44a and, most recently, 
benzoxazol-2-yl55 derivatives, have been installed on the sulfur atom. These heterocyclic 
thioglycosides can be activated by the remote activation concept by reagents, which do not 
necessarily activate common alkyl- and aryl-thioglycosides. Thus, pyrimidinyl thioglycosides, 
for example, were activated by TMSOTf, which does not activate alkyl-/aryl-thioglycosides, 
to give glycosides in good yields.56 AgOTf or ZrCl4-Ag2CO3 proved to be effective promoters 
for the recently introduced benzoxazolyl thioglycosides (SBox glycosides).55b As shown in 
Scheme 8, the thioglycoside acceptor 2A could be glycosylated by SBox glycoside 1A in 
excellent yield as the promoter does not activate the ethylthio-function of the acceptor 2A.55b 
 
Scheme 8 Glycosylation with SBox Thioglycoside. 
 
Notwithstanding the efficiency of thioglycosides as donors, problems can, of course, be 
encountered in various applications. The problems are connected both to the type of 
thioglycoside used and to the promoter employed. As to the promoter, MeOTf can, if the 
acceptor is unreactive, give methylation instead of glycosylation of the acceptor hydroxyl 
group.57 As previously reported, N-succinimide glycosides can be formed as major products 
in NIS-promoted glycosylations with unreactive acceptors.58 Soft nucleophilic centers, such 
as double bonds, could compete with the sulfur in its reaction with the electrophilic promoter, 
but allyl and pentenyl groups proved to be compatible with thioglycoside method performing 
glycosidation under controlled conditions.59 Problems have been encountered when the 
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acceptor hydroxyl group is adjacent to an allyl protecting group, which have resulted in 
internal addition to an activated double bond being the major reaction (Scheme 9).48a 
 
Scheme 9 Side-product of Thioglycosides Activation. 
 
The use of thioglycosides in glycosylations has been reviewed.60 Thioglycoside method is 
surely the most exploited in oligosaccharide syntheses, another very versatile and widely used 
approach is represented by glycosyl trichloroacetimidate method. Although the first paper 
on this method was published as recently as 1980,61 it has already become a classical 
approach. This is essentially because only catalytic amounts of promoter are required to 
provide very high glycosyl donor properties whereas the here so far described methods 
generally require at least equimolar amounts of promoting system, which is obviously often 
associated with disadvantages of various sort. Glycosyl trichloroacetimidates are synthesized 
by reacting the free hydroxyl of lactols with trichloroacetonitrile under basic conditions. This 
reaction is generally high-yielding and, because of its reversibility, high anomeric control can 
often be achieved. In the presence of a weak base, such as potassium carbonate, the β-imidate 
can be isolated as the kinetic product, whereas the use of strong bases, such as sodium hydride 
or 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), results in the formation of the 
thermodynamically more stable α-trichloroacetimidates (Scheme 10).62 
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Scheme 10 Anomeric Control in Trichloroacetimidate Synthesis. 
 
Controlling the anomeric configuration of glycosyl trichloroacetimidates isn’t only of 
academic interest. The two diasteromers exhibit different reactivity, α anomers are generally 
more stable, thus less reactive, and require slightly harsher conditions to be activated. 
Furthermore, the use of diasteroisomerically pure glycosyl donors is of utmost importance 
when a SN2 mechanism in the glycosylation medium is invoked. 
Recently, Yu and coworkers introduced a class of fluorinated analogues of the Schmidt’s 
donors: glycosyl N-phenyl trifluoroacetimidates.63 Schmidt and co-workers also pioneered 
the preparation of glycosyl trifluoroacetimidates, whereupon the toxic CF3CN with low 
boiling point (-63.9 °C) was used.64 
Glycosyl N-phenyl trifluoroacetimidates are synthesized in high yield by treatment of the 
corresponding 1-hydroxyl sugar with N-phenyl trifluoroacetimidoyl chloride in the presence 
of Cs2CO3 or K2CO3 in lab grade non-anhydrous CH2Cl2 or acetone at room temperature 
(Scheme 11). 
 
Scheme 11 Synthesis of N-Phenyl Trifluoroacetimidates. 
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It should be mentioned that moisture in the solvent was found to be important, it might 
increase the solubility of K2CO3 and/or result in the presence of HO- to facilitate the 
deprotonation of 1-OH sugars, otherwise the reaction was found sluggish.65 Furthermore, 
thermodinamically favoured α anomers were produced predominantly due to the anomeric 
effect of the corresponding 1-O-potassium sugars. When DIPEA is used as base in anhydrous 
dichloromethane almost exclusively β anomers were obtained.66 
Unlike trichloroacetonitrile, N-phenyl trifluoroacetimidoyl chloride is not commercially 
available and it has to be synthesized by reacting trifluoroacetic acid with aniline in a PPh3-
Et3N-CCl4 system (Scheme 12).67 
 
Scheme 12 Synthesis of N-phenyl Trifluoroacetimidoyl Chloride. 
 
Aniline can easily be replaced by other nucleophiles, thus variously N-substituted 
trifluoroacetimidate donors might be prepared, providing an additional element for tuning the 
reactivity of the glycosyl trifluoroacetimidate donors.68 The presence of electron-withdrawing 
fluorine atoms on the leaving group greatly influences both reactivity and stability of N-
phenyl trifluoroacetimidate donors. As a matter of fact, if compared with the chlorinated 
analogues, they are less prone to undesired degradation reactions during glycosylations and 
exhibit improved storability properties. Like glycosyl halides, trichloro- and trifluoro-
acetimidate moieties are too labile to survive protecting group manipulations. Thus, 
installation of the imidate leaving group at the anomeric centre is the last step of multistep 
glycosyl donor syntheses.  
Generally in the early steps, a temporary protecting group is installed at the anomeric centre, 
in order to safely manipulate the other hydroxyl groups on the saccharide backbone. Both 
glycosyl trichloro- and N-phenyl trifluoro-acetimidates are relatively stable under basic or 
neutral conditions, but react readily in presence of catalytic amounts of Brønsted or Lewis 
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acids. Originally, pTsOH and BF3·Et2O were used,61 while currently the latter and TMSOTf69 
are the most frequently employed promoters. Glycosylations with these promoters take place 
at low temperatures and in high yields. Besides the activators mentioned thus far, several 
additional promoters have been introduced, these include strong protic and Lewis acids. 
One of the aim of our lab is the development of new mild, moisture-stable, non-corrosive 
glycosylation promoting systems for the trihaloacetimidate methods. Several mild promoters 
have been proposed during the last years, such as the system I2/Et3SiH, as source of in situ 
generated HI,70 and lanthanide salts such as Sm(OTf)371 or Yb(OTf)3.72 
More recently, commercially available acid washed molecular sieves (AW 300 MS) proved to 
effectively activate trihaloacetimidates without any further promoter.73 The last and very 
powerful promoting system developed in our lab concerns the use of catalytic amounts of 
Bi(OTf)3.74 Especially in the cases of Yb(OTf)3, AW 300 MS and Bi(OTf)3 the glycosylation 
conditions proved to be extremely mild and compatible with a number of acid sensitive 
protecting groups. In the case of Yb(OTf)3-catalyzed glycosylations, it has been proved the 
stability of the extremely labile dimethoxytrityl group (DMT), never used before in 
glycosylation media.75 
The higher stability of N-phenyl trifluoro- compared with that of trichloro-acetimidates has 
also an effect on the reactivity. Generally, Schmidt’s donors are activated at lower 
temperatures and by smaller amounts of promoter than those required by the fluorinated-
analogues. These observations allowed the development of an effective one-pot procedure in 
which trichloroacetimidates are initially chemoselectively activated by catalytic amounts of 
Yb(OTf)3 or Bi(OTf)3 in the presence of partially protected N-phenyl trifluoroacetimidates. 
After completion of this first glycosidation step, conditions are adjusted so to activate the 
protected N-phenyl trifluoroacetimidate for the second glycosidation step.76 It should be 
observed that the presence of three fluorine atoms is responsible by itself of the higher amount 
of promoter required for effectively activating glycosyl trifluoroacetimidates, whereas the 
presence of a bulky group on the nitrogen might entails the better yields often registered with 
N-phenyl trifluoroacetimidates, if compared with trichloroacetimidate donors. 
In Table 1 is shown a comparative study on BF3·Et2O-catalyzed glycosylations with glycosyl 
trichloro- vs trifluoro-acetimidate donors.77 As evident from the table, best results are 
achieved with 0.25 equivalents of promoter for trichloroacetimidate donor and with 0.5 
equivalents in the case of the fluorinate-analogue, in both cases the desired product was 
isolated in 73% yield. 
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Table 1 BF3·Et2O-catalyzed Glycosylation: Glycosyl Trichloroacetimidates vs 
Trifluoroacetimidates. 
 
The effect of the phenyl group in N-phenyl trifluoroacetimidate donors is generally related to 
the prevention of undesired side-reactions, that often take place with Schmidt’s donors, such 
as β-elimination78 or rearrangement to unreactive glycosyl trichloroacetamides.79 N-phenyl 
trifluoroacetimidate donors proved to be very effective glycosylating agents in several 
different syntheses sometimes furnishing better results than the Schimidt’s donors, but are not 
yet as diffused as the trichloro-analogues. 
Besides the introduction of new promoters, another technical development related to glycosyl 
trichloroacetimidates as glycosyl donors was the introduction of the inverse procedure.80 In 
the original procedure, the promoter is added to a mixture of glycosyl donor and acceptor. It 
was assumed that highly reactive glycosyl trichloroacetimidates might partially decompose 
prior to being exposed to the glycosyl acceptor. Consistently with this hypothesis, adding the 
glycosyl donor to a mixture of the acceptor and promoter resulted in increased yields 
(Scheme 13).  
Scheme 13 The Normal and the Inverse Procedure. 
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Glycosylation of the disaccharide acceptor 5A with the reactive fucosyl imidate 4A gave 
trisaccharide 6A in a 43% yield by the normal procedure and in a 78% yield by the inverse 
procedure. 
A completely different glycosyl donor’s family is represented by 1,2-anhydro sugars. 
Glycals recently came into the limelight because of the work of Danishefsky and coworkers, 
who developed a highly efficient procedure for their oxidation to 1,2-anhydro sugars with 
dimethyldioxirane (DMDO).81 Reaction of the epoxides 8A and 12A, promoted by ZnCl2 in 
tetrahydrofuran or dichloromethane, produced 1,2-trans-glycosides (Scheme 14).  
 
Scheme 14 Iterative Glycosylation with Glycals. 
 
Glycosylation of glycals by this method gives a reiterative glycosylation strategy for the 
synthesis of oligosaccharides. Unfortunately, it was established that the glycosylation reaction 
is not always stereospecific.82 A potentially useful feature of the glycosides formed in 
glycosylations with 1,2-anhydro sugars is that they possess a free 2-OH ready for further 
transformations, for example, into 2-deoxy glycosides,83 or for configurational inversion as in 
the synthesis of β-mannosides from β-glucosides.84 1,2-anhydro sugars are very versatile 
because they can also be readily converted into other types of glycosyl donors, such as 
thioglycosides, glycosyl fluorides and phosphates. 
 
Glycosyl phosphate triesters can be considered the nature’s glycosyl donors. Nucleotide 5’-
diphospho sugars (NDPs) (Figure 5) are the natural substrates of glycosyl trasferases, that are 
the enzymes responsible for the biosynthesis of oligosaccharides in living systems.85 
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Figure 5 Nucleotide 5’-Diphospho Sugar. 
 
Despite this strong suggestion from nature, glycosyl phosphate triesters were introduced as 
glycosyl donors in the scenario of oligosaccharide synthesis only relatively recently by 
Ikegami and co-workers.86 Stoichiometric amounts of TMSOTf proved to efficiently activate 
glycosyl phosphates at low temperatures. A variety of other Lewis acids, such as SnCl2, ZnI2, 
Zn(OTf)2 and BF3·Et2O, was screened achieving in all cases moderate results.87 
Most frequently, diphenyl and di-n-butyl phosphates are used. Recently, Singh and coworkers 
introduced the cyclic propane-1,3-diyl phosphates (Figure 6).88 
 
Figure 6 Most Commonly Used Glycosyl Phosphates. 
 
Glycosyl phosphates proved to be very effective glycosylating agents in the syntheses of 
various biologically relevant oligosaccharides both in solution and on solid-support.89 
Furthermore, their versatility was demonstrated in orthogonal and regioselective glycosylation 
strategies.87 Glycosyl phosphate 14A could be activated in the presence of thioglycoside-
acceptor 15A at very low temperature to furnish the desired disaccharide 16A in good yield 
(Scheme 15). The disaccharide donor thus obtained was further activated by the use of 
MeOTf/DTBP system for the coupling with the glycal 17A, affording the trisaccharide 18A in 
68% yield. 
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Scheme 15 Orthogonal Glycosylation with Glycosyl Phosphates and Thioglycosides. 
 
Orthogonal glycosylation strategies, similar to that described above, had previously been 
established for glycosyl donors other than glycosyl phosphates.  
One of the reason for the growing interest toward glycosyl phosphates is their compatibility 
with the automated solid-phase approach. Recently, Seeberger and coworkers developed the 
first automated solid-phase oligosaccharide synthesizer.8 A peptide synthesizer was adapted to 
carbohydrate synthesis. Specific coupling cycles were designed for glycosyl 
trichloroacetimidate and phosphate methods. The success of the approach was demonstrated 
by the assembly of the phytoalexin elicitor (PE) dodecasaccharide in automated fashion 
(Scheme 16). Two different glycosyl phosphate donors, 19A and 20A, were synthesized. 
Levulinoyl esters were employed as 6-O temporary protecting groups and the 2-O-pivaloyl 
group was used to control the stereochemical outcome of the glycosylation reaction via 
neighbouring participation effect. Each cycle incorporated double glycosylations (at -15 °C) 
and double deprotections to ensure high yielding steps (Table 2). A branched hexasaccharide 
was constructed in ten hours in over 80% yield, whereas dodecasaccharide 21A was prepared 
in 17 hours and in 50% yield using the same cycle. 
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Scheme 16 Automated Solid Phase Synthesis of Protected Phytoalexin Elicitor β-Glucan. 
 
 
Table 2 General Cycle Used with Glycosyl Phosphate Donors. 
 
Despite the efficiency and versatility of glycosyl phosphate donors, their use isn’t widely 
spread. This can be attributed to different reasons. First of all, their synthesis often requires 
the use of moisture-sensitive, expensive, or non-commercially available reagents.90 
Furthermore glycosyl phosphates are unstable toward prolonged time purifications on silica 
gel. Synthetic procedures requiring only fast filtration of the reaction crude are generally 
preferable. Once in pure form, α- and β-glycosyl phosphates were found to be completely 
stable to storage for several months at 0 °C. The use of stoichiometric amounts of promoter 
implies strong acidic condition in the glycosylation medium. This limits the number of 
protecting groups compatible with the method. Acid-labile protecting groups have to be 
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avoided, but an efficient protection strategy has been developed, using base-labile and UV-
detectable 9-fluorenylmethylcarbonate (Fmoc) as temporary group.91 
Besides glycosyl phosphates, a variety of other phosphorus containing leaving groups have 
been designed and proposed. Glycosyl phosphites were introduced by Schmidt,92 Wong93 
and Watanabe.94 They react with alcohols at low temperatures in the presence of catalytic 
amounts of Lewis acid promoters such as TMSOTf, BF3·Et2O and Sn(OTf)2, thus creating 
glycosides. The typical activators are ZnCl2, ZnCl2-AgClO4 and BiCl3.87, 95 
Glycosyl thio compounds with phosphorus in the leaving group, such as 
dithiophosphates96,87 or phosphorodiamidimidothioates,97 have also been studied (Figure 
7). 
 
Figure 7 Glycosyl Dithiophosphate and Phosphorodiamidimidothioate Donors. 
 
Despite their efficiency, none of the glycosylation methods described so far is generally 
applicable. The choice of the suitable glycosylation method for a given glycosidation depends 
on several parameters, among the others the specific linkage to be formed and the nature of 
the coupling partners. Generally the best results cannot be predicted in advance and come 
after several experimental attempts. Often a complementarity is found among the methods and 
for this reason many new glycosylation methods are being developed. Although we are still 
far to it, very efficient methodologies have been described and, besides the ones already 
illustrated, some others are worth mentioning.  
n-Pentenyl glycosides, introduced by Fraser-Reid,98 provide excellent stability under a 
variety of protecting group manipulations. These glycosyl donors are activated by 
electrophilic halogenation of the double bond, which results in cyclization and the release of 
the aglycone, thus providing active glycosylating carbocation (Scheme 17). 
 
Scheme 17 Glycosylation with n-Pentenyl Glycosides. 
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These glycosylation reactions are promoted by NBS, iodonium dicollidine perchlorate (IDCP) 
or the corresponding triflate (IDCT). NIS in combination with catalytic amounts of protic or 
Lewis acids such as TfOH99 or TESOTf,100 was introduced as a more active catalyst. The n-
pentenyl glycosylation was used in the synthesis of biologically important molecules.101 
Glycosyl sulfoxides as glycosyl donors were introduced by Kahne.102 When activated by 
triflic anhydride or catalytic amounts of triflic acid, glycosyl sulfoxides react with unreactive 
substrates giving glycosides in good yields. The reaction is reported to procede through the 
glycosyl α-triflate, which forms the basis of a very useful method for the synthesis of β-
mannopyranosides.103 Compared with glycosyl sulfoxides, glycosyl sulfones are far less 
reactive. Neverthless, activation of sulfones of some 2-deoxy sugars has been successfully 
used in glycosylations using MgBr2·Et2O.104 
 
Stereoselectivity of Glycosidation Reactions 
The effectiveness of a glycosylation doesn’t only rely on the coupling yield. The 
stereoselectivity is a crucial issue in glycosylation reactions. Problems of stereocontrol arise 
as result of difficulties in accomplishing clean SN2 reactions at the anomeric center. The ready 
assistance of the endocyclic oxygen in the glycosyl donor’s leaving group diparture and 
subsequent stabilisation of the carbocation gives a considerable SN1 component to these 
reactions rendering stereocontrol difficult. Depending on the spatial orientation of the 
substituent on the anomeric center, the newly formed glycosidic linkage can either be α or β, 
but it can also referred to as 1,2-trans or 1,2-cis, highlighting the relation with the substituent 
at the neighbouring carbon (Figure 8). 
 
Figure 8 Anomeric Configurations of D-Glucose and D-Mannose. 
 
The latter description is rather diffused, because it furnishes an easy way of understanding the 
difficulty of making a determinate glycosidic bond. 1,2-trans-Glycosides can be easily 
synthesized exploiting neighbouring group participation. When a glycosyl donor is 
equipped at O-2 position with an acyl group, the departure of the leaving group on the 
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anomeric position is anchimerically assisted by the carbonyl moiety and the acyloxonium ion 
24A is readily formed (Scheme 18). 
 
Scheme 18 Neighbouring Group Participation. 
 
Reaction of the nucleophile with the acyloxonium ion 24A takes place from the upper face of 
the ring and therefore results in the formation of 1,2-trans-glicoside 25A with regeneration of 
the acyloxy group. The nucleophile might also react with the other electrophile carbon, thus 
forming the undesired orthoester 26A (Scheme 19). 
 
Scheme 19 1,2-Orthoester Formation. 
 
In the most commonly used glycosylation methods, strong Lewis and Brønsted acids are used 
as promoters and the orthoester formation is a reversible process. When mild promoters are 
used, such as lanthanide salts for the trihaloacetimidate methods,71,72 glycosyl orthoesters 
become non-reactive side-products that negatively affect the glycosylation yield. 
Electrophilicity of the carbonyl carbon can be decreased in order to avoid this side-reaction. 
Sterically hindered pivaloyl groups are often used, but their cleavage require harsher 
conditions than those used for the common acetyl and benzoyl groups. Recently, 
methoxycarbonyl group was introduced as neighbouring participating group.105 The use of 
this protecting group guarantees complete 1,2-trans-stereoselectivity, orthocarbonate side-
products being not detected even in glycosylations assisted by very mild promoters. 
Furthermore, cleavage of methoxycarbonyl moieties requires the same conditions as for acetyl 
and benzoyl groups. Neighbouring group participation represents the most reliable tool to 
control the stereoselectivity of glycosylation reactions with various glycosyl donors. However 
the neighbouring group participation is limited to the synthesis of 1,2-trans-glycosides, but, 
since its effectiveness, it is sometimes used for the indirect synthesis of 1,2-cis-mannosides 
(Scheme 20). In this approach, the first step takes the advantage of the ready formation of 1,2-
trans-glucoside 28A by neighbouring group participation from glucosyl donor 27A, which 
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possesses orthogonally removable acetyl at O-2. After selective removal of this protecting 
group, the C-2 configuration of the resulting 29A is inverted by nucleophilic displacement or 
oxidation-reduction type reactions, thus creating the 1,2-cis-mannoside 30A. 
 
SCHEME 20 Synthesis of β-D-Mannopyranosides by Configurational Inversion at C-2. 
 
Other approaches to achieving stereoselective glycosylations have been developed. 
Obviously, the major challenge is represented by formation of 1,2-cis-glycosides, but it’s 
useful when not necessary to rely on alternative methods for the control of the 
stereochemistry of glycosylations also for 1,2-trans-linkage formation. Participating groups 
are generally carbonyl based functionalities. These groups don’t only influence the 
stereochemical outcome of the reactions but also the reactivity of glycosyl donors. Their 
electron-withdrawing nature has a destabilizing effect on the carbocation intermediate that is 
formed after the departure of the glycosyl donor leaving group. Glycosyl donors equipped 
with electron-withdrawing protecting groups are called disarmed and exhibit decreased 
reactivity.106 Depending on specific synthetic demands, this effect might be undesired and 
also 1,2-trans-selectivity has to be achieved in a different fashion. 
The solvent effect is widely used for controlling the stereoselectivity of glycosylation 
reactions. A prerequisite for the use of the solvent effect is the avoidance of participating 
groups at glycosyl donors O-2. Ether-type protecting groups have a low participation 
tendency and are therefore commonly used for this purpose. In these cases, benzyl ethers are 
the most frequently used derivatives for hydroxyl groups, whereas for amino sugars, the azido 
function serves as an excellent non-participating masked form of the amino group. In non-
coordinating solvents, such as toluene and CH2Cl2, glycosylation reactions procede through a 
tight ion pair, favouring an SN2-like mechanism with inversion of configuration at the 
anomeric carbon (Scheme 21).107 
The accomplishment of a pure SN2 reaction is very difficult. The ready participation of the 
endocyclic oxygen in leaving group displacement gives a considerable SN1 component and, 
generally, anomeric mixtures, enriched in the inversion product, are obtained. When 
glycosylation reactions are conducted in coordinating solvents, the stereoselectivity is altered 
by the direct involvement of the solvent in the reaction mechanism. Experimental evidence 
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has shown that ether-type solvents favour formation of α-glycosides, whereas the use of 
nitrile-type solvents shifts the selectivity toward the preferential formation of β-anomers. 
 
Scheme 21 Halide Ion-Catalized Glycosylation. 
 
This effect on the stereoselectivity was rationalized invoking an SN1-type reaction mechanism 
in which a sugar-solvent adduct is formed as intermediate.108 After the departure of the 
leaving group from the glycosyl donor, the oxocarbenium ion 31A is solvated by the 
coordinating solvent (Scheme 22). 
 
Scheme 22 Solvent Participation in Glycosylations. 
 
In the case of ether-type solvents, the kinetic formation of the α-adduct 32A is rapidly 
followed by its conversion into the thermodinamically favoured β-oxonium intermediate 33A. 
The β-adduct 33A is more stable than the axial oxonium 32A because of the reverse anomeric 
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effect. The presence of a positive charge on the exocyclic heteroatom, favours the equatorial 
displacement of the aglycone because of dipolar effects (Figure 9). 
 
Figure 9 Dipole-Dipole Interaction in Direct and Reverse Anomeric Effects. 
 
Intermediate 33A then reacts with the nucleophile to form the axial glycoside 34A, thus 
achieving the desired α-stereoselectivity. When nitrile-type solvents are used, the same model 
can be applied. In this case, the conversion of the α-adduct 35A into the termodinamically 
more stable β-nitrilium ion 36A is slower than in the case of ether-type solvents. This is due 
to the formation of nitrilium-nitrile-conjugate species that, stabilized by polydispersion of the 
positive charge, evolves to the corresponding β-adduct very slowly. The nucleophile, in this 
case, attaks the α-adduct with an equatorial approach leading to the formation of the desired 
β-glycoside 37A. This model is well established and the solvent effect is widely recognized. It 
had been supported by several experimental evidences, collected in the course of the years. 
Reaction at different temperatures and rates were conducted and the nitrilium ion was also 
trapped.109  
Although the solvent and the neighbouring participation effect are the most used methods, 
other approaches have been developed in order to control the sereoselectivity of glycosylation 
reactions. Protecting groups on position other than O-2 can influence the stereochemistry of 
glycosylations exploiting long range participation or sterical and torsional effects. The use of 
an acyl protection on O-4 of galactose and fucose donors proved to improve the α-selectivity 
of glycosylation reactions via long range participation effect (Scheme 23).87 
 31
 
Scheme 23 Long-Range Participation Effect. 
 
Furthermore, α-selectivity can also be enhanced by the use of bulky protecting groups on 
the primary hydroxyl of glycosyl donors. As shown in Scheme 24, the presence of the bulky 
dimethoxytrityl group on the O-6 of glucosyl N-phenyl trifluoroacetimidate 38A guaranteed 
the exclusive formation of the desired α-glycoside 40A in high yield (Scheme 24).75 
 
Scheme 24 Effect of the donor 6-O-substituents on α-selectivity of glycosylations. 
 
The use of 4,6-O-benzylidene protection on mannosyl donors is one of the keys to the 
efficient 1,2-cis-selectivity reported by Crich and coworkers in their work.110 4,6-O-
Benzylidene-protected mannosyl sulfoxides are first activated with triflic anhydride to give a 
covalent triflate, that is then displaced by the acceptor to give the β-mannoside with excellent 
yield and selectivity. In a more recent version, the α-mannosyl triflate is generated from a 
mannosyl thioglycoside by the combination of triflic anhydride and 1-benzenesulfinyl 
piperidine (BSP) before addition of the acceptor (Scheme 25).111 
 
Scheme 25 Synthesis of β-Mannosides via α-Triflate Formation. 
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The mechanism proposed and verified by Kinetic Isotope Effect invokes the formation of a 
transient contact ion pair (CIP) or a functionally equivalent “exploded” transition state 
(Scheme 26).112 In the CIP mechanism the triflate anion is necessarily closely associated with 
the face of the oxacarbenium ion from which it has just departed and shields that face against 
attack by the incoming alcohol. In the alternative mechanism there is a loose association of 
the nucleophile with the anomeric center as the leaving group departs. The minor amount of 
α-mannosides formed in these reactions most likely arise through the intermediacy of a looser, 
perhaps solvent-separated, ion pair (SSIP), which is in equilibrium with an initial CIP. The 
benzylidene group plays an important role in this equilibrium. It opposes to rehybridisation at 
anomeric carbon because of torsional effect and, so, shifts the complete set of equilibria 
toward the covalent triflate and away from the SSIP, thereby minimizing α-glycoside 
formation. 
 
Scheme 26 Proposed Glycosylation Mechanism for Crich Method. 
 
In most of the approaches described so far, the steric and electronical nature of the glycosyl 
donor is tuned to direct the stereochemistry of glycosylation reactions. Manipulation of the 
protection pattern of the glycosyl acceptor to control the stereochemical outcome of coupling 
reactions has received less attention. Two features of the acceptor are known to influence the 
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streochemical course of the reaction: the intrinsic reactivity of the hydoxy groups that 
function as nucleophile (axial hydroxyl groups are generally less reactive than equatorial 
hydroxyl groups)113 and steric factors, which result in matched/mismatched pairs of glycosyl 
dononors and acceptors.114 Recently, a new concept for stereochemical control of 
glycosylation reaction has been developed by locking the conformation of the 
monosaccharide acceptor.115 In the synthesis of key disaccharide building blocks for the 
assembly of the heparin backbone, the reaction of C-2-azido glucose trichloroacetimidate 41A 
with glucuronic acid acceptor 42A yielded anomeric mixture of disaccharide 43A (Scheme 
27). 
Scheme 27 Improvement of α-Selectivity by Conformational Locking of Glycosyl Acceptor. 
 
Glucuronic acid 42A adopts a 4C1 conformation with the C-4 hydroxyl group equatorially 
oriented. Locking the conformation of the glycosyl acceptor in a 1C4 conformation allowed 
the completely selective preparation of the desired cis-glycoside. Coupling glycosyl 
tricholoroacetimidate 41A with acceptor 44A resulted exclusively in formation of the α-linked 
disaccharide 45A in very good yield. 
 
The intramolecular aglycone delivery (IAD) method is a new and effective strategy 
developed to improve stereocontrol and yields in difficult glycosylations. It was introduced by 
Hindsgaul and coworkers for the preparation of β-D-mannopyranosides.116 The strategy 
involves the initial covalent attachment of the glycosyl acceptor to a group on O-2 of the 
glycosyl donor (Scheme 28). Activation of the anomeric leaving group in the tethered 
derivative 46A by an electrophile is then expected to proceed intramolecularly via a concerted 
mechanism. Thus, the derivative 46A results in formation of 48A via 47A. On quenching with 
water, 48A releases O-2 and yields the glycoside 49A. 
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Scheme 28 Intramolecular Aglycone Delivery. 
 
This concept was implemented using isopropylidene ketal type tethering. As shown in 
Scheme 29, the 2-O-acetyl thioglycoside 50A was transformed into the isoprenyl ether 51A 
using Tebbe’s reagent. Acid-catalyzed addition of the glycosyl acceptor 52A afforded the 
tethered derivative 53A. Glycosylation by activation of the thioglycoside with NIS afforded 
the β-mannopyranoside 54A with excellent stereoselectivity. 
 
Scheme 29 Intramolecular Aglycone Delivery Using Isopropylidene Ketal Tethering. 
 
The method worked well on simple molecules; however its exstension to higher 
oligosaccharides and complex structures had limited success.117 Numerous variations of the 
above intramolecular glycosylation were studied, including changes in the position of linkers 
and variations in the length, the type and the rigidity of the linker.118 
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Regioselectivity of Glycosidation Reactions 
Glycosylation reactions have to fulfil the essential requirement of regioselectivity. This issue 
is generally settled by the use of protection strategies. Protecting group manipulations 
represent an essential aspect of all total syntheses of organic molecules. This is particularly 
true in oligosaccharide synthesis, because of the multifunctional nature of carbohydrates. 
Most of the functional groups present on these molecules are of the same sort - hydroxyl 
groups – and necessitate regioselective protection strategies. As previously anticipated, all the 
functional groups that could potentially compete with the desired nucleophile in the attack on 
glycosyl donor are, generally, suitably protected.119 When a simple disaccharide has to be 
synthesized, theoretically, only one kind of protecting group can be used for both reaction 
partners. Even in this simple case, however, regioselective protecting group manipulations 
have to be exerted on both molecules, either to differentiate the anomeric center from the 
other hydroxyl groups of glycosyl donor and to regioselectively protect all the nucleophilic 
groups on the acceptor but the one desired. All the protecting groups used in carbohydrate 
chemistry have to be stable in glycosylation conditions and must be installed and removed 
without compromising the stability of both saccharide ring and the sensitive glycosidic bond. 
These requirements limit the number of protecting groups that are used in carbohydrate 
chemistry, if compared with those used in other fields of organic chemistry. On the other 
hand, like in any other area of organic synthesis, in oligosaccharide syntheses it’s extremely 
crucial to rely on a wide range of protecting groups, in order to project efficient synthetic 
strategies. 
By far, the most important protecting groups in carbohydrate chemistry are those used for the 
protection of hydroxyl groups, including the anomeric hemiacetal. Amino-protecting groups 
(for amino-deoxy sugars) and carboxyl protection (for uronic acids) are also of interst. Several 
procedures can be followed for installation and cleavage also in regioselective fashion120 of 
the most important protecting groups used in carbohydrate chemistry.  
In oligosaccharide synthesis beyond the level of disaccharides, temporary and permanent 
protecting groups must frequently be distinguished. Permanent protecting groups will remain 
through all synthetic steps until the liberation of final target oligosaccharide. The removal of 
temporary protecting groups during the synthetic sequence will reveal a free hydroxyl group, 
most often to produce a glycosyl acceptor ready for glycosylation (Scheme 30). 
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Scheme 30 Schematic Synthesis of a Trisaccharide. 
 
The two different types of protecting groups require different qualities. It must be possibile to 
introduce and remove permanent groups in bulk with regiocontrol and high efficiency. 
Obviously, they should be stable to conditions used for the removal (and introduction) of 
temporary groups. In the synthesis of branched structures or structures with substituents 
(phosphates, sulfates, acetates, etc.), it might be required the preparation of building blocks 
whose hydroxyl groups have to be differentiated from each other by orthogonal sets of 
temporary protecting groups. The idea of orthogonal protection was defined by Baranay and 
Mettifield as “a set of completely independent classes of protection groups, such that each 
class can be removed in any order and in the presence of all other classes”.121  
Preferably only one type of permanent protecting group should be used, to allow only one 
final deprotection step, an aspiration seldom possible to realize. Very few of the large 
numbers of protecting groups available fulfil the criteria for permanent protecting groups. 
More or less only acetates, benzoates, benzyl ethers, benzylidene and isopropylidene acetals 
have the stability and, at the same time, the efficient introduction/deprotection properties 
needed to make them suitable for this purpose. 
For effectively synthesize complex oligosaccharidic targets, it’s clear that differently 
protected precursors have to be prepared. For this scope, it’s essential to dispose of synthetic 
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methodologies for distinguishing between the several hydroxyl groups present on the 
saccharidic backbone in order to regioselectively install a given protection on a determinate 
position.122 General considerations on the reactivity of the various hydroxyl groups present on 
the sugar ring have to be discussed. In aldo-hexo-pyranoses three different kind of hydroxyl 
groups can be distinguished: the hemiacetalic at C-1, the primary at C-6, and three secondary 
hydroxyl groups at C-2, C-3 and C-4. The reactivity of the hemiacetalic OH is clearly 
different from the others. Unlike the other positions, the anomeric center in acidic conditions 
undergoes nucleophilc attack and, because of this, can be easily differentiated. Installation of 
a temporary protecting group at the anomeric position in Fischer conditions is generally the 
first operation of a multi-step building block synthesis. Most of the procedures for protecting 
groups installation exploit the nucleophilicity of the hydroxyl functions of the sugars. In these 
cases the primary position is appreciably more reactive than the other non-anomeric positions. 
The primary alchool can be effectively chemoselectively functionalized with a bulky 
protecting group (such as DMT, TBDMS, TIPS, etc.) in the presence of free secondary 
hydroxyl groups. The ability of distinguishing between the three secondary position is 
strongly dependent by their configuration. Consistent with well-known generalizations from 
cyclohexane chemistry, equatorial secondary hydroxyl groups of pyranoid compounds tend to 
react more readily than axial groups.  
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Oligosaccharide Synthesis 
For the successful synthesis of oligosaccharides, both chemical reactions and tactics are 
important concerns. All the methodologies developed for effectively promote, stereo- and 
regio-chemically direct glycosylation reactions have to be skilfully combined in order to 
achieve the desired oligosaccharide targets in high yields and reasonable time. For the 
efficient synthesis of oligosaccharides, stepwise or convergent methods can be employed 
(Figure 11). 
 
Figure 11 Stepwise and Convergent Methods in the Synthesis of Oligosaccharides. 
 
In the stepwise format the synthesis might start either from the reducing or the nonreducing 
end. The first approach is generally more convenient. Because of their reactivity, during 
glycosylations most glycosyl donors often undergo side-reactions (hydrolysis, rearrangement, 
etc.). Thus, in order to maximize coupling yields, they are used in slight excess compared 
with glycosyl acceptors. Starting from the non-reducing end implies the use of 
oligosaccharide donors and, therefore, the waste of precious oligosaccharide structures in case 
of decomposition. The use of monosaccharide donors and oligosaccharide acceptors is 
preferable instead. Unreacted glycosyl acceptors can be easily recovered from the 
glycosylation medium and directly reused. Hydrolysis or decomposition products require 
more synthetic steps to be converted into the parent glycosyl donors. The recent development 
of new anomeric protecting groups and some substituent groups that can be easily converted 
into leaving groups, however, has enabled the alternative format (starting from the non-
reducing end) to be used. The concept of stepwise synthesis is especially important for the 
construction of relatively small oligomers, but the convergent format is preferably employed 
for the synthesis of larger saccharides, especially in the syntheses of oligosaccharides 
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possessing repeating units in their structures. Furthermore, block syntheses reduce the overall 
number of steps and the convergent nature of this strategy makes it more efficient. Also, block 
syntheses afford greater flexibility in synthetic design. Specifically critical steps can be 
performed at early stages on smaller molecules, thereby facilitating chromatographic 
separations. In block syntheses, the reducing end unit of a block has to fulfil opposite 
requirements. It should be stable enough to serve as a glycosyl acceptor in the synthesis of the 
block and, at the same time, it should be reactive enough to serve as glycosyl donor in the 
assembly of the oligosaccharide from the blocks. Several strategies have been adopted to 
settle this issue. One solution to this problem is to exchange the anomeric substituent after 
the synthesis of the block. During the synthesis of the block, the reducing end is protected by 
a temporary protecting group (T), that is then removed converting the block into a glycosyl 
donor with a leaving group (X) at the reducing end (Scheme 31). 
 
Scheme 31 Block Synthesis by Reactivation via Exchange of the Anomeric Substituent. 
 
A drawback of this strategy is that the conversion of the block into a glycosyl donor requires 
several steps, which are especially undesirable in the case of larger fragments. An alternative 
approach uses different types of glycosyl donors in sequential glycosylation steps. As 
Scheme 32 shows, the key intermediate 56A carries an unprotected hydroxyl and has an 
anomeric substituent (Y) that withstands glycosylation with donor 55A. After glycosylation, 
the newly generated block 57A can be used directly as a donor, without any replacement of 
the anomeric substituent, to provide the oligosaccharide 59A. An example of this strategy is 
reported in Scheme 15 of this chapter.  
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Scheme 32 Block Synthesis by Sequential Glycosylations with Different Types of Glycosyl 
Donors. 
 
Nicolaou and coworkers proposed the two-stage activation strategy,34 where two types of 
anomeric substituents are used. One type, having Y at the anomeric center, serves as glycosyl 
acceptor (56A), the other one, possessing X, is used as glycosyl donor 55A (Scheme 33). 
 
Scheme 33 Block Two-Stage Activation. 
 
After glycosylating 56A with 55A, the anomeric substituent Y in the coupling product 57A is 
converted back into X (60A), so the resulting block can be used as a donor in further 
glycosylations. Using acceptor 61A of the same type as before makes the process suitable for 
further reiteration. Nicolaou used glycosyl fluorides as glycosyl donors and thioglycosides as 
acceptors and the procedure took advantage of the ready conversion of thioglycoside into 
glycosyl fluorides with NBS and DAST, as also shown in Scheme 4 in this chapter. 
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In active-latent glycosylation strategy, the glycosyl donor capability of an acceptor is turned 
on by a slight chemical modification in its aglycone. Glycosylation of the latent compound 
64A by the active donor 63A affords the latent disaccharide 65A (Scheme 34). 
Scheme 34 Active-Latent Glycosylation. 
 
Conversion of disaccharide aglycone (R2) into an active form (R1), transforms 65A into active 
glycosyl donor 66A that can be used in further chain elongations. This approach has been 
used by Danishefsky in iterative glycosylations using glycals as latent compounds and 1,2-
anhydro sugars as active glycosyl donors, as depicted in Scheme 14 in this chapter. 
 The armed-disarmed concept can also be counted among the several glycosylation strategies 
used in block syntheses. As shown in Scheme 35, the armed glycosyl donor 55A can be 
coupled with the disarmed 67A without self condensation of the latter. The resulting disarmed 
compound 68A can be used as a glycosyl donor in further coupling, either by arming it, by 
exchanging the protecting groups, or by using a more powerful promoter capable of activating 
the disarmed compound. Besides general synthetic strategies, some new methods and 
techniques are also worthy of discussion. In the traditional approaches of oligosaccharide 
synthesis, the product of a glycosylation reaction had to be isolated and it required some 
chemical transformations to make it suitable for the next glycosylation reaction. 
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Scheme 35 Block Armed-Disarmed Glycosylation. 
 
In some of the synthetic strategies that it will be showed in Chapter E, Chapter F and herein 
described, such as in the sequential and in the armed-disarmed glycosylations, the product of 
one glycosylation reaction is used directly in the next coupling reaction. This opened the way 
for omitting the isolation step and performing multiple glycosylations in a one-pot fashion 
(Figure 12). 
Figure 12 General Scheme of One-Pot Glycosylation. 
 
Several glycosylation strategies can be performed in a one-pot manner. Often different types 
of glycosyl donors are employed in one-pot sequential glycosylations. Generally, the 
orthogonality between the different classes of the used donors is not required. Glycosylation 
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are performed starting from the non reducing end, sequentially activating glycosyl donors 
with increasing stability. The first one-pot glycosylation sequence using this approach 
performed the progressive glycosylation of thioglycoside acceptor 71A by glycosyl bromide 
70A, and then of O-glycoside 73A by the newly formed thioglicoside donor 72A (glycosyl 
bromide → thioglycoside → O-glycoside) (Scheme 36).123 
 
Scheme 36 One-pot Sequential Glycosylation Using Different Types of Glycosyl Donors. 
 
Similar one-pot glycosylation sequences were performed using glycosyl trichloroacetimidate 
→ thioglycoside → O-glycoside; glycosyl fluoride → thioglycoside → O-glycoside or 
glycosyl phosphate → thioglycoside → glycal. 
Armed-disarmed type glycosylations can also be readily performed in a one-pot fashion. In 
this case the leaving group on the glycosyl donors is always the same. The control of the 
chemoselectivity is exerted by tuning the glycosyl donor reactivities through suitable 
protection strategies. The ability to control glycosyl donor reactivity by careful selection of 
hydroxyl protecting groups is one of the underlying principles of programmable one-pot 
oligosaccharide syntheses. Wong and coworkers set up a procedure for determining glycosyl 
donor reactivity by a competitive HPLC experiment.9 Donors and acceptors with donor 
capability (thioglycosides with one hydroxyl group exposed) with various protecting group 
patterns provided a set of building blocks with diverse reactivities. The relative reactivity 
values (RRVs), as observed by HPLC, were tabulated in a database, from which the computer 
program ‘Optimer’ was created. After the user has selected an oligosaccharide structure, the 
program lists the best combination of building blocks for its preparation. With this strategy, 
oligosaccharides containing three to six monosaccharides are rapidly assembled in minutes or 
hours by mixing the selected building blocks in sequence, with the most reactive first. 
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‘Optimer’ has been successfully applied to the synthesis of linear and branched 
oligosaccharide structures, as well as to the construction of a 33-membered oligosaccharide 
library.124 
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Chapter B 
  
Straightforward access to 2-O-deprotected allyl glycosides by  
BiBr3-promoted activation of peracetylated glycosyl iodides. 
 
Introduction 
Chemical manipulation of monosaccharide functional groups is the fundamental initial stage 
for accessing the building-blocks needed for oligosaccharide synthesis or, more in general, for 
preparing useful precursors of chiral synthetic targets. The desired differentiation of the 
several hydroxyl groups of a sugar molecule often implies multiple synthetic steps in which 
the appropriate variety of protecting groups is installed and then suitably elaborated according 
to the synthetic requirement. These processes can be time-consuming, as several synthetic 
operations and related purifications should be performed. Therefore, over the last year, some 
effort has been devoted towards the development of expeditious synthetic procedures 
providing rapid differentiation of monosaccharide protecting groups through multiple stages 
performed sequentially without any purification of intermediates.1 In this regard, herein it was 
reported a simple and rapid protocol for accessing monosaccharides bearing the versatile allyl 
group at the anomeric position, a free hydroxyl group at C-2, and acetyls on the other 
carbinolic positions. The approach relies on the feasible activation of glycosyl iodides with 
the use of sub-stoichiometric amounts of  BiBr3. 
 
Results and discussion 
The procedure was disclosed in the course of an investigation aimed at finding catalytic 
activators of per-acetylated glycosyl iodides to be employed in glycosidations as an alternative 
to known current protocols requiring excess amounts of expensive or not environmentally 
friendly promoters such as AgOTf  or Hg(II) salts.2 These precursors, despite their instability 
to both thermal conditions and light exposure, have been widely employed in carbohydrate 
chemistry as useful synthetic intermediates. In fact glycosyl iodides can be rapidly generated 
in situ within a few minutes by exposing commercially available peracetylated sugars to the 
combined system I2/Et3SiH according to a procedure developed in our laboratories a few 
years ago.3a As it will be shown in Chapter D, the combined system I2/Et3SiH is also able to 
afford partially protected mono- and disaccharides starting from densely O-benzylated 
glycosides. Glycosyl iodides can be produced, starting from 1-O-acylated precursors, also 
with other reactant system such as HI 55-58%/Ac2O,3b catalytic amounts of BiI3 in the 
presence of Me3SiI or MeSiCl3,3c Me3SiI,3d I2/thiolacetic acid or I2/1,3-propanedithiol,3e 
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I2/HMDS3f. This class of glycosyl halides can be also obtained from hemiacetals, under 
neutral conditions by using iodoenamines3g or with a polymer bound triarylphospahe-iodine 
complex and imidazole.3h Additionally, glycosyl phosphates, imidates, trifluoroacetates, 
chlorides, and bromides are converted under neutral conditions into the respective glycosyl 
iodides by treatment with LiI or NaI in 1 M solutions of LiClO4 in DCM.3i Few examples in 
the literature report that glycosyl iodides can be synthesized also from glycosyl phosphites,3j 
from densely O-trimethylsylilated glycosides3k and from 1,2-O-ketene acetal.3l This class of 
glycosyl halides can be employed as crude products, after a simple extractive work-up, in 
sequential one-pot schemes allowing the preparation of useful building blocks necessary for 
oligosaccharide assembly, such as 1,2-ethylidenes, 1,2-orthoesters, glycals, thio- and 
selenoglycosides3a,4 (Figure 1). 
O
AcO
AcO
OAc
AcO
I
glycosyl iodides
O
AcO
AcO
O
AcO
O
H3C
OR
1,2 - orthoesters
O
AcO
AcO
O
AcO
O
H3C H
1,2 - ethylidenes
O
AcO
AcO
AcO
1,2 - glycals
O
AcO
AcO
OAc
AcO
SR
R = Me, Et, -(CH2)9CH=CH2
thioglycosides
O
AcO
AcO
OAc
AcO
XPh
X = S or Se
thio- and seleno-
aryl glycosides  
Figure 1 
 
As expected, sub-stoichiometric amounts of InCl3 (a known activator of glycosyl bromides)5 
are capable of promoting in high yield the anomeric allylation of glucosyl iodide 2B with the 
predicted 1,2-trans-selectivity arising from a vicinal participation effect (Scheme 1). 
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    DCM, reflux, 5-10 min
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DCM, AllOH (4 eq),
overnight
b) Extractive work-up
 
Scheme 1 InCl3-promoted activation of glycosyl iodide 2B. 
In searching for alternative catalytic reagents of higher reactivity, several bismuth(III) salts 
were examined whose catalytic halophilic reactivity had been evidenced in some useful 
synthetic transformations such as Friedel-Crafts alkylations6a, 6b (Figure 2 and 3) and 5-exo-
trig cyclization via halide activation6c (Figure 4). 
Br LA (0.1 eq), 4 Å MS
DCM, rt, 16 h, 69-100 %
LA = InCl3, InBr3, In(OTf)3, In(NO3)3, InI, BiCl3, Bi(OTf)3
Figure 2 
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R R
R' R''
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120°C
25-82%
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Figure 3 
 
 
 
 
Figure 4 
When BiBr3 was used, the reaction outcome was rather different than with InCl3, and a 
mixture of products was recovered in which allyl glycoside 4B, deprotected at O-2, 
predominated over minor, although not negligible, amounts of peracetylated allyl glycoside 
3B (Scheme 2).  
X
R1
R2
Br
X
R1
R2Bi(OTf)3 (0.1 eq)
MS 4Å, 
DCM (0.05 M), 16 h, rt.
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Scheme 2 BiBr3-promoted activation of glycosyl iodide 2B. 
As shown in Scheme 2, the composition of the reaction mixture was examined under a 
variety of conditions (reactions at rt or in refluxing DCM, with 2 or 4 equivalents of allyl 
alcohol). The best yield of the 2-O-deprotected compound 4B (57 %) was achieved with 4 eq 
of allyl alcohol in refluxing DCM, and in the presence of freshly activated 4 Å molecular 
sieves. Remarkably, under these conditions the reaction is sufficiently fast (ca 90 minutes) so 
that the whole synthetic sequence shown in Scheme 2 can be performed within a few hours. 
Other solvents (1,2-dichloroethane, toluene, dioxane, acetonitrile) were also tested, but lower 
yields were invariably obtained. The anomeric profile of the obtained allylated products was 
also interesting: while compound 4B was obtained with some predominance of the α-anomer, 
the peracetylated allyl glycoside 3B was obtained with predominant, though not exclusive β-
selectivity. Given that the allyl group is frequently used for anomeric transient protection, the 
described two steps sequence appeared of synthetic value because it achieved the rapid 
chemical discrimination of the anomeric, the O-2, and the remaining oxygenated positions. 
From a literature survey it appeared that a similar transformation can be carried out with a 
slight improved yield (63% of 4B, β/α 3:1) by treating penta-O-acetyl-β-glucose with allyl 
alcohol (4 eq) in the presence of a stochiometric excess of BF3.OEt2 (1.5 eq).7 However, the 
overall reaction takes much longer times (overnight) than required by the here presented 
sequential procedure. Equally prolonged times (and high temperatures) have been very 
recently reported to be required by several zeolites for inducing similar transformations 
(glycosidation with concomitant 2-O deprotection) in the coupling of β-configured 
peracetylated sugars with either phenols or long-chain alcohols.8 In contrast to the above 
mentioned BF3.OEt2-based procedure, the anomeric profile observed in this latter approach 
was analogous to that obtained under the here described conditions. Further sparse examples 
of glycosidations proceeding with 2-O deacetylation of the glycosyl donor have been 
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occasionally described as minor side processes.9 Once established the best reaction 
conditions, the scope of the procedure was examined with a wide range of alternative 
saccharidic precursors (Table 1). With peracetylated galactose and mannose precursors the 
yields of the corresponding 2-OH allyl glycosides were again of synthetic interest, albeit 
lower than with glucose (Table 1, entries 5 and 8 vs entry 1). Notably, a lower yield of 2-O-
deprotected product was obtained when commercial acetobromo galactose was used in place 
of the corresponding iodinated precursor (entries 6 and 5, respectively). Acetylated 6-deoxy 
sugars such as L-rhamnose or fucose were instead found to afford a large predominance of the 
peracetylated 1,2-trans allyl glycosides (entries 9 and 10). Adoption of an alternative 2-O-
acyl group such as benzoyl (entry 4), or a methoxycarbonyl10 (entry 7) suppressed, under 
otherwise identical conditions, the process of 2-O-deprotection, and was effective in the 
exclusive generation of the corresponding 1,2-trans glycosides. These latter results indicate 
that BiBr3–promoted anomeric allylation without 2-O-deprotection can also be usefully 
achieved under suitable structural conditions of the substrates, and this may offer an 
alternative to protocols based on Fischer glycosidations, that require toxic and high-boiling 
allyl alcohol as the solvent. The use of alternative primary acceptors (n-propanol, n-pentenyl 
alcohol) in place of allyl alcohol was also tested with a gluco-configured acetylated precursor 
and it did not result in a remarkably different reaction mixture composition (compare entries 2 
and 3 with entry 1), although the best results in the 2-O-deprotection were obtained with allyl 
alcohol. An especially interesting result was obtained with a disaccharide such as D-lactose, 
which afforded the 2-O-deprotected product in very good overall yield and α-selectivity (entry 
11). It should be noted that in previously reported approaches7,8 of 2-O-deprotective 
glycosidation no disaccharide was surveyed. Additionally, only per-acetylated β-configured 
galacto- and gluco sugars, more prone to the acid-promoted anomeric activation, were used in 
those procedures, whereas the present protocol can be generally independent of the anomeric 
configuration of the starting compound, the initial iodination step being efficient with both 
anomers.3 
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Table 1 BiBr3-promoted activation of glycosyl halides[a] 
Entry Starting compound Products Yield (α/β) 
1  O
AcO
AcO
OAc
AcO OAc
1B  
O
AcO
AcO
OAc
AcO
OAll
3B 35 % (1:10)  
O
AcO
HO
OAc
AcO
OAll
4B 57 % (3.0:1)  
2[b]  1B O
AcO
AcO
OAc
AcO OnPr
5B 29 % (1:4.7)  
O
AcO
HO
OAc
AcO OnPr
6B 45 % (2.7:1)  
3[c] 1B 
O
AcO
AcO
OAc
AcO O
7B 35 % (only β)
O
AcO
HO
OAc
AcO O
8B 43 % (2.9:1)  
4 O
BzO
OBz
OBz
BzO
OBz
9B  
O
BzO
OBz
OBz
BzO OAll
10B 61 % (only β)  
5 
O
AcO
AcO
OAc
OAc
AcO
11B  
O
AcO
AcO
OAc
OAll
AcO
12B 48 % (only β)  
O
AcO
HO
OAc
OAll
AcO
13B 45 % (1.3:1) 
6[d] 11B 12B 51 % (only β) 13B 35 % (1.6:1) 
7 
O
AcO
MeO2CO
OAc
OAc
AcO
14B  
O
AcO
MeO2CO
OAc
OAll
AcO
15B 66 % (only β) 
8 
 
 
O
AcO
OAc
OAc
OAc
AcO
16B  
O
AcO
OAc
OAc
OAll
AcO
17B 25 % (3.7:1) 
O
AcO
OH
OAc
OAll
AcO
18B N. D.[e]  
9 
O
AcO
Me
OAc
OAc
OAc
19B  
O
AcO
Me OAll
OAc
OAc
20B 68 % (only β)  
O
AcO
Me
OAll
OAc
OH
21B 30 % (2.4:1) 
10 
OAcOMe
OAc
AcOAcO
22B  
OAcOMe
OAll
AcOAcO
23B 74 % (4.5:1)  
11 
O
AcO
O
AcO
AcO
OAc
O
AcO
AcO
OAc
OAc
24B
 
O
AcO
AcO
OAc
O
AcO
O
AcO
OAc
OAc
OAl
25B 29 % (1:6)  
O
AcO
AcO
OAc
O
AcO
O
AcO
HO
OAc
OAll
26B 48 % (only α)  
[a] General conditions: sugar, I2 (1.4 eq), Et3SiH (1.4 eq), refluxing DCM. Exctractive work-up, then: 
glycosyl iodide, allyl alcohol (4 eq), 4Å MS, BiBr3 (0.3 eq), DCM, reflux. [b] n-Propanol used in 
place of allyl alcohol. [c] n-Pentenyl alcohol used in place of allyl alcohol. [d] Tetraacetyl bromo 
galactose was used in place of the corresponding iodide. [e] The isolated yield could not been 
determined as the anomeric products were contaminated by inseparable 2,3,4,6-tetra-O-acetyl 
mannopyranose. Estimated yield by NMR: ca 35 % (α/β ca 1). 
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After having established the scope and the limitations of the protocol, some experiments 
were performed to gain some mechanistic information on the process. First, allyl 2,3,4,6-tetra-
O-acetyl galactopyranoside was exposed to the typical reaction conditions above described, 
and no appreciable 2-O-deacetylation was detected, evidencing that the removal of the acetyl 
group is not occurring after allylation of the anomeric position. In a second experiment, allyl 
orthoester 27B, prepared via the corresponding iodide 2B,3 was exposed to BiBr3 and allyl 
alcohol (Scheme 3). Interestingly, this treatment led to a mixture of allylated compounds 3B 
and 4B within short times even at room temperature, with a more large relative predominance 
of 2-O-deprotection but a lower α-selectivity. The outcome of this experiment is highly 
suggestive of an allylated orthoester as one of the feasible intermediates generated in the rate- 
determining step in which BiBr3 promotes the activation of the anomeric iodide. In order to 
ascertain the origin of the aglycon moiety in the final product, allyl orthoester 27B was treated 
under the same conditions previously adopted but in the presence of methanol rather than allyl 
alcohol as the external nucleophile. The product profile (Scheme 3) displayed a predominant, 
albeit not exclusive, content of methyl glycosides, which implies that the aglycon can be 
provided from the reaction medium and it’s not necessarily incorporated into the initial 
orthoester intermediate. 
O
O
AcO
AcO
AcO
O
H3C OAll
O
OAc
AcO
AcO
AcO
OAll O
HO
AcO
AcO
AcO
OAll
O
HO
AcO
AcO
AcO
OMe
27B
+
3B 15 % (β/α ca 10) 4B  60 % (β/α  ca 1.3)
4B ca 20 % (β/α ca 1.3)
28B ca 40 % (α/β ca 1)
+
DCM, 
BiBr3 (0.3 eq), 
rt
 
Scheme 3 BiBr3-promoted activation of orthoester 27B. 
Due to the interest in the search of 2-O-participating groups (as it will be shown in Chapter 
F) serving in Bi(OTf)3-promoted 1,2-trans glycosidations11  and amenable to selective 
removal in the presence of acetyls, it took advantage of the present procedure for the 
straightforward access to 4B, a useful precursor of the 2-O-Fmoc trifluoroacetimidate donor 
31B (Scheme 4).  
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O
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O
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O
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Bi(OTf)3,
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29B 76% 30B 65%
31B 85%
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Scheme 4 Synthesis of donor 31B and its coupling with acceptor 32B. 
The Fmoc group was initially installed on compound 4B, and the resulting compound 29B 
was submitted to a sequence of anomeric deallylation and installation of the (N-
phenyl)trifluoroacetimidate leaving group.12 Bi(OTf)3-catalyzed coupling11 with model 
acceptor 32B smoothly afforded disaccharide 33B in good yield (70%). 
 
Conclusions 
 
In conclusion, it was shown that the sequence of anomeric iodination and BiBr3-promoted 
activation of the intermediate glycosyl iodides can afford within short times useful saccharidic 
building-blocks unprotected at 2-OH and bearing the selectively removable allyl anomeric 
group. Suitable structural conditions of substrates (6-deoxy sugars or use of benzoyl or 
methoxycarbonyl 2-O-participating groups) switch the preferential process to a glycosidation 
without concomitant 2-O-deprotection.  
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Experimental Section 
 
General methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded 
in CDCl3 (internal standard, for 1H: CHCl3 at δ 7.26; for 13C: CDCl3 at δ 77.0) on Varian 
spectrometers at 200 or 300 MHz and 50 or 75 MHz, respectively, or on a Bruker Avance 400 
spectrometer at 400 MHz. The chemical shifts are given in parts per million (ppm) on the 
delta (δ) scale. 1H NMR assignments were based on homo-decoupling experiments. 
Analytical thin layer chromatography (TLC) was performed on aluminium plates precoated 
with Silica Gel 60 F254 as the adsorbent. The plates were developed with 5% H2SO4 ethanolic 
solution and then heating to 130°C. Column chromatography was performed on Kieselgel 60 
(63-200 mesh). When specified, anhydrous solvents stored over molecular sieves (purchased 
from Aldrich) were used. Glycosidation promoter bismuth(III) triflate was coevaporated three 
times in toluene and dried under vacuum for 30-45 minutes before being dissolved in the 
presence of freshly activated 4Å with dioxane.  
  
Typical Procedure for BiBr3-Promoted Allylation: To a solution of peracetylated glucose 
(110 mg, 0.28 mmol) in dichloromethane (4 mL) were sequentially added iodine (102 mg, 
0.40 mmol) and triethylsilane (62.5 µL, 0.40 mmol; caution: exothermic reaction). After 
stirring for 5 min at reflux temperature, TLC analysis (petroleum ether/ethyl acetate, 6:4) 
displayed completion of the reaction. 
After cooling to room temperature, the mixture was diluted with dichloromethane and washed 
with a solution of saturated sodium hydrogen carbonate containing a minimal amount of 
sodium thiosulfate for reducing the residual amount of iodine. The aqueous phase was 
extracted with dichloromethane, and the collected organic phase was dried with sodium 
sulfate and concentrated in vacuo. Freshly activated 4 Å molecular sieves were added to the 
residue, and the mixture was suspended in anhydrous dichloromethane (4 mL). Allyl alcohol 
(4 equiv.) and BiBr3 (37 mg, 0.084 mmol) were then added, and the mixture was heated at 
reflux until TLC analysis (petroleum ether/ethyl acetate, 4:6) displayed 
complete consumption of the UV/Vis detectable glycosyl iodide (ca. 80 min). Some drops of 
pyridine were added, and the mixture was filtered through a short pad of silica gel (ethyl 
acetate), and the residue from the filtered liquor was chromatographed by silica gel flash 
chromatography (petroleum ether/ethyl acetate, 6:4) to yield peracetylated allyl glycoside 3B 
(40 mg, 37%; α/β, 1:10), and 2-O-free allyl glycoside 4B (55 mg, 57%; α/β, 3:1).  
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Allyl 2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranoside (3B)7. 
Foam (ca α/β 1:10 anomeric mixture). Data for the β-anomer: 1H 
NMR (300 MHz, CDCl3): δ = 5.94-5.74 (m, 1 H, -
CH2CH=CH2), 5.26 (dd, 3J = 17.4 Hz, 2J = 1.2 Hz, 1 H, -
CH2CH=CHcisHtrans), 5.20 (t, J3,4 = J2,3 =  9.3 Hz, 1 H, 3-H), 5.19 (dd, 3J = 10.4 Hz, 2J = 1.2 
Hz, 1 H, -CH2CH=CHcisHtrans), 5.08 (t, J3,4 = J4,5 =  9.3 Hz, 1 H, 4-H), 5.01 (dd, J1,2 = 7.8 Hz, 
1 H,  2-H), 4.55 (d, 1 H, 1-H), 4.37-4.29 (dd, 3J = 4.8 Hz, 2J = 13.2 Hz, 1 H, -
CHaHbCH=CH2), 4.25 (dd, J6a,6b = 12.0 Hz, J5,6a = 4.6 Hz, 1 H, 6a-H), 4.13 (dd, J5,6b = 2.4 Hz, 
1 H, 6b-H), 4.12-4.03 (dd, 3J = 6.0 Hz, 2J = 13.2 Hz, 1 H, CHaHbCH=CH2), 3.72-3.64 (m, 1H, 
5-H),  2.08, 2.04, 2.01, 1.99 (4 x s, 12 H, 4 x -COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 
170.5, 170.1, 169.2, 169.1, 133.2, 117.5, 99.4 (C-1), 72.7, 71.6, 71.1, 69.8, 68.3, 61.8, 20.4 
ppm. C17H24O10 (388.37): calcd C 52.57, H 6.23; found C 52.40, H 6.10.     
  
Allyl 3,4,6-tri-O-acetyl-α,β-D-glucopyranoside (4B)7. Oil (ca 
α/β 3.0:1 anomeric mixture). Data for the α-anomer: 1H NMR 
(300 MHz, CDCl3): δ = 6.00-5.80 (m, 1 H, -CH2CH=CH2), 5.30 
(m, 3J = 17.1 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.24 
(m, 3J = 10.2 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.22 (t, J3,4 = J2,3 =  9.7 Hz, 1 H, 3-
H), 4.99 (t, J4,5 =  9.7 Hz, 1 H, 4-H), 4.95 (d, J1,2 = 3.9 Hz, 1 H,  1-H), 4.36-4.01 (m, 2 H, -
CH2CH=CH2), 4.24 (dd, J6a,6b = 12.3 Hz, J5,6a = 4.5 Hz, 1 H, 6a-H), 4.04 (dd, J5,6b = 2.1 Hz, 1 
H, 6b-H), 3.99-3.93 (m, 1 H, 5-H), 3.71-3.62 (m, 1 H, 2-H), 2.23 (d, J2,OH = 7.5 Hz, 1H, OH-
2), 2.06, 2.04, 2.00 (3 x s, 9 H, 3 x -COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ =  171.0, 
170.5, 169.5, 132.9, 118.5, 97.3 (C-1), 73.3, 70.7, 69.0, 67.9, 67.6, 61.8, 20.7 ppm. 
Significative signals of the β-anomer, 1H NMR (300 MHz, CDCl3): δ =  5.09 (t, J2,3 =  J3,4 = 
9.6 Hz, 1 H, 3-H), 4.39 (d, J1,2 = 8.1 Hz, 1 H, 1-H), 3.57 (m, 1 H, 2-H) ppm. C15H22O9: calcd 
C 52.02, H 6.40; found C 51.80, H 6.31. 
  
n-Propyl 2,3,4,6-tetra-O-acetyl-α,β-D-glucopyranoside 
(5B)13 . Oil (ca α/β 1:4.7 anomeric mixture). Data for the β-
anomer: 1H NMR (300 MHz, CDCl3): δ = 5.16 (t, J2,3 = J3,4 =  
9.6 Hz, 1 H, 3-H), 5.04 (t, J4,5 =  9.6 Hz, 1 H, 4-H), 4.94 (dd, 
J1,2 = 8.1 Hz, J2,3 =  9.6 Hz, 1 H, 2-H), 4.45 (d, 1 H, 1-H), 4.22 (dd, J6a,6b = 12.0 Hz, J5,6a = 4.5 
Hz, 1 H,  6a-H), 4.08 (dd, J5,6b = 2.2 Hz, 1 H, 6b-H), 3.85-3.74 (m, 1 H), 3.69-3.61 (m, 1 H, 5-
H), 3.44-3.32 (m, 1 H), 2.04, 1.98, 1.97, 1.96 (4 x s, 12 H, 4 x -COCH3), 1.6-1.4 (m, 2 H, -
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OCH2CH2CH3), 0.85 (t, 3J = 6.9 Hz, 3 H, -OCH2CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): 
δ = 170.5, 170.1, 169.2, 169.1, 100.7 (C-1), 72.7, 71.6, 71.2, 70.2, 68.4, 61.9, 22.5, 20.5, 10.1 
ppm. C17H26O10: calcd C 52.30, H 6.71; found C 52.00, H 6.55.  
 
n-Propyl 3,4,6-tri-O-acetyl-α,β-D-glucopyranoside (6B). Oil 
(ca α/β 2.7:1 anomeric mixture). Data for the α-anomer, 1H 
NMR (300 MHz, CDCl3): δ = 1H NMR (300 MHz, CDCl3): δ = 
5.18 (t, J3,4 = J2,3 = 9.6 Hz, 1 H, 3-H), 4.95 (t, J4,5 = 9.6 Hz, 1 H, 
4-H), 4.87 (d, J1,2 = 3.9 Hz, 1 H, 1-H), 4.21 (dd, J6a,6b = 12.3 Hz, J5,6a = 4.5 Hz, 1 H, 6a-H), 
4.02 (dd, J5,6b = 2.1 Hz, 1 H, 6b-H), 3.98-3.88 (m, 1 H, 5-H), 3.75-3.40 (m, 3 H, 2-H and –
OCH2CH2CH3), 2.41 (d, J2,OH = 7.4 Hz, 1 H, 2-OH), 2.04, 2.03, 1.98 (3 x  s, 9 H, 3 x –
COCH3), 1.73-1.53 (m, 2 H, –OCH2CH2CH3), 0.92 (t, 3J  = 7.5 Hz, 3 H, –OCH2CH2CH3) 
ppm. 13C NMR (75 MHz, CDCl3): δ = 171.0, 170.6, 169.6, 98.1 (C-1), 73.4, 70.7, 70.4, 68.1, 
67.5, 62.0, 22.6, 20.5, 10.5 ppm. Significative signals of the β-anomer, 1H NMR (300 MHz, 
CDCl3): δ = 5.07 (t, J3,4 = J2,3 = 9.6 Hz, 1 H, 3-H), 4.97 (t, J4,5 = 9.6 Hz, 1 H, 4-H), 4.31 (d, 
J1,2 = 7.8 Hz, 1 H, 1-H) ppm. C15H24O9: calcd C 51.72, H 6.94; found C 51.45, H 6.75.  
 
n-Pentenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside 
(7B)14. Solid. [α]25D = -17.2 ° (c= 0.6, CHC13), m.p.= 47 
°C (light petroleum: diethyl ether). 1H NMR (300 MHz, 
CDCl3): δ =  5.86-5.67 (m, 1 H, -CH2CH=CH2), 5.18 (t, 
J3,4 = J 2,3 = 9.4 Hz, 1 H, 3-H), 5.06 (t, J 3,4 = J 4,5 = 9.4 Hz, 1 H, 4-H), 4.99 (dd, 3J = 16.9 Hz, 
2 J = 1.8 Hz, 1 H, -CH2CH=CHcisHtrans), 4.96 (dd, J 1,2 = 7.9 Hz, 1 H, 2-H), 4.95 (dd, 3J = 9.9 
Hz, 2 J = 1.8 Hz, 1 H, -CH2CH=CHcisHtrans), 4.47 (d, 1 H, 1-H), 4.24 (dd, J6a,6b = 12.3 Hz, J5,6a 
= 4.8 Hz, 1 H, 6a-H), 4.11 (dd, J5,6b = 2.5 Hz, 1 H, 6b-H), 3.90-3.81 (dt, 3J = 6.1 Hz, 2J = 9.6 
Hz, 1 H, -OCHaHbCH2CH2CH=CH2), 3.71-3.63 (m, 1 H, 5-H), 3.53-3.43 (dt, 3J = 6.6 Hz, 2 J 
= 9.6 Hz, 1 H, -OCHaHbCH2CH2CH=CH2), 2.06, 2.02, 2.00, 1.98 (4 x s, 12 H, 4 x -COCH3) 
ppm. 13C NMR (75 MHz, CDCl3): δ = 170.5, 170.2, 169.3, 169.2, 137.7, 115.0, 100.8 (C-1), 
72.9, 71.8, 71.4, 69.2, 68.6, 62.0, 29.8, 28.6, 20.5 ppm. C19H28O10: calcd C 54.80, H 6.78; 
found C 54.53, H 6.65. 
 
n-Pentenyl 3,4,6-tri-O-acetyl-α,β-D-glucopyranoside 
(8B). Oil (ca α/β 2.9:1 anomeric mixture). Data for the α-
anomer, 1H NMR (300 MHz, CDCl3): δ = 5.87-5.70 (m, 1 H, 
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-CH2CH=CH2), 5.19 (t, J3,4 = J2,3 = 9.6 Hz, 1 H, 3-H), 5.02 (dd, 3J = 17.1 Hz, 2J = 1.8 Hz, 1 
H, -CH2CH=CHcisHtrans), 5.02-4.90 (m, 2 H, -CH2CH=CHcisHtrans and 4-H), 4.87 (d, J1,2 = 3.6 
Hz, 1 H, 1-H), 4.23 (dd, J6a,6b = 12.3 Hz, J5,6a = 4.5 Hz, 1 H, 6a-H), 4.04 (dd, J5,6b = 2.4 Hz, 1 
H, 6b-H), 3.97-89 (m, 1 H, 5-H), 3.78-3.69 (dt, 3J = 6.7 Hz, 2J = 9.9 Hz, 1 H, -
CHaHbCH2CH2CH=CH2), 3.69-3.59 (m, 1 H, 2-H), 3.53-3.43 (dt,3J = 6.4 Hz, 2J = 9.6 Hz, 1 
H, -CHaHbCH2CH2CH=CH2), 2.60 (br. s, 1 H, 2-OH), 2.05 (x 2), 2.00 (3 x s, 9 H, 3 x -
COCH3) ppm.  13C NMR (75 MHz, CDCl3): δ = 171.0, 170.5, 169.5, 137.6, 115.2, 98.3, 73.5, 
70.8, 68.2 (x 2), 67.7, 62.1, 30.2, 28.4, 20.6 ppm. Significative signals of the β-anomer, 1H 
NMR (300 MHz, CDCl3): δ = 5.09 (t, J3,4 = J2,3 = 9.9 Hz, 1 H, 3-H), 4.32 (d, J1,2 = 7.8 Hz, 1 
H, 1-H) ppm. C17H26O9: calcd C 54.54, H 7.00; found C 54.32, H 6.87. 
 
Allyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (10B)15. 
Foam [α]24D = +50.7 (c 1.1, CHCl3). 1H NMR (300 MHz, 
CDCl3): δ =  8.30-7.20 aromatic protons), 5.96 (t, J3,4 = J2,3 = 
9.6 Hz, 1 H, 3-H), 5.80-5.66 (m, 2 H, -CH2CH=CH2 and 4-H), 
5.62 (t, 1 H, 2-H), 5.24 (d, 3J = 17.4 Hz, 1 H, CH2CH=CHcisHtrans), 5.14 (d, 3J = 10.5 Hz, 1 H, 
-CH2CH=CHcisHtrans), 4.95 (d, J1,2 = 8.1 Hz, 1 H, 1-H), 4.68 (dd, J6a,6b = 11.8 Hz, J5,6b = 2.8 
Hz, 1 H, 6b-H), 4.60-4.05 (4 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 166.1, 165.8, 165.2, 
165.1, 133.5, 133.3, 133.2 (x 2), 133.1, 129.8-128.3, 117.9, 99.8 (C-1), 73.0, 72.2, 71.9, 70.1, 
69.8, 63.2 ppm. C37H32O10: calcd C 69.80, H 5.07; found C 69.65, H 5.21.  
  
Allyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (12B)16. 
1H NMR (300 MHz, CDCl3): δ = 5.90-5.70 (m, 1 H, -
CH2CH=CH2), 5.35 (dd, J3,4 = 3.3 Hz, J4,5 = 1.0 Hz, 1 H, 4-H), 
5.24 (dd, 3J = 17.1 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 
5.20 (dd, J1,2 = 7.5 Hz, J2,3 = 10.5 Hz, 1 H, 2-H), 5.17 (dd, 3J = 
10.5 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 4.99 (dd, 1 H, 3-H), 4.49 (d, 1 H, 1-H), 4.37-
4.27 (m, 1 H), 4.15 (dd, J6a,6b = 12.6 Hz, 1 H, 6-H), 4.11-4.03 (m, 2 H), 3.87 (br. t, J5,6a = J5,6b 
= 6.6 Hz, 1 H, 5-H), 2.11, 2.02, 2.01, 1.94 (4 x s, 12 H, 4 x -COCH3) ppm. 13C NMR (75 
MHz, CDCl3): δ = 170.2, 170.1, 170.0, 169.3, 133.2, 117.4, 99.9 (C-1), 70.8, 70.5, 69.9, 68.7, 
66.9, 61.2, 20.5 ppm. C17H24O10: calcd C 52.57, H 6.23; found C 52.35, H 6.10. 
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Allyl 3,4,6-tri-O-acetyl-α,β-D-galactopyranoside (13B)17. Oil 
(ca α/β 1.3:1 anomeric mixture). Data for the α-anomer, 1H 
NMR (300 MHz, CDCl3): δ = 6.00-5.80 (m, 1 H, -
CH2CH=CH2), 5.36 (dd, J3,4 = 3.0 Hz, J4,5 = 1.2 Hz, 1 H, 4-H), 
5.29 (dd, 3J = 17.1 Hz, 2J = 1.2 Hz, 1 H, -CH2CH=CHcisHtrans), 5.22 (dd, 3J = 10.5 Hz, 2J = 
1.2 Hz, 1 H, -CH2CH=CHcisHtrans), 5.11 (dd, J2,3 = 10.5 Hz, 1 H, 3-H), 4.99 (d, J1,2 = 3.9 Hz, 1 
H, H-1), 4.30-4.00 (m, 5 H, 5-H, 6-H2 and -CH2CH=CH2), 3.80 (m, 1 H, 2-H), 2.70 (bs, 1 H, 
2-OH), 2.10, 2.01 (x2) (2 x s, 9 H, 3 x -COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.6, 
170.3, 170.0, 133.0, 118.3, 97.6 (C-1), 70.6, 68.9, 68.1, 66.9, 66.7, 61.7 (C-6), 20.6, 20.5 ppm. 
Significative signals of the β-anomer, 1H NMR (300 MHz, CDCl3): δ =   4.89 (dd, J3,4 = 3.3 
Hz, J2,3 = 10.5 Hz, 1 H, 3-H), 4.38 (d, J1,2 = 7.5 Hz, 1 H, 1-H) ppm. 13C NMR (75 MHz, 
CDCl3): δ =101.9 (C-1) ppm. C15H22O9: calcd C 52.02, H 6.40; found C 51.85, H 6.30. 
 
Allyl 3,4,6-tri-O-acetyl-2-O-methoxycarbonyl-β-D-
glucopyranoside (15B). Oil. [α]25D = +7.5 (c 0.5, CHCl3). 1H 
NMR (300 MHz, CDCl3): δ = 5.90-5.72 (m, 1 H, -
CH2CH=CH2), 5.35 (bs, 1 H, 4-H), 5.22 (m, 3J = 17.4 Hz, 2J = 
1.2 Hz, 1 H, -CH2CH=CHcisHtrans), 5.14 (m, 3J = 10.5 Hz, 2J = 
1.2 Hz, 1 H, -CH2CH=CHcisHtrans), 4.98-4.97 (m, overlapped signals, 2 H, 1-H and 3-H), 4.50 
(1H, dd, J1,2 = J2,3 = 3.9 Hz, 1 H, H-2), 4.35-4.00 (m, 4 H, 6-H2 and -CH2CH=CH2), 3.86 (t, 
J5,6a = J5,6b = 6.9 Hz, 1 H, 5-H), 3.75 (s, 3 H, -OCH l3), 2.08, 1.98, 1.93 (3 x s, 9 H, 3 x -
COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.1, 170.0, 169.8, 154.7, 133.1, 117.4, 99.8 
(C-1), 72.8, 70.6, 70.4, 70.0, 66.9, 61.0, 55.0, 20.4 ppm. C17H24O11: calcd C 50.49, H 5.98; 
found C 50.25, H 6.04. 
 
Allyl 2,3,4,6-tetra-O-acetyl-α,β-D-mannopyranoside  
(17B)18. Oil (ca α/β 3.7:1 anomeric mixture). Data for the α-
anomer, 1H NMR (300 MHz, CDCl3): δ = 6.00-5.80 (m, 1 H, 
-CH2CH=CH2), 5.35 (dd, J3,4 = 10.2 Hz, 1-H, 3-H), 5.29 (dd, 
3J = 17.1 Hz, 2J = 1.2 Hz, 1 H, -CH2CH=CHcisHtrans), 5.27 (t, J4,5 = 10.2 Hz, 1 H, 4-H), 5.24 
(dd, J2,3 = 3.1 Hz, 1 H, 2-H), 5.22 (dd, 3J = 10.5 Hz, 2J = 1.2 Hz, 1 H, CH2CH=CHcisHtrans), 
4.85 (d, J1,2 = 1.5 Hz, 1 H, 1-H), 4.27 (dd, J6a,6b = 12.1 Hz, J5,6a = 5.2 Hz, 1 H, 6a-H), 4.22-4.12 
(bdd, 3J = 5.4 Hz, 2J = 13.2 Hz, 1 H, -CHaHbCH=CH2), 4.11-3.95 (m, 3 H, 6b-H, -
CHaHbCH=CH2 and 5-H), 2.13, 2.09, 2.02, 1.97 (4 x s, 12 H, 4 x -COCH3) ppm. 13C NMR 
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(75 MHz, CDCl3): δ = 170.6, 170.0, 169.7, 169.6, 132.9, 118.3, 96.5 (C-1), 69.6, 69.0, 68.6, 
68.5, 66.2, 62.4, 20.6 ppm. Significative signals of the β-anomer, 1H NMR (300 MHz, 
CDCl3): δ = 5.48 (dd, J1,2 = 0.9 Hz, J2,3 = 3.6 Hz, 1 H, 2-H), 5.26 (t, J3,4 = J4,5 = 9.6 Hz, 1 H, 
4-H), 5.04 (dd, 1-H, 3-H), 4.68 (d, 1 H, 1-H), 3.68-3.60 (m, 1 H, 5-H), 2.19, 2.09, 2.04, 1.99 
(4 x s, 12 H, 4 x -COCH3) ppm. C17H24O10: calcd C 52.57, H 6.23; found C 52.35, H 6.15. 
 
Allyl 2,3,4-tri-O-acetyl-β-L-fucopyranoside (20B). Oil. 1H 
NMR (300 MHz, CDCl3): δ = 5.83-5.68 (m, 1 H, -
CH2CH=CH2), 5.23-5.05 (m, 4 H, -CH2CH=CH2 , 4-H and 2-
H), 4.93 (dd, J3,4 = 3.3 Hz, J2,3 =  10.5 Hz, 1 H, 3-H), 4.41 (d, 
J1,2 =  8.1 Hz, 1 H, 1-H), 4.32-4.20 (m, 3J = 4.5 Hz, 2J = 13.5 Hz, 1 H, -CHaHbCH=CH2), 4.05-
3.95 (m, 3J = 6.0 Hz, 2J = 13.5 Hz, 1 H, -CHaHbCH=CH2), 3.73 (q, J5,6 = 6.6 Hz, 1-H, 5-H), 
2.08, 1.96, 1.88 (3 x s, 9 H, 3 x -COCH3), 1.13 (d, 3 H, 6-CH3) ppm. 13C NMR (75 MHz, 
CDCl3): δ = 170.4, 169.9, 169.2, 133.4, 117.0, 99.6 (C-1), 71.1, 70.0, 69.5, 68.8, 68.7, 20.5, 
20.4, 20.3, 15.8 ppm. C15H22O8: calcd C 54.54, H 6.71; found C 54.35, H 6.65. 
 
Allyl 3,4-di-O-acetyl-α,β-L-fucopyranoside (21B). Oil (ca 
α/β 2.4:1 anomeric mixture). Data for the α-anomer, 1H NMR 
(300 MHz, CDCl3): δ = 5.95-5.80 (m, 1 H, -CH2CH=CH2), 
5.35-5.20 (m, 3 H, -CH2CH=CH2  and 4-H), 5.11 (dd, J3,4 = 3.3 
Hz, J2,3 =  10.5 Hz, 1 H, 3-H), 4.94 (d, J1,2 =  3.6 Hz, 1 H, 1-H), 4,25-3.95 (m, 3 H, -
CH2CH=CH2 and 5-H ), 3.91 (bdd, 1 H, 2-H), 2.61 (bs, 1 H, 2-OH), 2.12, 2.01 (2 x s, 6 H, 2 x 
-COCH3), 1.10 (d, J5,6 = 6.3 Hz, 3 H, 6-H3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.5 (x 
2), 133.3, 118.0, 97.7 (C-1), 71.2 (x 2), 68.8, 66.9, 64.8, 20.8, 20.6, 15.8 ppm. Significative 
signals of the β-anomer, 1H NMR (300 MHz, CDCl3): δ = 4.89 (dd, J3,4 = 3.3 Hz, J2,3 =  10.5 
Hz, 1 H, 3-H), 4.34 (d, J1,2 =  8.1 Hz, 1 H, 1-H), 2.11, 2.01 (2 x s, 6 H, 2 x -COCH3), 1.18 (d, 
J5,6 = 6.3 Hz, 3 H, 6-H3) ppm. C13H20O7: calcd C 54.16, H 6.91; found C 54.21, H 6.80. 
 
Allyl 2,3,4-tri-O-acetyl-α,β-L-rhamnopyranoside (23B)19. Oil 
(ca α/β 4.5:1 anomeric mixture). Data for the α-anomer,  1H NMR 
(200 MHz, CDCl3): δ = 5.96-5.70 (m, 1 H, -CH2CH=CH2), 5.23 
(dd, 3J = 17.2 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.20 
(dd, J2,3 = 3.4 Hz, J3,4 = 9.7 Hz, 1 H, 3-H), 5.18 (dd, J1,2 = 1.8 Hz, 1 H, 2-H), 5.15 (dd, 3J = 
10.1 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 4.99 (t, J4,5 = 9.7 Hz, 1 H, 4-H), 4.70 (d, 1 H, 
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1-H), 4.18-3.88 (m, 2-H, -CH2CH=CH2), 3.88-3.74 (m, 1 H, 5-H), 2.07, 1.98, 1.91 (3 x s, 9 H, 
3 x -COCH3), 1.15 (d, J5,6 = 6.2 Hz, 3 H, 6-CH3) ppm. 13C NMR (50 MHz, CDCl3): δ = 169.9, 
169.8, 169.7, 133.1, 117.8, 96.3 (C-1), 70.9, 69.7, 68.9, 68.1, 66.2, 20.6. β-anomer, 1H NMR 
(300 MHz, CDCl3): δ = 5.92-5.77 (m, 1 H, -CH2CH=CH2), 5.44 (d, J2,3 = 3.0 Hz, 1 H, 2-H), 
5.24 (dd, 3J = 17.5 Hz, 2J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.19 (dd, 3J = 10.5 Hz, 2J = 
1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.03 (t, J3,4 = J4,5 = 10.2 Hz, 1 H, 4-H), 4.97 (dd, 1 H, 3-
H), 4.63 (s, 1 H, 1-H), 4.32 (dd, 3J = 4.8 Hz, 2J = 12.9 Hz, 1 H, -CHaHbCH=CH2), 4.07 (dd, 3J 
= 6.3 Hz, 2J = 12.9 Hz, 1 H, -CHaHbCH=CH2), 3.55-3.42 (m, 1 H, 5-H), 2.16, 2.03, 1.96 (3 x 
s, 9 H, 3 x -COCH3), 1.26 (d, J5,6 = 6.0 Hz, 3 H, 6-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ 
= 170.1 (x 3), 133.2, 118.0, 96.9 (C-1), 71.1, 70.7, 70.5, 70.0, 69.1, 20.8, 20.7, 20.5, 17.4 
ppm. C15H22O8: calcd C 54.54, H 6.71; found C 54.40, H 6.60. 
 
Allyl 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl-(1→4)-2,3,6-tri-O-acetyl-
α,β-D-glucopyranoside (25B)20. Foam (ca α/β 
1:6 anomeric mixture). Data for the β-anomer, 
1H NMR (200 MHz, CDCl3): δ = 5.93-5.70 (m, 1 H, -CH2CH=CH2), 5.31 (bd, J3,4 = 3.4 Hz, 1 
H, 4′-H), 5.23 (dd, 3J = 17.3 Hz, 2J = 1.6 Hz, 1 H, -CH2CH=CHcisHtrans), 5.16 (t, J2,3 = J3,4 = 
9.6 Hz, 1 H, 3-H), 5.15 (dd, 3J = 10.6 Hz, 2J = 1.6 Hz, 1 H, -CH2CH=CHcisHtrans), 5.07 (dd, 
J1,2 = 7.9 Hz, J2,3 = 10.4 Hz, 1 H, 2′-H), 4.92 (dd, 1 H, 3′-H), 4.89 (br. dd, J1,2 = 8.0 Hz, J2,3 = 
9.6 Hz, 1 H, 2-H), 4.53-4.42 (2 x d, 2 H, 1-H and 1′-H), 4.34-3.92 (m, 6 H), 3.84 (brt, J5,6a = 
J5,6b = 6.8 Hz, 1 H, 5′-H), 3.77 (t, J3,4 = J4,5 = 9.3 Hz, 1 H, 4-H), 3.63-3.50 (m, 1 H, 5-H), 2.11, 
2.09, 2.02, 2.01 (x 2), 2.00, 1.92 (7 x s, 21 H, 7 x –COCH3) ppm. 13C NMR (50 MHz, 
CDCl3): δ = 170.2 (x 2), 170.0, 169.8, 169.6, 169.4, 168.8, 133.2, 117.5, 100.9 (C-1′), 99.2 
(C-1), 76.2, 72.8, 72.5, 71.6, 70.9, 70.6, 69.9, 69.1, 66.6, 62.0, 60.8, 20.6 ppm. C29H40O18: 
calcd C 51.48, H 5.96; found C 51.13, H 5.78. 
 
 Allyl 2,3,4,6-tetra-O-acetyl-β-D-
galactopyranosyl-(1→4)-3,6-di-O-acetyl-α-D-
glucopyranoside (26B). Oil. [α]25D = +62.3 (c 
1.2, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 
5.97-5.80 (m, 1 H, -CH2CH=CH2), 5.37-5.15 (m, 
4 H, 4′-H, -CH2CH=CH2, 3-H), 5.06 (dd, J1,2 = 7.6 Hz, J2,3 = 10.4 Hz, 1 H, 2′-H), 4.89 (dd, 
J3,4 = 3.3 Hz, 1 H, 3′-H), 4.86 (d, J1,2 = 3.4 Hz, 1 H, 1-H), 4.47 (d, 1 H, 1′-H), 4.40 (dd, J5,6a = 
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5.6 Hz, J6a,6b = 11. 6 Hz, 1 H, 6a-H), 4.21-3.80 (m, 7 H, 6b-H, 6′-H2, 5- H, OCH2-CH=CH2 
and 2-H), 3.64 (t, J3,4 = J4,5 = 9.6 Hz, 1 H, 4-H), 3.56-3.47 (bt, J 5,6a = J5,6b = 7.8 Hz, 1 H, H-
5′), 2.74 (brs, 1 H, 2-OH), 2.11, 2.08 (x 2), 2.01 (x 2), 1.92 (6 x s, 18 H, 6 x –COCH3) ppm. 
13C NMR (50 MHz, CDCl3): δ = 170.6, 170.2, 170.1, 170.0, 169.9, 168.9, 133.0, 118.3, 100.8 
(C-1′), 97.0 (C-1), 76.1, 73.2, 70.9, 70.3, 68.9 (x 2), 68.3, 66.5, 62.0, 60.7 (x 2), 20.7, 20.5 
ppm. C27H38O17: calcd C 51.10, H 6.04; found C 50.95, H 5.83.  
 
Allyl 2-(fluorenyl)methyloxycarbonyl-3,4,6-tri-O-acetyl-
α,β-D-glucopyranoside (29B). To a solution of 4B (248 mg, 
0.72 mmol) in anhydrous DCM (8 mL) were sequentially 
added pyridine (0.64 mL, 8.0 mmol) and FmocCl (259 mg, 
1.0 mmol). When the reaction was complete (ca 3 h), the mixture was diluted with DCM and 
washed with water. The aq phase was re-extracted with DCM, and the collected organic 
phases were dried and concentrated under vacuo. The residue was purified by silica-gel flash 
chromatography (eluent: petroleum ether/ethyl acetate mixtures) to yield 29B (oil, 311 mg, 76 
% yield) as an anomeric mixture (α/β 6:1). 29B α-anomer, 1H NMR (300 MHz, CDCl3): δ = 
7.80-7.28 (aromatic protons), 5.97-5.82 (m, 1 H, -CH2CH=CH2), 5.59 (t, J2,3 = J3,4 = 9.7 Hz, 1 
H, 3-H), 5.34 (dq, 3J = 17.2 Hz, 2J = 4J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.22 (dq, 3J = 
10.3 Hz, 2J = 4J = 1.5 Hz, 1 H, -CH2CH=CHcisHtrans), 5.17 (d, J1,2 = 3.6 Hz, 1 H, 1-H), 5.09 (t, 
J3,4 = J4,5 = 9.7 Hz, 1 H, 4-H), 4.79 (dd, 1 H, 2-H), 4.44-4.01 (m, 8 H), 2.10, 2.04, 2.01 (3 x s, 
9 H, 3 x –COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.3, 169.8, 169.6, 154.1, 143.0, 
142.9, 141.1 (x 2), 132.9, 127.8-119.9, 118.1, 94.6 (C-1), 73.8, 70.2, 69.9, 68.8, 68.5, 67.3, 
61.7, 46.4, 20.5, 20.4 ppm. Significative signals of the β-anomer, 1H NMR (300 MHz, 
CDCl3): δ = 5.32 (t, J2,3 = J3,4 = 9.7 Hz, 1 H, 3-H), 5.11 (t, J4,5 = 9.7 Hz, 1 H, 4-H), 4.88 (br. 
dd, J1,2 = 7.9 Hz, 1 H, 2-H), 4.64 (d, 1 H, 1-H), 3.76-3.68 (m, 1 H, 5-H), 2.09, 2.03, 1.97 (3 x 
s, 9 H, 3 x –COCH3) ppm. C30H32O11: calcd C 63.37, H 5.67; found C 63.14, H 5.75. 
 
2-(Fluorenyl)methyloxycarbonyl-3,4,6-tri-O-acetyl-D-
glucopyranose  (30B). To a solution of 29B (320 mg, 0.56 
mmol) in 4:1 DCM/MeOH (5 mL), was added PdCl2 (13 mg, 
0.07 mmol). The mixture was stirred for 10 h at rt, 
concentrated, resuspended in DCM/MeOH 95:5, and then filtered through a short pad of 
silica-gel. The filtered liquor was concentrated and the residue purified by silica-gel flash 
chromatograhphy (eluent: petroleum ether/ethyl acetate mixtures) to yield 30B (oil, 193 mg, 
O
AcO
AcO
FmocO
AcO
OAll
O
AcO
AcO
FmocO
AcO
OH
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65 % yield) as an anomeric mixture (α:β 3.5). 30B α-anomer,1H NMR (300 MHz, CDCl3): δ 
= 7.80-7.28 (aromatic protons), 5.61 (t, J2,3 = J3,4 = 9.7 Hz, 1 H, 3-H), 5.50 (bs, 1 H, 1-H), 
5.09 (t, J3,4 = J4,5 = 9.6 Hz, 1 H, 4-H), 4.78 (dd, J1,2 = 3.6 Hz, 1 H, 2-H), 4.40-4.04 (m, 6 H), 
2.07, 2.02, 1.99 (3 x s, 9 H, 3 x –COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.8, 170.1, 
169.7, 154.2, 143.0, 142.9, 141.1 (x 2), 127.8-120.0, 89.8 (C-1), 74.3, 70.2, 69.7, 68.4, 67.0, 
61.8, 46.4, 20.6 ppm. Significative signals of the β-anomer, 1H NMR (300 MHz, CDCl3): δ = 
5.32 (t, J2,3 = J3,4 = 9.7 Hz, 1 H, 3-H), 3.79-3.71 (m, 1 H, 5-H) ppm. C27H28O11: calcd C 61.36, 
H 5.34; found C 61.12, H 5.18. 
 
2-O-(Fluorenyl)methyloxycarbonyl-3,4,6-tri-O-
acetyl-α,β-D-glucopyranosyl 
(N-Phenyl)trifluoroacetimidate (31B). 
To a solution of 30B (106 mg, 0.20 mmol) in acetone 
(4 mL) were sequentially added at 0 °C Cs2CO3 (74 mg, 0.23 mmol) and (N-
phenyl)trifluoroacetimidoyl chloride (50 mL, 0.40 mmol). The mixture was allowed to warm 
to rt and after 1 h from the start the solvent was removed under vacuo. The residue was 
purified via column chromatography on neutral aluminium oxide (Brockman grade 2, eluent: 
petroleum ether/ethyl acetate mixtures) to yield 31B (oil, 119 mg, yield 85%) as  an anomeric 
mixture (α/β 2.5:1). 31B α-anomer, 1H NMR (300 MHz, CDCl3): δ = 7.80-6.75 (aromatic 
protons), 6.74 (bs, 1 H, H-1), 5.66 (t, J2,3 = J3,4 = 9.9 Hz, 1 H, 3-H), 5.23 (t, J4,5 = 9.9 Hz, 1 H, 
4-H), 5.05 (dd, J1,2 = 3.3 Hz, 1 H, 2-H), 4.50-4.10 (m, 6 H), 2.14, 2.11, 2.09 (3 x s, 9 H, 3 x –
COCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.3, 169.7, 169.4, 154.0, 143.0, 142.8, 
141.2, 128.7, 127.9, 127.1, 125.0, 124.5, 120.0, 119.1, 91.8 (C-1), 73.0, 70.6, 67.6, 61.2, 46.3, 
20.5 ppm. Significative signals of the β-anomer, 1H NMR (300 MHz, CDCl3): δ = 5.90 (bs, 1 
H, H-1), 5.39 (t, J2,3 = J3,4 = 9.9 Hz, 1 H, 3-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 94.2 (C-
1). C35H32F3NO11: calcd C 60.09, H 4.61; found C 59.90, H 4.50. 
 
Methyl 2-O-(fluorenyl)methyloxycarbonyl-3,4,6-tri-O-
acetyl-β-D-glucopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-α-D-glucopyranoside (33B). 
Donor 31B (35 mg, 0.05 mmol) and acceptor 32B (13 mg, 
0.035 mmol) were coevaporated three times in anhydrous 
toluene and then dried in vacuo for 30 minutes. The mixture was then dissolved at 0 °C (ice 
bath) under argon with anhydrous DCE (1 mL) in the presence of freshly activated 4 Å AW 
O
AcO
AcO
FmocO
AcO
O CF3
NPh
O
BnO
O
O
AcO
AcO
FmocO
AcO
OMe
O
O
Ph
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molecular sieves. After stirring for 15 minutes, a solution of Bi(OTf)3 in dioxane (17 mg/mL, 
135 μL, 3.5 μmol) was added. After further 10 minutes the ice bath was removed and the 
mixture was left under stirring until TLC analysis displayed the consumption of the donor (ca 
90 min from the addition of the promoter). The reaction was quenched with pyridine, and the 
mixture was filtered through a short pad of silica gel. The residue from the filtered liquor was 
submitted to silica-gel flash chromatography (eluent: toluene/acetone 7:1) to yield 
disaccharide 32B as a foam (21 mg, 70% yield). 32B: [α]25D = +29.3 (c 1.1, CHCl3). 1H NMR 
(CDCl3, 300 MHz): δ = 7.70-7.20 (aromatic protons), 5.56 (s, 1H, benzylidene acetal CH), 
5.27 (t , J2,3 = J3,4 = 9.7 Hz, 1 H, 3'-H), 5.09 (t, J4,5 = 9.7 Hz, 1 H, 4'-H), 4.97 (d, J1,2 = 7.5 Hz, 
1 H, 1'-H), 4.93 (dd, 1 H, 2'-H), 4..83 (d, J1,2 = 3.6 Hz, 1 H, 1-H), 4.72 (s, 2 H, benzyl CH2), 
4.40 (dd, 3J = 7.8 and 10.5 Hz, 1 H, Fmoc –OCH2CH), 4.32-4.06 (m, 5 H, overlapped 
signals), 3.98 (t, J2,3 = J3,4 = 9.7 Hz, 1 H, 3-H), 3.86 (td, 3J = 4.5 and 9.7 Hz, 1 H, 5-H), 3.80-
3.70 (m, 2 H, 2-H and 6ax-H), 3.70-3.65 (m, 1H, 5'-H), 3.60 (t, 1 H, 4-H), 3.42 (s, 3 H, -
OCH3), 2.09, 2.03, and 1.94 (3 x s, 9 H, , 3 x –COCH3) ppm. 13 C NMR (CDCl3, 75 MHz): δ 
= 170.4, 170.0, 169.2, 169.4, 154.1, 133.1, 143.2, 142.9, 141.2, 138.3, 137.4, 128.9-127.2, 
126.0, 125.0, 129.0, 101.3 (x2) (C-1' and benzylidene acetal CH), 100.1 (C-1), 82.3, 79.5, 
77.7, 77.2, 75.4, 75.2, 72.8, 71.9, 70.2, 69.1, 68.5, 62.2, 61.9, 55.4, 46.5, 20.6, 20.5 (x2). 
C48H50O16: calcd C 65.30, H 5.71; found C 65.05, H 5.53. 
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Chapter C 
A selective and operationally simple approach for removal of 
methoxy-, allyloxy- and benzyloxycarbonyl groups from carbinols. 
 
  
Introduction 
Alkoxycarbonyl groups have long been extensively used in the protection of amino 
functionalities. However their application to carbinol functions is only currently receiving a 
wide interest as it was widely showed in Table 14a, especially in carbohydrate chemistry.1  
 
Name of the alkyl carbonate Structure Cleavage 
Methyl carbonate O
OO R 
Basic solvolysis 
Ethyl carbonate O
OO
R
 
Basic solvolysis 
Methoxymethyl carbonate O
OOO
R
 
Basic solvolysis 
Acid solvolysis 
9-Fluorenylmethyl carbonate 
(Fmoc-OR) 
O OR
O
 
TEA,Py 
Bromoethyl carbonate 
(BEC-OR) 
O
OO
RBr
 
Zn, AcOH 
2-(Methylthiomethoxy)ethyl carbonate  
(MTMEC-OR) 
O
OO
ROS
 
Hg(ClO4)2, 2,4,6-collidine, 
acetone, H2O (9:1); then 
NH3, dioxane, H2O (1:1). 
2,2,2-Trichloroethyl carbonate 
(Troc-OR) 
O
OROCl3C  
Zn, AcOH; Sm, I2, MeOH; 
In, NH4Cl, H2O, MeOH. 
2-(Trimethylsilyl)ethyl carbonate  
(TMSEC-OR, Teoc-OR) 
O
ORO
Me3Si
 
TBAF 0.2 M, THF; 
ZnCl2, DCM. 
Cis-[4-[[(-
Methoxytrityl)sulfenyl]oxy]tetrahydrofu
ran-3-yl]oxy carbonate  
(MTFOC-OR) 
O
ORO
O
TrSO  
I2 0.5 M, Py, H2O 9:1 v:v 
2-(Phenylsulfonyl)ethyl carbonate 
(Psec-OR) O
ORO
S
O
O  
TEA, py 
Isobutyl carbonate O
ORO  
AcOH, reflux 
t-Butyl carbonate (BOC) O
ORO
 
TFA, DCM 
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Vinyl carbonate O
ORO  
Basic hydrolysis 
Allyl carbonate  
(Alloc-OR) 
O
ORO  
Pd(Ph3P)4 (cat.), HCOONH4; 
Pd(Ph3P)4 (cat.), Bu3SnH; 
PdCl2(Ph3P)2 
(cat.), dimedone; 
Pd(Ph3P)4 (cat.), NaBH4, 
EtOH. 
Cinnamyl carbonate O
ORO
Ph
 
-2.3 V, Hg, MeCN 
Propargyl carbonate 
(Poc-OR) 
O
ORO  
[BnNEt3]2MoS4, MeCN 
p-Chlorophenyl carbonate 
(CPC-OR) 
O
OROCl
 
LiOOH, THF/H2O, 0°C 
p-Nitrophenyl carbonate O
OROO2N
 
Imidazole (cat.), 
H2O/dioxane 
4-Ethoxy-1-Naphthyl carbonate 
O
OEt
OR
O
 
-1.6 V, C-anode, 
acetone/H2O 
6-Bromo-7-hydroxycoumarin-4-
ylmethyl carbonate 
(Bhcmoc-OR) 
O O
O
O
OR
Br
HO  
hv, H2O 
Benzyl carbonate 
(Cbz-OR) O
ORO  
H2, Pd/C, EtOH; 
cycloexadiene, Pd/C (cat.), 
DMF; 
-2.7 V, R4NX, DMF; 
Basic hydrolysis; 
CAN or TBAF or TFA or 
HBr or HCl; 
NaBrO3, Na2S2O4, 
AcOEt/H2O. 
o-Nitrobenzyl carbonate 
O
ORO
NO2
 
hv, pH 7 
p-Nitrobenzyl carbonate 
O
ORO
O2N
 
H2, Pd/C, EtOH, dioxane, 
H2O, K2HPO4; 
electrolytic reduction. 
 
p-Methoxybenzyl carbonate 
O
ORO
MeO
 
Ph3CBF4, 0°C; 
DDQ; 
strong acids. 
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3,4-Dimethoxybenzyl carbonate 
O
ORO
MeO
MeO
 
Ph3CBF4, 0°C; 
DDQ; 
strong acids.  
Anthraquinon-2-ylmethyl carbonate 
(Aqmoc-OR) 
O
O
O OR
O
 
hv, H2O/THF 
2-Dansylethyl Carbonate 
(Dnseoc-OR) 
N
SO O
O OR
O  
DBU, MeCN 
2-(4-Nitrophenyl)ethyl carbonate 
(Npeoc-OR) 
O
ORO
O2N
 
hv; 
Basic solvolysis 
2-(2,4-Dinitrophenyl)ethyl carbonate 
(Dnpeoc-OR) O
ORO
O2N
NO2
 
Basic solvolysis 
2-(2-Nitrophenyl)proyl carbonate 
(NPPOC-OR)  O
ORO
NO2
 
hv, MeOH/H2O 
2-Cyano-1-phenylethyl carbonate 
(Cpeoc-OR) O
ORO
NC
O2N  
DBU 0.1 M, MeCN 
Phenacyl carbonate O
O
O
OR
 
hv,  
N-methylcarbazole 
3’,5’-Dimethoxybenzoin carbonate 
(DMB-O2COR) 
O
PhMeO
OMe
RO
O
O
 
hv, THF 
Table 1 
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Other relevant synthetic applications based on the use of alkoxycarbonylated carbinols are: 
• substitutions or rearrangements of O-alkoxycarbonylated allyl alcohols promoted by 
palladium catalysis2 (Figure 1)  
 
Figure 1 
• masking of aldehyde or ketone carbonyl groups via O-methoxycarbonylation of 
cyanohydrins3 (Figure 2).   
Figure 2 
One of the most relevant advantages of alkoxycarbonyl groups is their easy installation on 
carbinols under mild basic conditions compatible with a wide range of functionalities.1 
Alkoxycarbonyl groups can be removed under two different cleavage pathways. The first 
pathway is an acyl nucleophilic substitution process which is the basis of many solvolytic 
methods that confer little advantage to carbonates as protecting groups. In general, the 
conditions needed to attack esters are also efficient for carbonates3 although these latter are 
less reactive than esters towards basic solvolysis owing to the reduced electrophilicity of the 
carbonyl group due to the resonance deactivation generated by two oxygens substituents.4b 
The second pathway is based on a common general mechanism entailing an initial alkyl 
scission followed by spontaneous loss of CO2 (Figure 3).4a In this way, several 
alkoxycarbonyl groups, i.e. allyloxycarbonyl (Alloc), benzyloxycarbonyl (Z), 
fluorenylmethoxycarbonyl (Fmoc) groups, can be selectively removed under specific 
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conditions. Alternative cleavage pathways resembling an acyl nucleophilic substitution have 
instead been applied to de-O-methoxycarbonylation.3,5 
R: Bn, All and others
Sub
O
O
O R
Sub
OH1) Alkylcleavage
2) - CO2
 
Figure 3 Common general mechanism for removal of many alkoxycarbonyl groups from 
alcohols  
Over the last years my research group has been appreciating numerous advantages in using 
the methoxycarbonyl group in carbohydrate chemistry. Actually it can be quantitatively and 
quickly installed on saccharidic carbinols to yield products easily purified by a simple 
extractive work-up. The adopted protocol, based on the use of cheap methyl chloroformate 
and TMEDA, is also suited for the regioselective protection of diols.6 In addition, 
methoxycarbonyl groups can be removed under Zemplen conditions at rates comparable with 
those of acetyls,5 thus representing an effective alternative to the use of sterically encumbered 
acyl groups which are installed and removed under more forced conditions. In this regard, 
methoxycarbonyl was found to serve as an excellent non bulky participating group in 1,2-
trans glycosidations conducted under very mild acidic conditions7 where 1,2-orthoester 
coupling products predominated on adopting conventional acyl protecting groups.8 In 
contrast, in the experience of my research group allyloxy- and benzyloxycarbonyl groups 
were found to be less effective in inducing 1,2-trans selective glycosidations because of their 
trend to furnish undesired cyclic 1,2-carbonates9; differently, 9-fluorenylmethoxycarbonyl 
groups required the best α-selective glycosidation solvent mixture (PhCH3/Et2O 4:1) to afford 
1,2-trans mannosides in high yield and stereocontrol as it will show in Chapter F.  
Due to the emerged manifold advantages of methoxycarbonyl group and in order to expand 
the scope of methoxycarbonyl as transient protecting groups in oligosaccharide synthesis, the 
current work has been spurred by the search for deprotection conditions compatible with the 
stability of acyl protecting groups.  
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Results and discussion 
Since a carboxylic ester possesses a hard center (carboxyl carbon) and a soft center (carbinol 
carbon), using the principles of hard/soft acid base theory,19,20 hard nucleophiles are predicted 
to show a preference for attack on the carboxy carbon (hard-hard interaction) rather than the 
carbinol carbon (hard-soft interaction) (Figure 4).  
 
Figure 4 
 
In evaluating the various hard nucleophiles which are available, “naked” fluoride anion21 is 
one choice. Similarly, pertinent internal bifunctional systems consisting of a hard acid and a 
hard nucleophile should attack the carboxylic ester at the carboxy center rather than at the 
carbinol center and, therefore, accomplish acyl-oxygen cleavage without affecting the 
stereochemistry of a chiral center at the carbinol carbon. On the other hand, the alternative 
approach of cleaving esters via nucleophilic attack at the carbinol carbon under non-
hydrolytic conditions in non-hydroxylic solvents can be employed. Thiophenoxide, 
alkanethiolate, trithio-carbonate, ethanedithiolate, sulfide, phenyl selenide, hydrogen selenide, 
and telluride anions are representative of the soft nuclephile class. Besides, the most widely 
used combination systems, consisting of a hard acid and a soft nucleophile, are: trimethylsilyl 
iodide, aluminium halide-ethanethiol, aluminium halide-dialkyl sulfide, aluminium triiodide, 
magnesium bromide, magnesium iodide, and catechol boron bromide. 
 
Additionally, methyl esters can be cleaved with different reactant system based on: 
 78
1. a Lewis acid in the presence of a nucleophilic additive such as 
AlBr3/tetrahydrothiophene (Figure 5), AlCl3/Me2S;4a 
 
Figure 5 
2. a Lewis acid where a ligand of the acidic species promotes the alkyl cleavage such as 
AlCl3/C6H5N(Me)2, BCl3;4a  
3. a powerful nucleophile reacting in dipolar aprotic solvent such as NaCN/HMPA, 
Cs2CO3/PhSH/DMF, catalytic KF or K2CO3/PhSH/NMP 190°C (Figure 6), n-
PrSLi/HMPA (Figure 7), Ph3SiSH/ Cs2CO3/2,6-di-t-butylcresol/DMF (Figure 8);4a  
 
Figure 6 Ester O-alkyl cleavage are carried out chemoselectively under non-hydrolytic 
neutral condition in high yields. 
 
Figure 7 
 
Figure 8 
4. other reactant system: NaBH4/I2, LiI/Py reflux (Figure 9), (CH)3SiOK/THF (Figure 
10), [MeTeAlMe2]2/toluene (Figure 11), (Bu3Sn)2O/benzene, Me3SnOH/1,2-DCE 
(Figure 12), NaOCH2CH2CN/THF (Figure 13).4a 
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Figure 9 
 
Figure 10 (CH)3SiOK, in ether or in THF, often cleaves methyl esters when conventional 
hydrolysis fails. It was even found effective for cleavage of an ethyl ester when other 
methods failed. Hindered esters are cleaved with this reagent. 
 
Figure 11 
 
Figure 12 
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Figure 13 This method was used to prevent formation of coumarin i. 
Because of the obvious structural analogy between a methyl ester and a methyl carbonate, the 
most practical methodologies were investigated out of those described for cleaving methyl 
esters by an alkyl scission mechanism. A single example of methoxycarbonyl removal from a 
phenol with the system thiophenol/cesium carbonate in DMF is indeed reported,10 but in 
preliminary experiments it did not prove very effective on such densely functionalized 
substrates as 1C and 2C (Scheme 1). On the other hand, use of LiI in either refluxing ethyl 
acetate11 or refluxing pyridine12 appeared as an experimentally more convenient alternative. 
Both protocols were thereby initially examined on model compounds 1C and 2C purposely 
protected with a methoxycarbonyl adjacent to an acetylated position (Scheme 1). 
 
OOO
Ph
OMeRO
MeO2CO
OOO
Ph
OMeMeO2CO
RO
OOO
Ph
OMeRO
HO
OOO
Ph
OMeHO
RO
LiI, solvent
reflux
or
+
1C R: Ac
3C R: Bz
2C R: Ac
4C R: Bz
5C R: Ac
7C R: Bz
6C R: Ac
8C R: Bz
Overall yields higher than 75%
Regioisomeric ratio in the range 0.5-2  
Scheme 1 Removal of methoxycarbonyl groups from O-acylated model substrates.   
As a matter of fact, use of high-boiling pyridine was found necessary to guarantee a high 
yielding deprotection within short times, whereas longer reaction times and higher amounts of 
LiI were needed in refluxing ethyl acetate. Not unexpectedly, in all cases the desired 
deprotections were accompanied by rearrangement processes, so that, regardless of the 
structure of the starting compound, comparable amounts of 2-O- and 3-O-acetylated products 
were observed (Scheme 1). Interestingly, the extent of the acyl transfer was not significantly 
reduced when the vicinal acetyl group was replaced by the benzoyl functionality, well known 
for being much more reluctant to rearrangement processes (Scheme 1).13 Reasoning that the 
initially produced lithium alkoxide intermediate might cause the aforementioned 
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transacylation, a stoichiometric excess of an acid as weak as acetic acid (5 eq) was added to 
the reaction medium containing a lower excess of LiI (3 eq) with the aim of minimizing the 
transacylation process. As a matter of fact, this simple procedural modification led to a 
significant reduction of the acetyl transfer (compare Scheme 1 and Table 2, entries 1-2) 
whereas the intramolecular trans-benzoylation was practically suppressed with the gluco-
precursors 3C and 4C (Table 2, entries 3-4). In contrast, the benzoyl shift could not be 
avoided in the manno-precursor 15C due to the syn-relation of O-2 and O-3 (entry 7). These 
improved conditions were then tested on a range of protected saccharidic derivatives (Table 
2). The protocol proved effective at removing methoxycarbonyl group in the presence of a 
variety of different functionalities widely adopted in carbohydrate chemistry, including amino 
sugars N-derivatized with an acetyl (entry 5), a Troc (entry 8) and a phtalimido group (see 
below in Scheme 2). The procedure also worked well for removing allyloxy- and 
benzyloxycarbonyl groups (entries 11 and 12), as expected from an alkyl substitution 
mechanism. Interestingly, a benzyloxycarbonyl (Z) could be smoothly cleaved in the presence 
of a benzylidene (entry 11), whereas the routinely used hydrogenolytic removal1f of the 
benzyloxycarbonyl group would affect the benzylidene functionality. Furthermore, other 
functions sensitive to hydrogenolysis conditions, benzyl and allyl ethers, were instead stable 
under the here proposed conditions (entries 5, 6, 9). Very interestingly, reaction in entry 13 
shows that tert-buthoxycarbonyl (t-Boc) also proved to be a cleavable protecting group under 
the optimized conditions, even though in this case the direct involvement of the iodide anion 
in the scission step should be excluded on the basis of steric considerations. The procedure 
was operationally very simple and in all cases reactions took a few hours (generally less than 
4 hours). Besides the deprotection products, unreacted starting material generally represented 
the main saccharidic component of the crude reaction mixture. Removal of a 
methoxycarbonyl from the nitrogen of 1,3,4,6-O-acetyl glucosamine was also attempted and 
resulted in the recovery of the starting material to indicate the chemoselectivity of the 
reported conditions.14 
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Table 2 Removal of alkoxycarbonyl groups by the LiI/AcOH system. 
Entry Substrates Products and yield Time (min) 
AcO
OOO
Ph
OMe
BnO2CO
O
AcO
O
O
Ph
OMe
HO
O
HO
O
O
Ph
OMe
AcO
O
MeO2CO
O
O
Ph
OMe
AcO
O
AcO
O
O
Ph
OMe
HO
O
HO
O
O
Ph
OMe
AcO
O
BzO
O
O
Ph
OMe
MeO2CO
O
MeO2CO
O
O
Ph
OMe
BzO
O
BzO
O
O
Ph
OMe
HO
O
AcHN
BnO
AcO
MeO2CO
OAll O
AcHN
BnO
AcO
HO OAll
O
AcHN
BnO
HO
AcO OAll
O
MeO2CO
BnO
AcO
MeO2CO
OMe
O
HO
BnO
AcO
HO
OMe
O
HO
BnO
HO
AcO
OMe
O
HO
O
O
Ph
OMe
BzO
O
AcO
O
O
Ph
OMe
MeO2CO
OOO
Ph
OMe
BzO
OCO2Me OOO
Ph
OMe
BzO
OH
OOO
Ph
OMe
HO
OBz
O
TrocHN
O
O
Ph
OAll
MeO2CO
O
TrocHN
O
O
Ph
OAll
HO
O
MeO2CO
BnO
BnO
BnO
OAll
O
HO
BnO
BnO
BnO
OAll
O
AcO
O
O
OCO2Me
OMP
O
AcO
O
O
OH
OMP
O
AcO
O
O
Ph
OMe
HO
O
HO
O
O
Ph
OMe
AcO
O
AcO
O
O
Ph
OMe
HO
O
HO
O
O
Ph
OMe
AcO
OOO
Ph
OMe
AcO
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Ph
OMe
HO
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HO
O
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Ph
OMe
HO
OOO
Ph
OMe
AllO2CO
tBocO
1
1C 5C 6C
100
2
2C 6C 5C
90
 65% 19%
70% 17%
3
3C
4 4C
180
120
7C
8C
72%
86%
5a
9C 10C 11C
90
6b
12C 13C 14C 100
 72% 18%
59% 12%
7
15C
8
18C
16C
19C
39%
76%
17C34% 300
240
9
20C 21C75% 240
10
22C 23C 74%
150
11
24C 5C 6C
160
12
25C 6C 5C
60
 68% 13%
73% 17%
13
26C 27C 28C
300
62% 18%
 
General conditions: LiI (3 eq), AcOH (5 eq), pyridine, reflux. a Regiosiomers obtained as an 
inseparable mixture. Yields evaluated by 1H NMR.  bConditions: LiI (6 eq), AcOH (10 eq), 
pyridine, reflux. Minor regioisomer 14C could not be separated from the major one (13C). 
Yields evaluated by 1H NMR. 
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The feasible selective removal of methoxycarbonyl group was usefully exploited in the 
synthesis of protected trisaccharide 35C, a common trisaccharide motif incorporated into N-
glycans. In pursuing our interest for the use of moisture stable glycosidation promoters, initial 
coupling between galactosyl donor 29C and acceptor 30C was best performed under the 
activation of catalytic Yb(OTf)3 added as a solution in pivalonitrile (Scheme 2).15 The 
reaction afforded in satisfying yield (64 %) the desired 4-O-linked disaccharide 31C together 
with minor amounts (ca 10%) of the 3-O-linked disaccharide.16 Acetylation of 31C yielded 
protected lactosamine 32C that was then submitted to the proposed de-O-
methoxycarbonylation protocol to give 33C in a very good yield (84 %). This latter was 
coupled with the fucosyl donor 34C under catalytic activation with Bi(OTf)317 to yield the 
desired trisaccharide building-block 35C in high yield and α-selectivity. 
 
O
MeO2CO
OBnBnO
O
BnO
NPh
CF3
OBnOHO
NPht
HO
OAll
O
MeO2CO
OBnBnO
BnO O
BnO
O
NPht
RO
OAll
O
HO
OBnBnO
BnO O
BnO
O
NPht
AcO
OAll
O
OBnOBn
OBn
O
NPh
CF3
O
O
OBnBnO
BnO O
BnO
O
NPht
AcO
OAll
O
OBnOBn
OBn
+
31C R: H
32C R: Ac (quant)
29C
30C
Yb(OTf)3 (0.10 eq) 
in tBuCN, 
DCE, -10 to rt
Py, Ac2O
LiI (3.5 eq),
Py reflux
33C
34C
Bi(OTf)3 (0.05 eq) 
in dioxane, 
DCM/Et2O, -70 to rt
35C
64 %
84 %
86 % (α/β 8:1)  
Scheme 2 Synthesis of trisaccharide 35C. 
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Conclusions  
In conclusion in this chapter it has been described an operationally simple approach18 for the 
selective removal of methoxy-, allyloxy- and benzyloxycarbonyl carbonyl groups from 
alcohols. Combined use of LiI and acetic acid minimizes or even suppresses concomitant 
trans-acylation processes. In addition, this procedure is compatible with a wide range of 
functional groups which could be otherwise affected under previously reported cleavage 
conditions. The developed protocol offers a very useful option in designing synthetic routes 
towards highly functionalized carbohydrate targets. 
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Experimental Section 
General methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded 
in CDCl3 (internal standard, for 1H: CHCl3 at δ 7.26; for 13C: CDCl3 at δ 77.0) on Varian 
spectrometers at 200 or 500 MHz and 50 or 125 MHz, respectively, or on a Bruker Avance 
400 spectrometer at 400 MHz. The chemical shifts are given in parts per million (ppm) on the 
delta (δ) scale. 1H NMR assignments were based on homo-decoupling experiments. MALDI-
MS spectra were recorded in the positive mode: compounds were dissolved in acetonitrile at a 
concentration of 0.1 mg/mL and one microliter of these solutions were mixed with one 
microliter of a 20 mg/mL solution of 2,5-dihydroxybenzoic acid in 7:3 CH3CN/H2O. 
Analytical thin layer chromatography (TLC) was performed on aluminium plates precoated 
with Silica Gel 60 F254 as the adsorbent. The plates were developed with 5% H2SO4 ethanolic 
solution and then heating to 130°C. Column chromatography was performed on Kieselgel 60 
(63-200 mesh). When specified, anhydrous solvents stored over molecular sieves (purchased 
from Aldrich) were used. Glycosidation promoters bismuth(III) triflate and ytterbium(III) 
triflate were coevaporated three times in toluene and dried under vacuum for 30-45 minutes 
before being dissolved in the presence of freshly activated 4Å with dioxane and pivalonitrile, 
respectively.  
Methyl 2-O-acetyl-4,6-O-benzylidene-α-D-
glucopyranoside (5C). White solid; [α]26D +107.5° (c 1.2, 
CHCl3). Lit22: [α]D +108.7° (c 3, CHCl3). M.p. 132-133 °C, 
1H NMR (400 MHz, CDCl3) δ 7.50-7.30 (aromatic protons), 
5.53 (s, 1H, benzylidene acetal CH), 4.93 (d, J1,2 = 3.6 Hz, 
1H, H-1), 4.78 (1H, t, J2,3 = 9.6 Hz, H-2), 4.28 (1H, dd, J5,6eq = 4.0 Hz, J6eq,6ax = 10.0 Hz, H-
6eq), 4.15 (1H, t, J3,4 = 10.0 Hz, H-3), 3.85 (1H, td, J4,5 = J5,6ax = 10.0 Hz, H-5), 3.74 (1H, t, H-
6ax), 3.65 (1H, dd, H-2), 3.53 (1H, t, H-4), 3.39 (3H, s, 1-OCH3), 2.14 (3H, s, -COCH3). 13C 
NMR (100 MHz, CDCl3) δ 170.7 (-COCH3), 136.9 (aromatic C); 129.2, 128.3 and 126.2 
(aromatic CH); 101.9 (benzylidene acetal CH), 97.4 (C-1), 81.2, 73.5, 68.8, 68.5, 61.9, 55.3 
(1-OCH3), 20.08 (-COCH3). [M + Na]+ calculd 347.11, found 347.25. Anal. Calcd. for 
C16H20O7: C, 59.25, H, 6.22. Found: C, 59.00; H, 6.34. 
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Methyl 3-O-acetyl-4,6-O-benzylidene-α-D-
glucopyranoside (6C). White solid; [α]26D +111.5° (c 1.0, 
CHCl3). M.p. 175-176 °C (lit23 176-177 °C). 1H NMR (400 
MHz, CDCl3) δ 7.40-7.30 (aromatic protons), 5.49 (1H, s, 
benzylidene acetal CH), 5.32 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3), 4.80 (1H, d, J1,2 = 3.6 Hz, H-1), 
4.30 (1H, dd, J5,6eq = 4.8 Hz, J6eq,6ax = 10.0 Hz, H-6eq), 3.85 (1H, td, J4,5 = J5,6ax = 10.0 Hz, H-
5), 3.75 (1H, t, H-6ax), 3.65 (1H, dd, H-2), 3.58 (1H, t, H-4), 3.46 (3H, s, 1-OCH3), 2.12 (3H, 
s, -COCH3). 13C NMR (100 MHz, CDCl3) δ 171.1 (-COCH3), 137.0 (aromatic C); 129.1, 
128.2 and 126.2 (aromatic CH); 101.5 (benzylidene acetal CH), 100.1 (C-1), 78.6, 72.3, 71.8, 
68.9, 62.7, 55.6 (1-OCH3), 21.0 (-COCH3). [M + Na]+ calculd 347.11, found 347.30. Anal. 
Calcd. for C16H20O7: C, 59.25, H, 6.22. Found: C, 59.06; H, 6.37. 
  
Methyl 2-O-benzoyl-4,6-O-benzylidene-α-D-
glucopyranoside (7C). White solid; [α]26D +113.0° (c 1.1, 
CHCl3). Lit1: [α]24D +118.3° (c 2.1, CHCl3). M.p. 170-171 
°C (lit24 170.3-170.6 °C). 1H NMR (400 MHz, CDCl3) δ 
8.10-7.35 (aromatic protons), 5.57 (1H, s, benzylidene acetal CH), 5.08 (1H, d, J1,2 = 3.6 Hz, 
H-1), 5.05 (1H, dd, J2,3 = 9.6 Hz, H-2), 4.37-4.30 (2H, overlapped signals, H-3 and H-6eq), 
4.02 (1H, td, J4,5 = J5,6ax = 10.0 Hz, J5,6eq = 4.8 Hz, H-5), 3.79 (1H, t, J6ax,6eq = 10.0 Hz, H-6ax), 
3.62 (1H, t, H-4), 3.39 (3H, s, 1-OCH3). 13C NMR (100 MHz, CDCl3) δ 165.2 (-COPh), 137.0 
and 133.3 (aromatic C); 129.9, 129.5, 129.2, 128.4, 128.3, 128.1, 126.3 (aromatic CH); 102.0 
(benzylidene acetal CH), 97.8 (C-1), 81.4, 74.1, 68.9, 68.8, 62.0; 55.4 (1-OCH3). [M + Na]+ 
calculd 409.13, found 409.05. Anal. Calcd. for C21H22O7: C, 65.28, H, 5.74. Found: C, 65.05; 
H, 5.90. 
  
Methyl 3-O-benzoyl-4,6-O-benzylidene-α-D-
glucopyranoside (8C). White solid; [α]26D +36.5° (c 1.3, 
CHCl3). M.p. 215-216 °C (lit3 216.6-217.0 °C). 1H NMR 
(400 MHz, CDCl3) δ 8.10-7.30 (aromatic protons), 5.60 (1H, 
t, J2,3 = J3,4 = 9.6 Hz, H-3), 5.53 (1H, s, benzylidene acetal CH), 4.86 (1H, d, J1,2 = 3.6 Hz, H-
1), 4.34 (1H, dd, J5,6eq = 3.6 Hz, J6eq,6ax = 10.0 Hz, H-6eq), 3.95 (1H, td, J4,5 = J5,6ax = 10.0 Hz, 
H-5), 3.90-3.70 (3H, overlapped, H-2, H-4 and H-6ax), 3.49 (3H, s, 1-OCH3). 13C NMR (100 
MHz, CDCl3) δ 166.6 (-COPh), 136.9 and 133.0 (aromatic C); 129.8, 128.9, 128.2, 128.1, 
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126.1 (aromatic CH); 101.5 (benzylidene acetal CH), 99.5 (C-1), 78.8, 73.0, 72.0, 68.9, 62.7; 
55.5 (1-OCH3). [M + Na]+ calculd 409.13, found 409.25. Anal. Calcd. for C21H22O7: C, 65.28, 
H, 5.74. Found: C, 65.10; H, 5.85.  
 
Allyl 2-acetamido-4-O-acetyl-6-O-benzyl-2-deoxy-β-D-
glucopyranoside (10C). 1H NMR (400 MHz, CDCl3) δ 7.30-
7.25 (aromatic protons), 5.90-5.75 (1H, m, -CH=CH2), 5.26 
(1H, bd, Jtrans = 17.2 Hz, -CH=CHcisHtrans), 5.17 (1H, bd, Jcis = 10.2 Hz, -CH=CHcisHtrans), 4.86 
(1H, t, J3,4 = J4,5 = 9.6 Hz, H-4), 4.62 (1H, d, J1,2 = 8.8 Hz, H-1), 4.53 and 4.49 (2H, 2xd, Jgem = 
12.0 Hz, -CH2Ph), 4.35-4.30 (1H, m, -CHaHbCH=CH2), 4.10-4.05 (1H, m, -CHaHbCH=CH2), 
3.95-3.85 (1H, m, H-3), 3.65-3.50 (4H, overlapped signals, H-2, H-5 and H2-6), 1.99 and 1.97 
(6H, 2xs, 2x –COCH3). 13C NMR (50 MHz, CDCl3) δ 172.1 and 170.5 (2x –COCH3), 155.2 (-
CO2CH3), 137.7 (aromatic C), 133.6 (-CH=CH2), 128.3 and 127.7 (aromatic CH), 117.7 (-
CH=CH2), 99.3 (C-1), 73.4 (x2), 72.4, 72.1, 69.8, 69.2; 57.7 (C-2), 23.3 (–NHCOCH3), 20.8 
(–OCOCH3). 10C and 11C were obtained as an inseparable mixture (10C/11C 4:1).  
 
Allyl 2-acetamido-3-O-acetyl-6-O-benzyl-2-deoxy-β-D-
glucopyranoside (11C). Significant signals of BF: 1H NMR (400 
MHz, CDCl3) δ 5.03 (1H, t, J = 9.2 and 10.4 Hz, H-3), 2.07 and 
1.92 (6H, 2xs, 2x –COCH3). [M + Na]+ calculd 416.12, found 416.00. Anal. Calcd. for 
C20H27NO7: C, 61.06, H, 6.92. Found: C, 60.85; H, 6.85. 
 
Methyl 3-O-acetyl-6-O-benzyl-α-D-glucopyranoside (14C). 
Significant signals: 1H NMR (400 MHz, CDCl3) δ 5.06 (1H, t, J2,3 = 
J3,4 = 9.6 Hz, H-3), 4.78 (1H, d, J1,2 = 3.5 Hz, H-1), 4.63-4.55 (2H, 
AB, J = 12.0 Hz, -CH2Ph), 3.44 (3H, s, -OCH3), 2.14 (3H, s, -COCH3). Compound 14C could 
not be separated from the major regioisomer 13C. 
 
Methyl 4-O-acetyl-6-O-benzyl-α-D-glucopyranoside (13C). Oil, 
[α]28D +81.7° (c 1.2, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.35-
7.25 (aromatic protons), 4.93 (1H, t, J3,4 = J4,5 = 10.0 Hz, H-4), 4.82 
(1H, d, J1,2 = 3.5 Hz, H-1), 4.59 and 4.50 (2H, AB, J = 12.0 Hz, -
CH2Ph), 3.90-3.80 (1H, m, H-5), 3.81 (1H, t, J2,3 = 9.5 Hz, H-3), 3.63 (1H, bdd, H-2), 3.56-
3.49 (2H, m, H2-6), 3.44 (3H, s, -OCH3), 3.14 and 2.77 (2H, 2x bs, OH-2 and OH-3), 1.98 
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(3H, s, -COCH3). 13C NMR (125 MHz, CDCl3) δ 170.8 (-COCH3), 137.7 (aromatic C); 128.3, 
127.8, and 127.7 (aromatic CH), 99.0 (C-1), 73.4, 72.8, 72.6, 71.1, 68.7, 68.5, 55.4 (1-OCH3), 
20.8 (-COCH3). [M + Na]+ calculd 349.13, found 349.34. Anal. Calcd. for C16H22O7: C, 
58.89, H, 6.79. Found: C, 58.70; H, 6.91. 
 
Methyl 3-O-benzoyl-4,6-O-benzylidene-α-D-
mannopyranoside (16C). Solid, [α]28D -22.3° (c 1.0, 
CHCl3). Lit25: [α]D .-24° (c 1.3, CH2Cl2). M.p. 131-132 °C 
(lit3 131-132 °C). 1H NMR (400 MHz, CDCl3) δ 8.00-7.25 
(aromatic protons), 5.61 (1H, s, benzylidene acetal CH), 5.54 (1H, bd, J3,4 = 10.0 Hz, H-3), 
4.77 (1H, bs, H-1), 4.35-4.25 (3H, overlapped signals; H-2, H-4, and H-6 eq), 4.05-3.95 (1H, 
m, H-5), 3.91 (1H, t, H-6ax), 3.43 (3H, s, -OCH3). 13C NMR (100 MHz, CDCl3) δ 165.6 
(COPh), 137.2 and 133.2 (aromatic C); 129.8, 128.9, 128.4, 128.3, and 126.0 (aromatic CH), 
101.8 and 101.6 (benzylidene acetal CH and C-1), 76.0, 71.5, 69.5, 68.8, 63.7, 55.0 (1-OCH3). 
[M + Na]+ calculd 409.13, found 409.27. Anal. Calcd. for C21H22O7: C, 65.28, H, 5.74. 
Found: C, 65.02; H, 5.90.  
  
Methyl 2-O-benzoyl-4,6-O-benzylidene-α-D-
mannopyranoside (17C). Foam, [α]27D -35.2° (c 1.0, 
CHCl3). 1H NMR (500 MHz, CDCl3) δ 8.10-7.40 (aromatic 
protons), 5.66 (1H, s, benzylidene acetal CH), 5.46 (1H, bd, 
J1,2 = 1.5 Hz, J2,3 = 3.4 Hz, H-2), 4.84 (1H, d, H-1), 4.38-4.30 (2H, overlapped signals), 4.04 
(1H, t), 3.96-3.86 (2H, overlapped signals), 3.43 (3H, s, -OCH3). 13C NMR (125 MHz, 
CDCl3) δ 168.0 (COPh), 137.1 and 133.4 (aromatic C); 129.9-128.3, and 126.2 (aromatic 
CH), 102.2 and 99.6 (benzylidene acetal CH and C-1), 79.4, 72.5, 68.8, 67.4, 63.3, 55.2 (1-
OCH3). [M + Na]+ calculd 409.13, found 409.08. Anal. Calcd. for C21H22O7: C, 65.28, H, 
5.74. Found: C, 65.08; H, 5.85.    
 
Allyl 4,6-O-benzylidene-2-deoxy-2-[(2,2,2-
trichloroethoxy)carbonylamino]-α-D-glucopyranoside 
(19C). Solid, [α]28D +55.4° (c 1.0, CHCl3). Lit26: [α]D .+59.5° 
(c 1.04, CHCl3). M.p. (MeOH) 167-168 °C (lit5 168 °C). 1H 
NMR (400 MHz, CDCl3) δ 7.50-7.20 (aromatic protons), 6.00-5.80 (1H, m, -CH=CH2), 5.55 
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(1H, s, benzylidene acetal CH), 5.38 (1H, d, JNH,2 = 8.0 Hz, 2-NH), 5.31 (1H, bd, Jtrans = 17.2 
Hz, -CH=CHcisHtrans), 5.24 (1H, bd, Jcis = 10.4 Hz, -CH=CHcisHtrans), 4.93 (1H, d, J1,2 = 2.8 
Hz, H-1), 4.82 and 4.68 (2H, AB, Jgem = 10.8 Hz, -CH2CCl3), 4.27 (1H, dd, J5,6eq = 4.4 Hz, 
J6ax,6eq = 10.0 Hz, H-6 eq), 4.23-4.18 (1H, m, -CHaHbCH=CH2), 4.05-4.00 (1H, m, -
CHaHbCH=CH2), 4.00-3.80 (3H, overlapped signals), 3.75 (1H, t, J = 10.2 Hz), 3.57 (1H, t, J 
= 9.2 Hz). 13C NMR (100 MHz, CDCl3) δ 154.8 (-NHCOCH2CCl3), 137.0 (aromatic C), 
133.2 (-CH=CH2), 129.3, 128.4, and 126.4 (aromatic CH), 118.3 (-CH=CH2), 101.9 
(benzylidene acetal CH), 97.0 (C-1), 81.8, 74.7, 69.8, 68.7, 68.6 62.6; 55.7 (C-2). [M + Na]+ 
calculd 504.04, found 504.17. Anal. Calcd. for C19H22Cl3NO7: C, 47.27, H, 4.59. Found: C, 
47.08; H, 4.70. 
 
 Allyl 3,4,6-tri-O-benzyl-α-D-glucpyranoside (21C). Solid, [α]28D 
+86.7° (c 1.0, CHCl3). Lit27: [α]D +93.3° (c 1, CHCl3). M.p. 71-72 
°C (lit6 71.5-73.5 °C). 1H NMR (400 MHz, CDCl3) δ 7.50-7.00 
(aromatic protons), 6.00-5.80 (1H, m, -CH=CH2), 5.33 (1H, dq, Jtrans 
= 17.2 Hz, -CH=CHcisHtrans), 5.23 (1H, bd, Jcis = 9.2 Hz, -CH=CHcisHtrans), 4.98 (1H, d, J1,2 = 
3.6 Hz, H-1), 5.00-4.50 (6H, 3x AB, 3x –CH2Ph), 4.35-4.20 (1H, m, -CHaHbCH=CH2), 4.10-
4.05 (1H, m, -CHaHbCH=CH2), 3.85-3.75 (4H, overlapped signals), 3.75-3.65 (2H, 
overlapped signals). 13C NMR (100 MHz, CDCl3) δ 138.6, 138.1, and 137.9 (aromatic C), 
133.5 (-CH=CH2), 128.3-127.6 (aromatic CH), 117.8 (-CH=CH2), 97.5 (C-1), 83.3, 77.4, 
75.3, 74.9, 73.4, 72.9, 70.6, 68.4 (x2). [M + Na]+ calculd 513.24, found 513.33. Anal. Calcd. 
for C30H34O6: C, 73.45, H, 6.99. Found: C, 73.21; H, 7.05. 
  
p-Methoxyphenyl 2-O-acetyl-3,4-O-isopropylidene-β-D-
galactopyranoside (23C). Oil, [α]28D +16.2° (c 1.3, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 6.95-6.75 (aromatic protons), 
5.20 (1H, t, J1,2 = J2,3 = 8.0 Hz, H-2), 4.82 (1H, d, H-1), 4.30-
4.17 (2H, overlapped signals, H-3 and H-4), 4.55-3.90 (2H, m, H-5 and H-6a), 3.75 (3H, s,–
OCH3), 2.12 (3H, s, -COCH3), 1.59 and 1.34 (6H, 2xs, isopropylidene methyls). 13C NMR 
(100 MHz, CDCl3) δ 169.6 (-COCH3), 155.3 and 151.0 (aromatic C); 118.1 and 114.5 
(aromatic CH), 110.9 (-C(CH3)2), 99.5 (C-1), 77.0, 73.6 (x2), 72.5, 62.0, 55.5 (-OCH3), 27.5 
and 26.3 (-C(CH3)2), 21.2 (-COCH3). [M + Na]+ calculd 349.14, found 349.32. Anal. Calcd. 
for C16H22O7: C, 58.89, H, 6.79. Found: C, 58.81; H, 6.93. 
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Methyl 4,6-O-benzylidene-α-D-glucopyranoside (27C). 
1H NMR (400 MHz, CDCl3) δ 7.55-7.30 (aromatic protons), 
5.51 (1H, s, benzylidene acetal CH), 4.73 (1H, d, J1,2 = 4.0 
Hz, H-1), 4.27 (1H, dd, J5,6eq = 4.4 Hz, J6eq,6ax = 9.6 Hz, H-
6eq), 3.90 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3), 3.78 (1H, td, J5,6eq = 5.6 Hz, J4,5 = J5,6ax = 10.0 Hz, 
H-5), 3.71 (1H, t, H-6ax), 3.58 (1H, dd, H-2), 3.45 (1H, t, H-4), 3.42 (3H, s, 1-OCH3). 13C 
NMR (100 MHz, CDCl3) δ 137.0 (aromatic C); 129.2, 128.3 and 126.3 (aromatic CH); 101.9 
(benzylidene acetal CH), 99.9 (C-1), 80.9, 72.7, 71.4, 68.9, 62.3, 55.4 (1-OCH3). [M + Na]+ 
calculd 405.15, found 405.20. Anal. Calcd. for C14H18O6: C, 59.57, H, 6.43. Found: C, 59.30; 
H, 6.35. 
 
Methyl 2-O-tert-butoxycarbonyl-4,6-O-benzylidene-α-D-
glucopyranoside (28C). 1H NMR (400 MHz, CDCl3) δ 
7.55-7.30 (aromatic protons), 5.54 (1H, s, benzylidene acetal 
CH), 5.00 (1H, d, J1,2 = 3.6 Hz, H-1), 4.58 (1H, dd, J2,3 = 9.6 
Hz H-2), 4.28 (1H, dd, J5,6eq = 4.4 Hz, J6eq,6ax = 9.6 Hz, H-6eq), 4.18 (1H, t, J3,4 = 9.6 Hz, H-3), 
3.84 (1H, td, J5,6eq = 4.8 Hz, J4,5 = J5,6ax = 10.0 Hz, H-5), 3.75 (1H, t, H-6ax), 3.55 (1H, t, H-4), 
3.40 (3H, s, 1-OCH3), 1.50 (9H, s, -C(CH3)3). 13C NMR (100 MHz, CDCl3) δ 152.9 (CO), 
136.9 (aromatic C); 129.1, 128.2 and 126.2 (aromatic CH); 101.9 (benzylidene acetal CH), 
97.5 (C-1), 82.9, 81.1, 75.9, 68.7, 68.5, 62.0, 55.3 (1-OCH3), 27.6 (-C(CH3)3). [M + Na]+ 
calculd 405.16, found 405.25.  
 
Allyl 2-O-methoxycarbonyl-3,4,6-tri-O-
benzyl-β-D-galactopyranosyl-(1→4)-6-O-
benzyl-2-deoxy-2-(phthalimido)-β-D-
glucopyranoside (31C). A mixture of donor 
29C7 (84 mg, 0.12 mmol) and diol 30C28 (36 mg, 84 μmol) was coevaporated three times 
with anhydrous toluene (3 x 2 mL), and then dried in vacuo for 30 minutes. After adding 4Å 
AW 300 MS, the mixture was dissolved under argon with DCE (2 mL), cooled to -10 °C, and 
stirred for 15 min. A solution of Yb(OTf)3 in pivalonitrile (0.047 M, 0.2 mL, 9.4 μmol) was 
then added, and the mixture was allowed to gradually warm to rt. After two hours the reaction 
was quenched with some drops of pyridine and the mixture filtered on a short plug of silica 
gel repeatedly washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, 
and the residue purified by silica-gel flash-chromatography (eluent: petroleum ether/ethyl 
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acetate from 3:1 to 7:3) to yield disaccharide 31C as an oil (50 mg, 64 % overall yield). Foam. 
[α]27D +4.8° (c 0.87, CHCl3). 1H NMR (500 MHz, CDCl3) δ 7.90-7.15 (aromatic protons), 
5.80-5.65 (1H, m, -CH=CH2), 5.22 (1H, d, J1,2 = 8.5 Hz, H-1), 5.17 (1H, t, J1,2 = J2,3 = 8.5 Hz, 
H-2′), 5.12 (1H, bd, Jtrans = 18.0 Hz, -CH=CHcisHtrans), 5.03 (1H, bd, Jcis = 10.0 Hz, -
CH=CHcisHtrans), 4.95-4.20 (8H, 4x AB, 4x -CH2Ph), 4.47 (1H, bt, J2,3 = J3,4 = 10.0 Hz, H-3), 
4.39 (1H, d, H-1′), 4.30-4.20 (2H, overlapped signals, H-2 and -CHaHbCH=CH2), 4.05 (1H, 
bdd, Jvic = 6.0 Hz, Jgem = 13.0 Hz, -CHaHbCH=CH2), 3.85 (1H, bd, J3,4 = 2.5 Hz, H-4′), 3.81 
(3H, s, -CO2CH3), 3.80-3.65 (4H, overlapped signals), 3.70-3.40 (3H, overlapped signals). 13C 
NMR (100 MHz, CDCl3) δ 167.9 (phtalimido CO), 155.1 (–CO2CH3); 138.5, 138.0, 137.6, 
137.3 (aromatic C); 133.8 (-CH=CH2), 128.7-123.3 (aromatic CH), 117.2 (-CH=CH2), 101.7 
(C-1′), 97.3 (C-1), 82.7, 82.2, 75.6, 74.5, 74.1, 73.7, 73.6, 73.2, 74.5 (x2), 69.7, 69.6, 68.5, 
68.3; 55.9 and 55.0 (C-2 and –OCH3). [M + Na]+ calculd 952.35, found 952.50. Anal. Calcd. 
for C53H55NO14: C, 68.45, H, 5.96. Found: C, 68.21; H, 5.85.  
 
Allyl 2-O-methoxycarbonyl-3,4,6-tri-O-
benzyl-β-D-galactopyranosyl-(1→4)-3-O-
acetyl-6-O-benzyl-2-deoxy-2-(phthalimido)-
β-D-glucopyranoside (32C). To a solution of 
disaccharide 31C (39 mg, 0.042 mmol) in pyridine (0.8 mL) was added acetic anhydride (0.4 
mL) and the solution was kept overnight at rt . The mixture was diluted with DCM and the 
organic phase was washed with water. The organic phase was dried with sodium sulphate, 
concentrated in vacuo and the residue was repeatedly coevaporated with toluene to give 
disaccharide 32C (41 mg, quantitative yield) which was directly submitted to the next 
deprotection step. [α]23D +15.4° (c 1.5, CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.90-7.15 
(aromatic protons), 5.80-5.65 (1H, m, -CH=CH2), 5.71 (1H, dd, J2,3 = 10.4, J3,4 = 9.6 Hz, H-3), 
5.37 (1H, d, J1,2 = 8.4 Hz, H-1), 5.12 (1H, qd, Jtrans = 16.8 Hz, -CH=CHcisHtrans), 5.03 (1H, bd, 
Jcis = 10.0 Hz, -CH=CHcisHtrans), 5.01 (1H, dd, J1,2 = 8.0 Hz, J2,3 = 10.0 Hz, H-2′), 4.70-4.35 
(8H, 4x AB, 4x -CH2Ph), 4.43 (1H, d, H-1′), 4.30-4.25 (1H, m, -CHaHbCH=CH2), 4.24 (1H, 
dd, H-2), 4.05-4.00 (1H, m, -CHaHbCH=CH2), 4.01 (1H, t, J4,5 = 9.6 Hz, H-4), 3.89 (1H, bd, 
J3,4 = 2.8 Hz, H-4′), 3.90-3.75 (2H, m, 3.79 (3H, s, -CO2CH3), 3.70-3.65 (1H, m, H-5), 3.60-
3.48 (2H, m, H2-6′), 3.37-3.34 (2H, overlapped signals, H-3′ and H-5′), 1.75 (3H, s, -COCH3). 
13C NMR (100 MHz, CDCl3) δ 170.0 (–COCH3), 167.8 (phtalimido CO), 154.9 (–CO2CH3); 
138.5, 138.3, 137.8, 137.7 (aromatic C); 133.6 (-CH=CH2), 128.4-127.2 (aromatic CH), 117.4 
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(-CH=CH2), 100.6 (C-1′), 97.1 (C-1), 80.5, 76.0, 75.7, 74.6, 74.4, 73.4, 73.2, 73.1, 72.5, 72.0, 
71.3, 70.0, 68.0, 67.8, 55.0, 54.9, 20.5 (–COCH3). [M + Na]+ calculd 994.37, found 994.65.  
 
Allyl 3,4,6-tri-O-benzyl-β-D-
galactopyranosyl-(1→4)-3-O-acetyl-6-O-
benzyl-2-deoxy-2-(phthalimido)-β-D-
glucopyranoside (33C). Disaccharide 32C (41 
mg, 0.042 mmol) and LiI (20 mg, 0.15 mmol) were dissolved in pyridine (0.4 mL) and to the 
resulting solution was added acetic acid (12.5 μL, 0.21 mmol). The resulting mixture was 
refluxed for 4 hours, afterthen the reaction vessel was cooled to rt. The mixture was diluted 
with DCM and the organic phase was washed with water. The aqueous phase was re-extracted 
with DCM and ethyl acetate. Collected organic phases were dried and concentrated in vacuo 
to give a residue which was purified by silica gel flash-chromatography (eluent: petroleum 
ether/ethyl acetate 7:3) to yield 33C (32 mg, 84 %) as a foam. Foam. [α]26D +25.0° (c 1.2, 
CHCl3). 1H NMR (400 MHz, CDCl3) δ 7.85-7.10 (aromatic protons), 5.78 (1H, dd, J2,3 = 10.4, 
J3,4 = 9.2 Hz, H-3), 5.80-5.65 (1H, m, -CH=CH2), 5.37 (1H, d, J1,2 = 8.4 Hz, H-1), 5.13 (1H, 
bd, Jtrans = 17.2 Hz, -CH=CHcisHtrans), 5.03 (1H, bd, Jcis = 10.4 Hz, -CH=CHcisHtrans), 4.90-4.35 
(8H, 4x AB, 4x -CH2Ph), 4.35 (1H, d, J1,2 = 7.6 Hz, H-1′), 4.35-4.20 (2H, overlapped signals -
CHaHbCH=CH2 and H-2), 4.15-4.00 (3H, overlapped signals; H-2, H-6a and -
CHaHbCH=CH2), 3.89 (1H, bd, J3,4 = 2.4 Hz, H-4′), 3.88-3.80 (2H, overlapped signals, H-6b 
and H-2′), 3.78-3.73 (1H, m, H-5), 3.57 (1H, t, J5,6a = J6a,6b = 8.8 Hz, H-6′a), 4.53-3.40 (2H, 
overlapped signals, H-5 and H-6′b), 3.34 (1H, dd, J2,3 = 9.6 Hz, H-3′), 1.76 (3H, s, -COCH3). 
13C NMR (100 MHz, CDCl3) δ 170.2 (-COCH3), 167.9 (phtalimido CO), 138.6, 138.1 (x2), 
137.9, 137.7 (benzyl aromatic C); 133.6 (-CH=CH2), 128.7-123.3 (aromatic CH), 117.4 (-
CH=CH2), 103.3 (C-1′), 97.3 (C-1), 81.6, 76.0, 74.4, 73.4 (x3), 72.8, 72.2, 71.7 (x2), 70.0, 
68.3, 68.1, 54.9 (C-2), 20.5 (-COCH3). [M + Na]+ calculd 936.37, found 936.62. Anal. Calcd. 
for C53H55NO13: C, 69.65, H, 6.07. Found: C, 69.32; H, 5.95. 
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Allyl 2,3,4-tri-O-benzyl-α-L-
fucopyranosyl-(1→2)-3,4,6-tri-O-benzyl-
β-D-galactopyranosyl-(1→4)-3-O-acetyl-
6-O-benzyl-2-deoxy-2-(phthalimido)-β-D-
glucopyranoside (35C). A mixture of 
donor 34C7 (35.2 mg, 0.056 mmol) and 
acceptor 33C (26.0 mg, 0.028 mmol) was 
coevaporated three times with anhydrous toluene (3 x 2 mL), and then dried in vacuo for 30 
minutes. After adding 4Å AW 300 MS, the mixture was dissolved under argon with 
DCM/Et2O 4:1 (1.5 mL) at -10 °C, and stirred for 15 min. The mixture was then cooled to -70 
°C and a solution of Bi(OTf)3 in dioxane (0.019 M, 75 μL, 1.4 μmol) was then added. The 
mixture was allowed to gradually warm to rt and after 4.5 hours the reaction was quenched 
with some drops of pyridine and the mixture filtered on a short plug of silica gel repeatedly 
washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, and the residue 
purified by silica-gel flash-chromatography (eluent: toluene/ethyl acetate from 9:1 to 7:1) to 
yield trisaccharide 35C as a foam (32.5 mg, α/β 8:1, 86 % overall yield). 1H NMR (500 MHz, 
CDCl3) δ 7.85-7.10 (aromatic protons), 5.78 (1H, dd, J2,3 = 10.4, J3,4 = 9.2 Hz, H-3), 5.80-5.65 
(1H, m, -CH=CH2), 5.66-5.62 (2H, overlapped signals, H-1′′ and H-3), 5.34 (1H, d, J1,2 = 8.5 
Hz, H-1), 5.14 (1H, bd, Jtrans = 17.5 Hz, -CH=CHcisHtrans), 5.05 (1H, bd, Jcis = 10.5 Hz, -
CH=CHcisHtrans), 5.00-4.35 (14H, 7x AB, 7x -CH2Ph), 4.37 (1H, d, J1,2 = 7.6 Hz, H-1′), 4.35-
4.25 (3H, overlapped signals), 4.10-4.00 (4H, overlapped signals), 3.90 (1H, bd, J3,4 = 2.4 Hz, 
H-4′), 3.85-3.65 (4H, overlapped signals), 3.60-3.45 (4H, overlapped signals), 3.40 (1H, t, J = 
6.5 Hz), 1.69 (3H, s, -COCH3), 1.31 (3H, d, J5,6 = 7.0 Hz, H3-6′′). 13C NMR (100 MHz, 
CDCl3) δ 170.3 (-COCH3), 167.9 (phtalimido CO); 139.0, 138.9, 138.6 (x2), 138.2, 138.0, 
137.8 (benzyl aromatic C); 134.0 (bs, aromatic phtalimido C), 133.6 (-CH=CH2), 128.7-123.3 
(aromatic CH), 117.3 (-CH=CH2), 103.4 (C-1′), 97.5 and 97.1 (C-1 and C-1′′), 84.0, 79.2, 
78.2, 75.8, 75.6, 74.8, 74.4, 73.5, 72.9, 72.8, 72.5, 72.2, 72.1, 71.0, 70.8, 70.0, 68.2, 68.0, 
66.5, 54.8 (C-2), 20.5 (-COCH3). [M + Na]+ calculd 1352.57, found 1352.70. Anal. Calcd. for 
C80H83NO17: C, 72.22, H, 6.29. Found: C, 72.01; H, 6.50 
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Chapter D 
Easy and versatile approach for regioselective de-O-benzylation of 
protected sugars based on the I2/Et3SiH combined system. 
 
Introduction 
Benzyl is one of the most used protecting groups in organic synthesis for carbinol 
derivatization.1 Several advantages justify the popularity of this protecting group: a) the 
protection step can occur under either acidic or basic conditions; b) a benzyl group can be 
installed on the multiple sites of molecules equipped with several functional groups such as 
carbohydrates; c) the protecting group is stable to a wide range of chemical conditions and is 
removable under mild conditions.1 Hydrogenolysis is the commonest option for de-O-
benzylation and it is especially suitable for the total deprotection of poli-O-benzylated 
substrates. Consequently, benzyl protecting groups are frequently employed in organic 
synthesis for polihydroxylated targets and their removal is often performed at advanced stages 
of the synthetic schemes. Protected carbohydrates are frequently exploited as convenient 
precursors of chiral compounds2 through synthetic schemes routinely relying on O-benzylated 
intermediates. In addition, the use of O-benzylated saccharidic derivatives is also functional in 
tuning the reactivity of carbohydrate building-blocks in glycosidation chemistry: a large 
number of examples highlights the “arming” effect of benzyl groups on both glycosyl donors 
and acceptors in comparison with the depressed reactivity of sugars equipped with 
“disarming” acyl groups.3 Furthermore, benzyl groups are also widely used in 
stereocontrolled glycosidations where protecting but non-participating groups are needed on 
the glycosyl donor.4  
Rapid access to partially protected building-blocks is one of the most important goals5 in 
modern organic synthesis: on this regard, several procedures of regioselective de-O-
benzylation of densely O-benzylated saccharidic precursors have been described in the 
literature. Among these, only a few examples are relying on controlled hydrogenolysis,6 
whereas most approaches require acidic conditions. Indeed, the regioselecetive de-O-
benzylation of saccharidic compounds can be effected with stoichiometric amounts of strong 
and sensitive Lewis acids such as SnCl4 or TiCl4,7 (Figure 1) excess amounts of alanes 
(DIBAL, TIBAL, etc) at high temperatures8,9 (Figure 2) or under microwave activation,10 
BCl3 at low temperature,11 excess amounts of CrCl2 and LiI at high temperature.12  
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Figure 2 
 
In these cases regioselectivity is critically dependent on the possibility of the saccharidic 
substrate to generate a chelated structure with the Lewis acid present in each reagent system, 
whereas benzyl removal is accomplished by a nucleophilic agent introduced either as the 
counter anion of the chelated metal or as an independent species. Chelation control can also 
serve in regioselective de-O-benzylation of non-saccharidic substrates under acidic 
conditions.13 Other regioselective de-O-benzylation approaches for carbohydrates are 
requiring pre-existence of suitable functionalities, such as a free hydroxyl group14 (Figure 3) 
or an allyl group,15 adjacent to the site to be O-deprotected (Figure 4).  
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Very recently Crich and Vinogradova have shown that highly benzylated manno- and 
rhamno- derivatives can be deprotected with moderate selectivity at O-4 by treatment with a 
stoichiometric oxidant as DDQ16 (Figure 5).  
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Figure 5 Facile oxidative cleavage of 4-O-benzyl ethers with dichlorodicyanoquinone in 
Rhamno- and Mannopyranosides.  
 
Primary positions can be de-O-benzylated (and concomitantly triethylsilylated) with 
excellent regioselectivity on prolonged exposure of benzylated mono-, di- and trisaccharides 
to the Et3SiH/Co2(CO)8 combined system at high temperature under CO.17 Acetolysis is 
another approach often leading to selective de-O-benzylation (and concomitant acetylation) of 
primary positions, but in this case cleavage of glycosidic bonds can be a potential trouble.18 
TMSI has also been reported to produce selective de-O-benzylation of primary carbinols (via 
the corresponding trimethylsilyl ethers).19  
In this chapter it was described the wide and unprecedented scope of the I2/Et3SiH 
combined system in regioselective de-O-benzylation of sugars. This reagent permits the 
smooth generation of anhydrous HI and several useful applications were already established 
in our laboratory: for example, the combination of I2 (stoichiometric) and Et3SiH (catalytic) 
turned out to be an effective activating system for trihaloacetimidate glycosyl donors20 and it 
was successively exploited by Takahashi and co-workers in their protocols aimed at the 
stereoselective synthesis of 2,6-dideoxy β-glycosides.21 An analogous stoichiometric 
combination of these reagents in methanol was also found effective for the cleavage of 
benzylidene acetals.22 Additionally, stoichiometric amounts of both I2 and Et3SiH allow 
glycosyl iodides to be generated from 1-O-acylated precursors within a few minutes: as it was 
shown in Chapter B, this rapid step has been incorporated into several sequential procedures 
leading to a variety of useful saccharidic intemediates such as 1,2-orthoesters,23 -
ethylidenes,23 glycals,23 thio- and seleno-glycosides,24 2-O-deprotected allyl glycosides,25 as 
well as glycoconjugates with estradiol26 or melanogenic 5,6-dioxyindole.27 Further 
synthetically useful applications of I2/Et3SiH were also reported by other groups for the 
regioselective reductive opening of benzylidenes,28 the reductive Ferrier rearrangement of 
glycals,29 and the  Friedel-Crafts cyclization of aryl-substituted propargyl alcohols.30 
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Reaction of Et3SiH and I2 provides HI and Et3SiI under very simple experimental 
conditions.31 Given that HI and Me3SiI are known agents for ether cleavage,19,32,33 the feasible 
application of the convenient I2/Et3SiH system in the deprotection of carbohydrates has been 
explored, with a special focus on the difficult issue of regioselective de-O-benzylation  of 
sugars.   
 
Results and discussion 
Preliminary experiments examined the behaviour of tetra-O-benzylated methyl α-
glycopyranosides in the presence of a slight stoichiometric excess of I2 and Et3SiH in DCM. 
The regioselective de-O-benzylation of these substrates immediately appeared as a feasible 
task when working at low temperature. Galactoside 1D displayed high propensity to be 
deprotected at O-4 (Scheme 1) and it was chosen as the model compound for optimizing 
several experimental parameters such as the order of addition of reagents, their stoichiometry, 
the reaction temperature (Table 1). These experiments evidenced the effectiveness of the 
most experimentally convenient procedure (addition of Et3SiH to a preformed DCM solution 
containing I2 and the substrate). Other solvents such as toluene, 1,2-dichloroethane, 
acetonitrile and dioxane were found much less suitable for the purpose as sluggish reactions 
were observed. Investigation on the stoichiometry of the reagents revealed that a slight excess 
of both of them is required for obtaining high conversion of the starting material (compare 
entries 4-8 with entries 1-3). Use of less than one equivalent of either reagent provided 
incomplete de-O-benzylation (entries 1, 2) to suggest that only HI, and not Et3SiI, is 
responsible for deprotection (see below for other evidences on this point). The temperature 
range was found critical for maximizing the yield while allowing the reaction to proceed at an 
elevated rate. Actually, TLC analysis suggested that further deprotection of mono de-O-
benzylated products was competitive enough with the initial de-O-benzylation step of the 
fully protected saccharidic reagent. Thus, temperature control of the reaction medium was 
pivotal for tuning the course of all these potential processes. Under the optimized conditions 
(entry 6), D-galacto precursor 1D provided the 4-OH derivative 2D in an appreciable isolated 
yield (60 %) in only 15 minutes at the temperature range of -20 – -10 °C. Upon further 
warming the yield of 2D decreased owing to formation of higher amounts of multiple de-O-
benzylation products. In comparison with other known procedures for regioselective de-O-
benzylation of sugars, the here proposed approach looked advantageous under several aspects 
such as reaction rapidity, use of a slight stoichiometric excess of cheap and easy to handle 
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reagents, and recourse to non demanding experimental precautions (no inert atmosphere was 
actually required for high yields to be achieved). 
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Scheme 1 Regioselective de-O-benzylation of model compound 1D. 
 
Table 1: optimization of de-O-benzylation conditions. 
Entry Eq of I2 Eq of Et3SiH T(°C) Time 
(min) 
Isolated yield of 2D 
(%) (conversion) 
1 0.5 0.5 -20 60 29 
2 0.5 1.0 -20 to -5 60 35 (42) 
3 1.0 1.0 -20 to -15 50 43 
4 1.25 1.25 -25 to 0 60 48 
5 1.25 a 1.25 a -20 30 45 (67) 
6 1.25 1.25 -20 to -10 15 60 
7 1.25 1.25 -20 15 50 
8 1.25 1.25 -15 15 55 
General conditions: Et3SiH was added at the indicated temperature to a solution of 1D and 
I2 in anhydrous DCM. The reaction was quenched at the final temperature by addition of 
pyridine. a I2 and Et3SiH were premixed in DCM and the resulting solution was added to 1D 
dissolved in DCM. 
 
The procedure was then applied to gluco- and manno- precursors 3D and 4D (Table 2). 
Predominance of the the 4-OH regioisomer was again recorded but in both cases the 
corresponding 3-OH regioisomer was isolated together with the main product as an 
inseparable mixture. The regioselectivity ratio was strongly dependent on the precursor and 
 103
was much higher for the manno precursor 4D (7D/8D 8:1) than for the gluco derivative 3D 
(5D/6D 3.8:1). Interestingly, in these cases de-O-benzylation started at lower temperatures 
than with the galacto precursor, but gradual warming of the reaction medium ensured the 
completion in relatively short times.   
 
Table 2: De-O-benzylation of tetra-O-benzylated gluco- and manno-pyranoside precursors. 
Entry Reagent Time 
(min) 
T (°C) Products, combined yields 
(conversion), regiosomeric ratio 
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HO
BnO
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HO
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BnO
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1
3D
5
4D
5D 6D
7D 8D
+
+
70
75
-55 to -30
- 40 to -10
43 % (56 %), 5D:6D 3.8
44 % (60 %), 7D:8D 8
2 270 -55 to -30
41 % (61 %), 5D:6D 2.5
3D3a 265 -60 to -20 31 %, 5D:6D 3
3D4a 170 -60 to -30 29 %, 5D:6D 2
3D
 
General conditions: Et3SiH (1.25 eq) was added to a solution of 3D or 4D and I2 (1.25 eq) 
in anhydrous DCM at the starting temperature. The reaction was quenched at the final 
temperature by addition of pyridine. a Experiment was performed in DCM/n-Exhane 9:1. b 
Experiment was performed in the presence of  activated 4Å MS. 
 
It is also significant that the inseparable mixture of 7D and 8D was recently obtained in a 
sensibly lower yield (31 %) and regioselectivity (7D:8D less than 5) upon treatment of 4D 
with DDQ.16a Other saccharidic precursors bearing multiple benzyl protecting groups have 
been then screened and further interesting results emerged (Table 3). Like α-methyl 
glycosides (Tables 1 and 2), α-allyl glycosides proved compatible with the protocol 
(compare entry 1 of Table 3, with entry 6 of Table 1) thus offering a useful extension of the 
reaction scope in view of the wider chemical versatility of allyl aglycons. The stability of allyl 
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groups installed on non-anomeric carbinols also led to an improved regioselectivity in de-O-
benzylation of manno-configured sugars, for which partially O-allylated precursors can be 
effectively prepared by stannylidene-mediated protections.34 As shown in entries 2 and 3 of 
Table 3, 4-O deprotection of 3-O-allylated derivatives 11D and 13D occurred in satisfying 
yield and high regioselectivity: unlike the behaviour of the corresponding 3-O-benzylated 
counterpart 4D (Table 2, entry 2), no products freed at 3-OH were detected from these 3-O-
allylated precursors.  
Rather surprising was the result obtained from allyl lactoside 15D (Table 3, entry 4) which 
was deprotected in a very good yield at O-3 (gluco moiety) rather than at the expected 
position O-4′ (galacto moiety). This outcome eluded the trend inferred from entries in Tables 
1 and 2 (predominance of 4-OH products in all cases), and the previously observed higher 
reactivity of glucose vs galactose (compare activation temperatures in Tables 1 and 2) was 
initially considered to account for the apparently anomalous result. This hypothesis was 
immediately contradicted by results obtained from other disaccharide precursors 17D, 19D, 
and 21D (Table 3, entries 5-7): regardless of the nature of saccharidic components, these 
compounds were still selectively deprotected at a secondary carbinol of the reducing terminus 
adjacent to the glicosidic bond. Very interestingly, the 3-O-linked manno disaccharide 21D 
(entry 7) was preferentially deprotected at the axial O-2, cis-oriented to the encumbered 3-O-
glycosylated position, rather than at O-4. Notably, the deprotection yields of disaccharides 
were typically higher than with monosaccharide precursors despite the larger number of 
potential deprotection events. Also worthy of note is the stability of the glycosidic linkages on 
the disaccharides under the employed acidic conditions, despite the “arming” effect of the 
benzyl protecting groups that is expected to facilitate the acid-promoted scission of inter-
saccharidic linkages.35  
As with monosaccharides and disaccharide precursors, furanoside derivatives also displayed 
a peculiar regioselectivity trend. Glucofuranoside 23D (Table 3, entry 8) was selectively de-
O-benzylated to give the 5-OH regiosiomer 24D in a yield (58 %) comparable with that 
obtained with TiCl4.7b This was the only found case where the Et3SiH/I2 system gave both 
yield and regioselectivity similar to other previously established procedures. 
Mannofuranoside 25D (Table 3, entry 9) was also debenzylated at O-5, but in this case the 
putative furanoside intermediate free at O-5 evolved to give pyranoside 26D36 free at O-4 and 
minor amounts of an unidentified product (ca 10%) with neither a free hydroxyl group nor the 
allyl aglycon.37  
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Table 3: Regioselective de-O-benzylation of pyranoside or furanoside monosaccharides, and 
disaccharides. 
Entry Reagent T (°C) and time Products and isolated 
yields (conversion) 
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2
3
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4
5
6
15D
17D
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25D
18D
22D
26D
7
19D 20D
8
9
11D
12D
13D
14D
67 %
- 40 to - 25
50 min
- 60 to 0
2.5 h
- 65 to - 5
2.5 h
 -15
25 min
- 60 to - 20
1 h
- 60 to - 20
1.5 h
- 65 to +  10
2.5 h
- 60 to - 20
1 h
- 60 to - 20
75 min
51 %
48 %
83 %, (97 %)
73 % (93 %)
96 %
67 %
58 %
55 %
 
General conditions: Et3SiH (1.25 eq) was added to a solution of the benzylated sugar and I2 
(1.25 eq) in anhydrous DCM at the starting temperature. The reactions were quenched by 
addition of pyridine (entries 1-3) or solid NaHCO3 (2.5-5 eq) at the final temperature. 
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At this stage, a general survey of the obtained results and their comparison with previously 
reported approaches indicated an unprecedented direction of regioselectivity. As mentioned 
above, only 4-O deprotection of monosaccharides was somehow resemblant of the results 
described by Crich (stoichiometric DDQ), whose applicability is however restricted to date 
only to manno- and rhamno-configured substrates. 16a 
In order to better explain the origin of the obtained regioselectivity, some investigation was 
devoted to ascertain whether HI was the actual agent responsible of the deprotection. To this 
purpose, galacto precursor 1D was treated with a mixture of I2 and propandithiol according to 
the procedure described by Koreeda and coworkers some years ago for the in situ generation 
of anhydrous HI.38 As expected, the reaction afforded once more the free 4-OH galacto 
derivative 2D in high yield upon exposure to 0.6 eq of I2 and 1.2 eq of propandithiol (Scheme 
2). Under these conditions the reaction rate and the yield were both similar to those observed 
with I2 and Et3SiH.  
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DCM, -20 °C to -10 °C,
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Scheme 2 Regioselective de-O-benzylation of model compound 1D with I2 and 
propandithiol. 
 
This outcome supports the hypothesis that the in situ generated HI acts as the actual de-O-
benzylation agent.32 On the other hand, the negligible contribution of Et3SiI to the process is 
supported by the reported stability at 0 °C of saccharide benzyl ethers upon exposure to 
Me3SiI (reasonably more reactive than Et3SiI in ether cleavage) under the conditions adopted 
for the synthesis of glycosyl iodides of per-O-benzylated sugars.39 Additionally, in sharp 
contrast with all the results found with the I2/Et3SiH system, the regioselectivity of Me3SiI-
mediated de-O-benzylations leads to preferential modification of the sterically more 
accessible primary positions.19 As a matter of fact, only in the reaction described in entry 3 of 
Table 3 did we isolate minor amounts (5 %) of the 4-O-triethylsilylated ether of 14D. 
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On the basis of these evidences and according to a well established general mechanism of 
ether scission,32b HI is expected to activate the benzyloxy group by O-protonation to favour 
the subsequent benzyl removal by nucleophilic attack by the iodide anion (and release of the 
alcohol). Consistently, benzyl iodide was isolated as a by-product of the reactions. 
Once identified the actual promoter of the process, some consideration was made to 
rationalize the origin of the observed regioselectivity. Unlike many of the previously reported 
methods operating under Lewis acid conditions, HI-induced de-O-benzylation can not be 
regioselectively controlled by chelation effects. On the other hand, it can be observed that in 
all examined cases the liberation of the least accessible carbinols was favored and in no case 
O-benzylated primary positions were significantly affected.  Thus, a reasonable mechanistic 
sketch could suggest that initial HI-promoted O-protonation might occur reversibly at the 
most basic secondary benzyloxy groups, and the following de-O-benzylation step, promoted 
by the nearby iodide anion, may be somehow kinetically controlled by the relief of the steric 
strain associated with the expulsion of the benzyl group. This effect could account for either 
the preferential deprotection (Tables 1 and 2) at the 4-O-position, the most encumbered for 
pyranoside monosaccharides, and the highest level of regioselectivity associated with the 
removal of the axially oriented galactose 4-O-benzyl group (compare Table 1 and 2). 
Furthermore, the apparently anomalous behaviour of disaccharide derivatives (Table 3, 
entries 4-7) can actually be consistent with this hypothesis if the steric crowding around the 
benzylated carbinol group flanking a glycosidation site is acknowledged. A similar reasoning 
can also rationalize the liberation of 5-OH on the furan derivatives (Table 3, entries 8 and 9), 
which fortuitously, in the case of entry 8, provides a result similar to a de-O-benzylation 
occurring under chelation control of the regioselectivity. Some literature cases of acid-
promoted ether or acetal scissions seem to be governed by the “steric strain release effect” 
here invoked.40 
To further extend the substrate scope of the reaction, other kind of precursors such as 2,3,4-
tri-O-benzylated 6-deoxy pyranosides οr β-configured 2,3,4,6-tetra-O-benzylated 
glycopyranosides were exposed to the I2/Et3SiH system. Initial experiments appeared 
frustrating as complex mixtures were obtained (TLC analysis). However, upon pyridine or 
lutidine quenching, the TLC profile of the reaction mixtures got almost simpler and most 
products displayed higher mobility than during the course of the reaction. This apparently 
strange observation was ascribed to the feasible “in situ” generation of glycosyl iodide 
intermediates as a consequence of the higher anomeric reactivity of 6-deoxyglycosides and β-
O-linked glycosides, which could result in a fast HI-promoted expulsion of the aglycon 
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alcohol. Glycosyl iodides of “armed” densely O-benzylated sugars are poorly stable, so that 
they are very likely degraded under the TLC elution conditions to give more polar hydrolysis 
products. Experiments conducted with varied amounts of I2 and Et3SiH evidenced that 
anomeric iodination was faster than de-O-benzylation at any site, and thus part of the 
I2/Et3SiH reagent was consumed for this process. Interestingly, quenching of the reactions 
with bases as mild as pyridine or lutidine induced the reattachment of the initial aglycon 
alcohol with poor selectivity, so to give mixtures of α and β glycosides starting from 
anomerically pure substrates. These observations led us to foresee that addition of sufficient 
amounts of I2 and Et3SiH could induce a concomitant de-O-benzylation process together with 
the faster anomeric iodination. Thus, upon quenching the reaction would yield partially 
protected derivatives as anomeric mixtures. This overall result could be indeed very useful if 
the synthetic elaboration of the sugar entails subsequent removal of the aglycon, as for 
example in the preparation of glycosyl donors for oligosaccharide synthesis. 
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Table 4: Regioselective de-O-benzylation of 6-deoxy glycopyranosides and monosaccharide β-pyranosides 
Entry Reagent T (°C)  
and time 
Quenching 
conditions 
Products  
and yields (conversion) 
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A
1
27D
34D
39D
28D  (α/β 10)
2 27D 28D  (α/β 1)
3 27D
27D
29D
4
30D  (β/α 10)
5
6
31D
31D
32D  (α/β 1.5)
33D  (α/β 1)
7
8
40
35D R1: H, R2: OBn
36D R1: OBn, R2: H
37D
-60 to 0
2 h
-60 to 0
2 h
-60 to 0
2 h
-60 to 0
1 h
42 % (52 %)
40 % (50 %)
38 % (43 %)
57%
61 %
67 %a
28D
17 % (20 %)
31 % (35D/36D ca 2)
19 %a
-65 to 0
2 h
-65 to 0
2 h
-25 to -5
1 h
-30 to -15
40 min
46D %
9
+
50 % (62 %)38D
10D  (α/β 1)
-60 to - 10
80 min
 
General conditions: Et3SiH (1.8 eq) was added at the starting temperature to a solution of the benzylated 
sugar and I2 (1.8-2.1 eq) in anhydrous DCM. The mixture was allowed to warm up to the final temperature. The 
reaction was quenched at the final temperature according to the following conditions A-D, and then the reaction 
vessel was allowed to warm to rt. Condition A: allyl alcohol (5 eq) and NaHCO3 (5 eq); B: allyl alcohol (5 eq) 
and lutidine (5 eq); C: sat aq sodium carbonate; D: solution of lutidine (7 eq) and acetic acid (4 eq) in DCM. 
aProduct slightly contaminated by an unidentified regiosomer.  
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After several experiments, the use of 1.8 equivalents of both I2 and Et3SiH emerged as the 
best option for performing regioselective de-O-benzylation of sugars especially reactive at the 
anomeric positions. Application of such conditions to the L-rhamno precursor 27D (Table 4, 
entries 1-4) resulted in the regioselective deprotection at O-3, whereas prevalent O-4 
deprotection had been previously recorded in the presence of the bulkier benzyloxy group at 
C-6 (Table 2, entry 2) or through the DDQ metodology.16a Differentiated quenching 
conditions (Table 4, conditions A-D) were also developed in order to tune the anomeric 
composition of the product, or even to change the nature of the anomeric substituent. These 
data evidence that reattachment of the aglycon alcohol can proceed with variable 
stereoselectivity according to the nature of the base (Table 4, entries 1 and 2). On the other 
hand, hydrolysis of the iodide was also carried out by quenching with saturated aq sodium 
bicarbonate (Table 4, entry 3) even though partial reattachment of the original alcohol 
aglycon was also recorded. Even more interestingly, the aglycon of the starting compound 
could be exchanged for a synthetically versatile acetate group upon quenching with a DCM 
solution of premixed acetic acid and lutidine (Table 4, entry 4). The quenching with pyridine, 
applied in the initial experiments on precursors unaffected at the anomeric position by 
I2/Et3SiH (Tables 1-3), was soon abandoned after the formation of consistent amounts of 
glycosyl pyridinium species eroded the overall yield of the process.  
Application of the procedures to L-fucose confirmed the higher amenability of 6-deoxy 
sugars to O-3 deprotection  with concurrent modification at the anomeric position (Table 4, 
entries 5-6). Interestingly, per-O-benzylated β-glucoside 34D and β-galactoside 38D also 
revealed anomeric reactivity towards I2 and Et3SiH (Table 4, entries 7 and 8) as shown by the 
aglycon exchange in entry 7 and the partial  anomerization in entry 8. The de-O-benzylation 
regioselectivity was consistent with that of the corresponding α-pyranoside precursors 
(compare with Tables 1 and 2), and not negligible amounts of 3,4-diol 37D (slightly 
contaminated by another 1-O-acetylated derivative) were also isolated from the gluco 
precursor. The 1-O-acetylated galacto derivative 39D (Table 4, entry 9), highly prone to 
anomeric iodination with I2/Et3SiH,23 also reacted with a regioselectivity mirroring the 
behaviour of the corresponding α-methyl glycoside  1D (Table 1). At this stage it’s 
interesting to recall that in the case of β-O-allylated disaccharides 15D, 17D, and 19D (Table 
3, entries 4-6) no evidence of HI-promoted de-O-allylation had been recorded. This evidence 
highlights that de-O-benzylation of disaccharide substrates is much faster than their anomeric 
iodination, in stark contrast with the behaviour of monosaccharide β-glycosides. 
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A further extension of the reaction scope was pursued by examining the effect of acyl 
protecting groups on substrates bearing multiple benzyl groups. The electron withdrawing 
aptitude of acyl groups was expected to reduce the basic character of adjacent benzylated 
oxigens thus interfering with the preliminary protonation of the benzyloxy group necessary 
for triggering the iodide-induced benzyl removal. Consistently, this effect could switch the 
normal regioselectivity (controlled by steric factors) to favor deprotection of the carbinol sites 
more distant from the acyloxy groups. To assay this effect, compound 2D was readily 
acetylated or benzoylated under standard conditions to yield derivatives 41D and 43D (Table 
5). Both derivatives were exposed to the I2/Et3SiH system at low temperature. Interestingly, 
the regioselectivity of the process was really influenced by the presence of the ester 
functionality, the less proximal benzyl group at O-2 being preferentially removed in 
synthetically useful yields (entries 1 and 2). In these cases minor but not negligible amounts 
of pure by-products were isolated. In particular, compound 41D (entry 1) also gave the 6-O-
debenzylation product in 12 % yield as well as minor amounts (less than 10 %) of the 3-O-
deprotected derivative. This was the only case in which liberation of the primary carbinol was 
observed at an appreciable extent. Starting from compound 43D (entry 2), the liberation of 2-
OH was partially accompanied by 6-O-triethylsilylation (17% yield). As mentioned above, 
triethylsilylation of benzylated substrates is an uncommon event upon treatment with the 
I2/Et3SiH. The directing effect of acyl groups on regioselectivity further expands the synthetic 
potential of the method: selective 2-O-deprotections, which were never observed starting from 
per-O-benzylated monosaccharides (Tables 1, 2 and 3), were now possible starting from 4-O-
acylated precursors. 
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Table 5: Regioselective de-O-benzylation of 4-O-acylated galactopyranosides. 
Entry Reagent Time 
(min) 
Temp (°C) Product and 
yield (%) 
O
HO
BnO
AcO OBn
OMe
O
BnO
BnO
AcO OBn
OMe
O
HO
BnO
BzO OR
OMe
O
BnO
BnO
BzO OBn
OMe
42D41D
1
44D R: Bn    46 %
45D R: TES  17 %
43D
2
1.5 h
45 min
-20 to -5
-20 to -5
43 %
 
General conditions: Et3SiH (1.25 eq) was added to a solution of 41D or 43D and I2 (1.25 
eq) in anhydrous DCM at the starting temperature. The reaction was quenched at the final 
temperature by addition of pyridine.  
 
The usefulness of the methodology as a tool to streamline the synthesis of biologically 
useful oligosaccharides was demonstrated with the application of acceptors 2D and 16D, 
rapidly prepared in high yields as shown above. Coupling of acceptor 2D with galactosyl 
trifluoroacetimidate41 donor 46D under Bi(OTf)3 catalytic activation42 quickly afforded 
protected galabiose 47D (Scheme 3) in a very high yield and α-selectivity. Galabiose is 
contained in a range of biologically relevant oligosaccharide sequences, and this disaccharide 
fragment is frequently investigated for his potential role in tuning the adhesion of pathogenic 
bacteria.43 In another application, the de-O-benzylation procedure was incorporated into a 
one-pot sequence yielding the Lewis X mimic 49D where the glucosamine residue is replaced 
by a glucose (Scheme 3).44 For this purpose, fully protected lactose 15D was readily 
deprotected at O-3 as shown in Table 3 (entry 4), thenafter the fucosyl imidate 48D45 was 
directly added to the reaction vessel with an additional amount of iodine.20,46,47 The procedure 
afforded 49D in an acceptable 31 % overall yield and to the best of our knowledge this is the 
first example in which a benzyl ether cleavage is applied to a one-pot sequence for 
oligosaccharide synthesis. Indeed, reductive opening of benzylidenes is the most pursued 
strategy for liberating a carbinol position in one-pot protocols of carbohydrate derivatization 
and oligosaccharide synthesis. 5,48 
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O
BnO
BnO
HO OBn
OMe
O
OBn
BnO
BnO OBn
O
OBn
HO
OBn
OAllO
O
BnO
BnO
BnO OBn
O CF3
NPh
O
BnO
BnO
O OBn
OMe
O
BnO
BnO
BnO OBn
O
OBnBnO
O CF3
NPh
OBnMe
O
OBn
BnO
BnO OBn
O
BnO
O
OBn
OAllO
O
OBn
BnO
OBnMe
O
OBn
BnO
BnO OBn
O
OBn
BnO
OBn
OAllO
2D
16D
+
46D
47D
toluene/Et2O 4:1,
Bi(OTf)3 (0.06 eq) in dioxane
49D
-17 °C to -5 °C
30 min 91 %
15D
I2/Et3SiH
-15 °C, DCM
AW MS, 25 min
I2 (0.8 eq), 
DCM/Et2O/diox  4:1:1, 
-70 °C to rt, overnight
48D
31%
  
Scheme 3 Application of regioselectively deprotected products in the synthesis of 
biologically relevant oligosaccharides. 
  
Conclusion 
In this chapter it was demonstrated that the I2/Et3SiH combined system is a very useful 
reagent to effect regioselective de-O-benzylation of highly O-benzylated substrates. HI 
generated in situ appears to be the actual promoter of the process. Synthetically useful 
regioselectivity is frequently achieved to give partially protected building-blocks otherwise 
accessible only through longer synthetic sequences. The obtained results show that sterically 
hindered benzyl groups are preferentially removed and the relief of steric strain appears as the 
main factor ruling the regioselectivity. This effect could explain other known selective 
processes of ether or acetal scission occurring under acidic conditions and might be exploited 
in designing new selective acid promoted processes. Consistently with this mechanistic view, 
for each group of examined substrates a well defined regioselectivity trend was observed: 
tetra-O-benzylated hexopyranoside monosaccharides are preferentially deprotected at O-4, 
hexofuranosides at O-5, 6-deoxy pyranosides at O-3, per-O-benzylated disaccharides at a 
secondary carbinol site of the reducing terminus adjacent to the glycosidic bond. Interestingly, 
the regioselectivity of the process can also be switched by insertion of acyl protecting groups 
on the substrate that results in the de-O-benzylation at the farthest site from the acylated 
position.  
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Application of the reagent system (with an appropriate stoichiometry) to substrates 
especially reactive at the anomeric position (6-deoxy glycopyranosides and monosaccharide 
β-pyranosides) causes rapid anomeric iodination at low temperature besides de-O-
benzylation. However, the intermediate glycosyl iodides thus generated are reactive enough to 
be converted into a variety of synthetically useful products upon suitable quenching.  
As demonstrated in the synthesis of the Lewis X mimic 49D, the de-O-benzylation protocol 
can also be incorporated into one-pot procedures of oligosaccharide synthesis with an 
unprecedented use of benzyl as a transient protecting group. 
In addition to its wide applicative scope, the disclosed protocol exhibits a broad range of 
practical advantages over many of the current methodologies of regioselective de-O-
benzylations: reactions proceed rapidly at low temperatures and are performed without 
adopting inert atmosphere, the reagents are cheap and easy to handle and can be used in only 
slight stoichiometric excesses. 
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Experimental Section 
 
General methods and Material 
1H and 13C NMR spectra were recorded in CDCl3 (internal standard, for 1H: CHCl3 at δ 
7.26; for 13C: CDCl3 at δ 77.0) 1H NMR assignments were based on homo-decoupling 
experiments or bidimensional experiments. MALDI-MS spectra were recorded in the positive 
mode: compounds were dissolved in acetonitrile at a concentration of 0.1 mg/mL and one 
microliter of these solutions were mixed with one microliter of a 20 mg/mL solution of 2,5-
dihydroxybenzoic acid in 7:3 CH3CN/H2O. Analytical thin layer chromatography (TLC) was 
performed on aluminium plates pre-coated with Silica Gel 60 F254 as the adsorbent. The plates 
were developed with 5% H2SO4 ethanolic solution and then heating to 130°C. Column 
chromatography was performed on silica gel (63-200 mesh). Glycosidations were performed 
with commercial anhydrous solvents.  
Structural assignment of de-O-benzylation products was supported by their acetylation and 
observation of the consequent downfield acetylation shift at 1H NMR. The most significant 
data (downfield carbinol signals) are included in the NMR description of each compound that 
was acetylated. 
 
General procedure of de-O-benzylation with I2 and Et3SiH 
Anhydrous DCM (16-20 mL/mmol I2) was added to the poli-O-benzylated derivative and I2 at 
room temperature (see Tables for the relative amounts of reagents). After complete 
dissolution the mixture was cooled to the starting temperature of the reaction (see Tables) and 
then Et3SiH (see Tables for the relative amount) was added by a syringe. The reaction mixture 
was allowed to gradually warm or maintained at the same temperature (Tables) until TLC 
analysis displayed the optimal extent of conversion. The reaction was quenched as indicated 
in the Tables. In the case of condition  A (Table 4), allyl alcohol (5 eq) and solid NaHCO3 (5 
eq) were sequentially added. In the case of condition B, allyl alcohol (5 eq) and lutidine (5 eq) 
were sequentially added. In the case of condition  C,  sat aq sodium carbonate (5 mL/mmol I2) 
was added. In the case of condition  D, a solution of lutidine (7 eq) and acetic acid (4 eq) in 
DCM (3 mL/mmol I2). The mixture was allowed to warm to rt and was then diluted with 
DCM. The organic phase washed with water containing sodium thiosulfate (to remove 
residual amounts of iodine). Water phase was re-extracted with DCM, and collected organic 
phases were dried and concentrated in vacuo.  Silica-gel flash chromatography (eluent: 
hexane/ethyl acetate mixtures) yielded the de-O-benzylated products reported in the tables. 
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Procedure for the synthesis of galabiose disaccharide 47D 
Trifluroacetrimidate donor 46D (30 mg, 0.042 mmol) and acceptor 2D (14 mg, 0.030 mmol) 
were co-evaporated three times with toluene (3 x 0.5 mL) and dried under vacuum. After 
adding 4Å AW 300 MS, the mixture was dissolved under argon with 4:1 toluene/Et2O (1.5 
mL), cooled to -17 °C, and stirred for 15 min. A solution of Bi(OTf)3 in dioxane (14.5 
mg/mL, 80 μL, 1.8 μmol) was then added, and the temperature was allowed to raise up to -5 
°C over 30 minutes. Pyridine was added to quench the reaction and the mixture was filtered 
on a short plug of silica gel (eluent: DCM/MeOH/CH3CN 85:10:5), concentrated and purified 
by silica gel flash chromatography (eluent: hexane/ethyl acetate from 85:15 to 4:1) to yield 
47D as an oil (27 mg, 91 % yield). 
 
One-pot synthesis of Lewis X mimic 49D 
Protected lactose 15D (23 mg, 0.023 mmol) was co-evaporated three times with toluene (3 x 
0.5 mL) and dried under vacuum. The reaction vessel was purged with argon and then 4Å 
AW 300 MS, dry DCM (0.58 mL) and iodine (7 mg, 0.028 mmol) were sequentially added. 
After stirring for 10 min at rt, the vessel was cooled to – 15 °C and then Et3SiH (4.5 μL, 
0.028) was added by a syringe. After 25 minutes at -15 °C, the mixture was cooled to -78 °C 
and then a solution of fucosyl donor 48D (42 mg, 0.069 mmol) in DCM/Et2O/dioxane 2:1:1 
(2 mL) was added, followed by a solution of I2 (4.7 mg, 0.018 mmol) in DCM (0.27 mL). The 
temperature was allowed to raise up to rt overnight. The reaction was quenched with solid 
NaHCO3 and the mixture was filtered on a short plug of silica gel (eluent: 
DCM/MeOH/CH3CN 85:10:5), concentrated and purified by silica gel flash chromatography. 
The filtered liquor was washed with diluted aq thiosulfate and the organic phases were 
collected, dried and concentrated. The residue was chromatographed with n-pentane/ethyl 
acetate (from 10:1 to 6.5:1) to obtain an oil containing trisaccharide 49D contaminated with 
minor amounts of fucose self-coupling by products. PLC purification of this crude mixture 
(eluent: toluene/ethyl acetate 7.5:1) afforded pure 49D as an oil (9 mg, 31% overall yield).  
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Methyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside (2D). 1H NMR 
(CDCl3, 400 MHz) δ 7.40-7.15 (aromatic H), 4.70 (1H, d, J1,2 = 3.2 
Hz, H-1), 4.85-4.55 (6H, 3 x AB,3x –CH2Ph), 4.07 (1H, bs, H-4), 
3.93 (1H, bt, J5,6a = J5,6b = 6.0 Hz, H-5), 3.90-3.87 (2H, overlapped, 
H-2 e H-3), 3.75 (1H, dd, J6a,6b = 10.0 Hz, H-6a), 3.69 (1H, dd, H-
6b), 3.40 (3H, s, 1-OCH3), 2.62 (1H, bs, 4-OH). 13C NMR (CDCl3, 75 MHz) δ 138.4, 138.2, 
138.0 (aromatic C); 128.5-127.6 (aromatic CH), 98.6 (C-1), 77.6, 75.8, 73.6, 73.5, 72.7, 69.6, 
68.4, 68.1, 55.3 (-OCH3). Significant signals of acetylated 2D at δ 5.62 (d, 1H, J3,4 = 2.4 Hz, 
H-4), 2.08 (3H, s, -COCH3). MS (MALDI-TOF) calcd for (C28H32O6Na+) 487.21, found 
487.5.  
 
Methyl 2,3,6-tri-O-benzyl-α-D-
glucopyranoside (5D) and Methyl 
2,4,6-tri-O-benzyl-α-D-
glucopyranoside (6D). 
(regioisomeric mixure 5D/6D 3.8). 
1H NMR (CDCl3, 500 MHz) significant signals of 5D at δ 4.63 (1H, d, J1,2 = 3.6 Hz, H-1), 
3.79 (1H, t, J2,3 = J3,4 = 9.6 Hz, H-3), 3.60 (1H, bt, J4,5 = 9.6 Hz, H-4), 3.53 (1H, dd, H-2), 3.39 
(3H, s, 1-OCH3), 2.41 (1H, bs, 4-OH). Significant signals of 6D at δ 4.66 (1H, d, J1,2 = 3.6 Hz, 
H-1), 4.07 (1H, bt, J2,3 = J3,4 = 9.6 Hz, H-3), 3.41 (1H, dd, H-2), 3.34 (3H, s, 1-OCH3), 2.45 
(1H, bs, 4-OH). Significant signals of acetylated 5D at δ 5.02 (d, 1H, J3,4 = 9.6 Hz, H-4), 1.81 
(3H, s, -COCH3). Significant signals of acetylated 6D at δ 5.51 (d, 1H, J3,4 = 10.0 Hz, H-4), 
1.93 (3H, s, -COCH3). 13C NMR (CDCl3, 125 MHz) signals of 5D at δ 138.7, 137.9 (x2) 
(aromatic C), 128.5-127.5 (aromatic CH), 98.1 (C-1), 81.4, 79.5, 75.4, 73.5, 73.1, 70.6, 69.8, 
69.4, 55.2 (-OCH3). Significant signal of 6D at δ 97.5 (C-1). MS (MALDI-TOF) calcd for 
(C28H32O6Na+) 487.21, found 487.4. 
 
Methyl 2,3,6-tri-O-benzyl-α-D-
mannopyranoside (7D) and Methyl 
2,4,6-tri-O-benzyl-α-D-
mannopyranoside (8D).  
7D and 8D (regioisomeric mixure 
7D/8D 8).1H NMR (CDCl3, 400 MHz) signals of 7D at δ 7.40-7.20 (aromatici), 4.79 (1H, s, 
+
O
HO
BnO
BnO
OMe
BnO
O
BnO
HO
BnO
OMe
BnO
O
HO
BnO
OMe
BnO
BnO
O
BnO
HO
OMe
BnO
BnO
+
O
HO
BnO
OMe
BnO
OBn
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H-1), 4.75-4.49 (6H, 3 x AB, 3x –CH2Ph), 4.05 (1H, t, J3,4  = J4,5  = 9.6 Hz, H-4), 3.82-3.73 
(4H, segnali sovrapposti, H-2, H-5, H-6a, H-6b), 3.70 (1H, dd, J2,3 = 3.2 Hz, H-3), 3.34 (3H, s, 
1-OCH3), 2.53 (1H, bs, 4-OH).  Significant signals of 8D at δ 4.83 (1H, bs, H-1). 13C NMR 
(CDCl3, 125 MHz) signals of 7D at δ 138.4 (x3) (aromatic C), 128.4-127.4 (aromatic CH), 
99.0 (C-1), 79.6, 73.8, 73.5, 72.6, 71.7, 71.3, 70.3, 67.7, 54.8 (-OCH3). MS (MALDI-TOF) 
calcd for (C28H32O6Na+) 487.21, found 487.1. 
 
Allyl 2,3,6-tri-O-benzyl-α-D-galactopyranoside (10D). 1H NMR 
(CDCl3, 400 MHz) δ 7.40-7.20 (aromatic H), 5.94-5.90 (1H, m, -
OCH2-CH=CH2), 5.29 (1H, dd, Jtrans = 17.2 Hz, Jgem = 1.6 Hz, -
OCH2-CH=CHcisHtrans ), 5.18 (1H, dd, Jcis = 10.4 Hz, Jgem = 1.2 Hz, –
OCH2-CH=CHcisHtrans), 4.86 (1H, d, J1,2 = 3.2 Hz, H-1), 4.87-4.56 
(6H, 3 x AB, 3x –CH2Ph), 4.07 (1H, bs, H-4), 4.18-3.99 (2H, m, -OCH2-CH=CH2), 3.95 (1H, 
bt, J5,6a = J5,6b = 5.8 Hz, H-5), 3.90-3.84 (2H, overlapped signals, H-2 e H2-3), 3.72 (1H, dd, 
J6a,6b = 12.8 Hz, H-6a), 3.66 (1H, dd, H-6b), 2.57 (1H, bs, 4-OH). Significant signals of 
acetylated 10D at δ 5.62 (1H, bs, J3,4 = 3.2 Hz, H-4), 2.05 (3H, s, -COCH3). MS (MALDI-
TOF) calcd for (C20H34O6Na+) 513.23, found 513.6. 
 
Methyl 3-O-allyl-2,6-di-O-benzyl-α-D-mannopyranoside (12D). 
1H NMR (400 MHz, CDCl3) δ 7.43-7.26 (m, aromatic H), 5.98-
5.86 (m, 1H, -CH=CH2), 5.30 (1H, dd, Jtrans = 17.2 Hz, Jgem = 1.5 
Hz, -CH2CH=CHcisHtrans), 5.20 (dd, 1H, Jcis = 10.4 Hz, -
CH2CH=CHcisHtrans), 4.79 (d, 1H, J1,2 = 1.6 Hz, H-1), 4.73-4.60 
(4H, 2 x AB, 2 x –CH2Ph), 4.61 (1H, d, Jgem = 12.1 Hz, -CH2Ph), 4.10-3.95 (2H, m, -
CHaHbCH=CH2 and H-4), 3.85-3.71 (5H, m), 3.62 (1H, dd, J2,3 = 3.1 Hz, J3,4 = 9.5 Hz, H-3), 
3.37 (s, 3H, -OMe). 13C NMR (100 MHz, CDCl3) δ 138.23, 138.20 (aromatic C), 134.6 (-
CH=CH2), 128.3-127.5 (aromatic CH), 117.2 (-CH=CH2), 99.2 (C-1), 79.2, 73.6, 73.5, 72.6, 
71.3, 70.5, 70.4, 67.7, 54.8 (-OMe). Significant signals of acetylated 12D at δ 5.31 (1H, t, J3,4 
= J4,5 = 10.0 Hz, H-4), 1.98 (3H, s, -COCH3). MS (MALDI-TOF) calcd for (C24H30O6Na+) 
437.20, found 437.3. 
Methyl 3,6-di-O-allyl-2-O-benzyl-α-D-mannopyranoside 
(14D). 1H NMR (500 MHz, CDCl3) δ 7.40-7.20 (m, aromatic H), 
5.98-5.87 (m, 2H, 2 x -CH=CH2), 5.33-5.25 (m, 2H, 2 x -
O
HO
AllO
BnO
OMe
AllO
O
HO
BnO
OAll
BnO
OBn
O
HO
AllO
BnO
OMe
BnO
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CH2CH=CHcisHtrans), 5.23-5.15 (m, 2H, 2 x -CH2CH=CHcisHtrans), 4.78 (d, 1H, J1,2 = 1.5 Hz, 
H-1), 4.70 (2H, s, -CH2Ph), 4.10-3.93 (m, 5H, 2 x -CH2CH=CH2 and H-4), 3.81-3.67 (m, 4H), 
3.60 (dd, 1H, J2,3 = 3.0 Hz, J3,4  =  10.0 Hz, H-3), 3.36 (s, 3H, -OMe), 2.61 (bs, 1H, 4-OH). 
13C NMR (50 MHz, CDCl3) δ 138.2 (aromatic C), 134.64, 134.60 (2 x -CH=CH2), 128.3-
127.6 (aromatic CH), 117.2, 117.0 (2 x -CH=CH2), 99.2 (anomeric CH), 79.2, 73.5, 72.6, 
72.5, 71.2, 70.5, 70.4, 67.7, 54.8 (-OMe). MS (MALDI-TOF) calcd for (C20H28O6Na+) 
387.18, found 387.3. 
 
Allyl 2,3,4,6-tetra-O-benzyl-β-D-
galactopyranosyl-(1→4)-2,6-di-O-
benzyl-β-D-glucopyranoside (16D). 
1H NMR (CDCl3, 400 MHz) δ 7.45-
7.10 (aromatici), 6.00-5.90 (1H, m, -
OCH2-CH=CH2), 5.33 (1H, bd, Jtrans = 17.2 Hz, Jgem = 1.6 Hz, -OCH2-CH=CHcisHtrans), 5.19 
(1H, dd, Jcis = 10.4 Hz, Jgem = 1.5 Hz, –OCH2-CH=CHcisHtrans), 4.41 (1H, d, J1.2 = 7.2 Hz, H-
1'), 4.31 (1H, d, J1.2 = 7.2 Hz, H-1), 4.95-4.30 (13H, 6 x –CH2Ph and –OCHaHbCH=CH2), 
4.13 (1H, bdd, Jgem = 12.8 Hz, Jvic = 5.6 Hz, –OCHaHbCH=CH2), 3.85 (1H, d, J3,4  = 2.4 Hz, 
H-4'), 3.83-3.73 (3H), 3.65-3.55 (2H), 3.53-3.45 (4H), 3.35 (1H, dd, H-2, J2,3  = 9.2 Hz, H-2). 
13C NMR (100 MHz, CDCl3) δ 138.93, 138.42, 138.37, 138.33, 138.09, 137.54 (aromatic C), 
134.1 (-CH=CH2), 128.5-127.3 (aromatic CH), 117.1 (-CH=CH2), 103.7 and 102.0 (C-1 and 
C-1′), 82.4, 81.6, 81.4, 78.9, 75.4, 75.2, 74.7, 74.6, 74.2, 73.6 (x2), 73.2, 73.0, 72.9, 70.3, 
68.8, 68.5. Significant 1H NMR signals of acetylated 16D at δ 5.13 (1H, t, J2.3 = J3,4 = 9.6 Hz, 
H-3), 2.05 (3H, s, -COCH3). MS (MALDI-TOF) calcd for (C57H62O11Na+) 946.42, found 
946.2. 
 
Allyl 2,3,4,6-tetra-O-benzyl-α-D-
glucopyranosyl-(1→4)-2,6-di-O-
benzyl-β-D-glucopyranoside (18D). 1H 
NMR (CDCl3, 400 MHz) δ 7.40-7.00 
(aromatic H), 6.00-5.80 (1H, m, -
CH=CH2), 5.35 (1H, dq, Jtrans = 17.2 Hz, 
Jgem = 1.6 Hz, -CH=CHcisHtrans), 5.21 (1H, dq, Jcis = = 10.8 Hz, -CH=CHcisHtrans), 4.99 (1H, d,  
J1,2  = 3.6 Hz, H-1′), 4.45 (1H, J1,2 = 7.6 Hz, H-1), 5.00-4.40 (13 H, 6 x AB, 6 x CH2Ph and –
CHaCHbCH=CH2), 4.15 (1H, m, –CHaCHbCH=CH2), 4.00 (1H, t, J1,2 = 9.6 Hz, H-3′), 3.83 
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(1H, m, H-5′), 3.83-3.75 (2H), 3.67 (1H, dd, J = 5.6 and 11.2 Hz), 3.64-3.50 (4H), 3.46-3.43 
(2H), 3.38 (1H, dd, J2,3 = 10.2 Hz, H-2′). 13C NMR (50 MHz, CDCl3) δ 138.77, 138.49, 
138.40, 138.1, 137.8, 137.0 (6 x aromatic C), 134.1 (-CH=CH2), 128.4-127.2 (aromatic CH), 
117.1 (-CH=CH2), 102.3 and 100.6 (C-1 and C-1′), 82.1, 81.7, 80.7, 79.6, 75.6, 75.0, 74.4, 
74.2, 73.4, 73.2, 71.3, 70.3, 69.2, 68.3. Significant 1H NMR signals of acetylated 18D at δ 
5.31 (1H, t, J2.3 = J3,4 = 9.2 Hz, H-3), 1.82 (3H, s, -COCH3). MS (MALDI-TOF) calcd for 
(C57H62O11Na+) 946.42, found 946.5. 
 
Allyl 2,3,4,6-tetra-O-benzyl-β-D-
glucopyranosyl-(1→4)-2,6-di-O-
benzyl-β-D-glucopyranoside (20D). 1H 
NMR (CDCl3, 400 MHz) δ 7.50-7.05 
(aromatic H), 6.00-5.85 (1H, m, -CH=CH2), 5.35 (1H, bd, Jtrans  = 17.6 Hz, -CH=CHcisHtrans), 
5.20 (1H, bd, J = 10.6 Hz, -CH=CHcisHtrans), 4.46 (1H, d,  J1,2 = 7.6 Hz, H-1), 4.40 (1H, d,  J1,2 
= 7.6 Hz, H-1′), 4.90-4.30 (13 H, 6 x AB, 6 x –CH2Ph and –CHaCHbCH=CH2), 4.15 (1H, m, 
–CHaCHbCH=CH2), 3.80-3.70 (3H), 3.68-3.50 (7H), 3.45-3.37 (2H). 13C NMR (50 MHz, 
CDCl3) δ 139.0, 138.3 (x2), 138.1, 137.9, 137.7 (aromatic C), 134.1 (-CH=CH2), 128.4-127.2 
(aromatic CH), 117.1 (-CH=CH2), 103.2 and 102.1 (C-1 and C-1′), 84.7, 81.8, 81.5, 81.2, 
77.7, 75.6, 75.3, 75.1, 74.9, 74.7, 74.6, 74.3, 73.6, 73.1, 70.2, 68.7. Significant signals of 
acetylated 20D at δ 5.15 (1H, t, J2.3 = J3,4 = 9.2 Hz, H-3), 1.93 (3H, s, -COCH3). MS (MALDI-
TOF) calcd for (C57H62O11Na+) 946.42, found 946.6. 
 
Methyl 2,3,4,6-tetra-O-benzyl-α-D-
mannopyranosyl-(1→3)-4,6-di-O-benzyl-α-D-
mannopyranoside (22D). 1H NMR (CDCl3, 
500 MHz) δ 7.50-7.00 (aromatic H), 5.03 (1H, 
bs, H-1′), 4.47 (1H, bs,  H-1), 4.82-4.32 (12H, 6 
x –CH2Ph), 4.20 (1H, bt, J = 8.5 Hz, H-5), 4.13 
(1H, bs, sharper signal with D2O, H-2), 3.88 (1H, dd, J2,3 = 3.0 Hz, J3,4 = 9.0 Hz, H-3), 3.76 
(1H, bd, J5,6a = 8.0 Hz, H-6a), 3.75-3.60 (6H), 3.56 (1H, bs, exchange with D2O, OH-2), 3.51 
(1H, J = 8.5 Hz, H-6b), 3.28 (3H, s, -OCH3).  13C NMR (50 MHz, CDCl3) δ 138.6, 138.4, 
138.23, 138.17,  138.10, 137.6 (aromatic C), 128.3-127.2 (aromatic CH), 101.3 and 99.3 (C-1 
and C-1′), 82.4, 80.0, 75.6, 75.3, 74.9, 74.8, 73.9, 73.6, 73.4, 72.7, 72.1, 72.0, 71.2, 69.8, 69.3, 
O
BnO
OBn
BnO
O
HO
OBn
BnO
OAll
BnO O
O
BnO
OBn
BnO
O
BnO
O
HO
BnO
BnO
OMe
 121
69.1, 54.7. Significant signals of acetylated 22D at δ 5.24 (1H, bs, H-2), 2.16 (3H, s, -
COCH3). MS (MALDI-TOF) calcd for (C55H60O11Na+) 919.40, found 919.2. 
  
3,6-Di-O-benzyl-1,2-O-isopropylidene-α-D-glucofuranose 
(24D). 1H NMR (CDCl3, 400 MHz) δ 7.35-7.31 (aromatic H), 
5.92 (1H, d, J1,2 = 3.6 Hz, H-1), 4.70-4.53 (5H, 2x –CH2Ph 
and H-2), 4.20-4.10 (3H, overlapped signals, H-3, H-4 and H 
-5), 3.75 (1H, dq, J6a,6b = 10.0 Hz, J5,6a = 2.8 Hz, H-6a), 3.61 
(1H, dq, J5,6b = 5.7 Hz, H-6b), 2.67 (1H, d, J5-OH = 4.7 Hz, 5-
OH), 1.48  and 1.29 (6H, 2 x s, 2 x-CH3). Significant signals of acetylated 24D at δ 5.32 (1H, 
m, H -5), 2.01 (3H, s, -COCH3). MS (MALDI-TOF) calcd for (C23H28O6Na+) 423.18, found 
423.2. 
 
Allyl 2,3,6-tri-O-benzyl-α-D-mannopyranoside (26D). 1H NMR 
(400 MHz, CDCl3) δ  7.40-7.10 (aromatic H), 5.95-5.80 (1H, m, -
CH2CH=CH2), 5.26 (1H, dq, Jtrans = 15.6 Hz, Jall = Jgem = 1.6 Hz, -
CH2CH=CHcisHtrans), 5.19 (1H, dq, Jcis = 10.6 Hz, Jall = Jgem = 1.6 
Hz, -CH2CH=CHcisHtrans), 4.95 (1 H, d, J1,2 = 1.6 Hz, 1-H), 4.70-4.50 (6 H, 3 x AB, 3 x -
CH2Ph), 4.23-4.17 (1H, m, -CHaHbCH=CH2), 4.11-4.04 (1H, m, H-5), 4.02-3.94 (1H, m, -
CHaHbCH=CH2), 3.85-3.75 (5H). 13C NMR (100 MHz, CDCl3) δ  138.1 (x3) (aromatic C), 
133.7 (-CH=CH2), 128.3-127.5 (aromatic CH), 117.2 (-CH=CH2), 97.2 (C-1), 79.6, 73.9, 
73.4, 72.5, 71.8, 71.5, 70.3, 67.8. Significant signals of acetylated 26D at δ 5.34 (1H, t, J3,4 = 
J4,5 = 9.6 Hz, H-4), 1.94 (3H, s, -COCH3). MS (MALDI-TOF) calcd for (C20H34O6Na+) 
513.23, found 513.5. 
 
Allyl 2,4-di-O-benzyl-α,β-L-rhamnopyranoside (28D). 1H NMR 
(CDCl3, 400 MHz) signals of the α-anomer at δ 7.40-7.10 
(aromatici), 6.00-5.80 (1H, m, -CH=CH2), 5.28-5.10 (2H, m, -
CH=CH2), 4.87 (1H, bs, H-1), 4.92-4.55 (4H, 2 x AB, 2 x –CH2Ph), 
4.14 (1H, m, -CHaHbCH=CH2), 4.00-3.85 (2H, m, H-3 and -CHaHbCH=CH2), 3.76 (1H, bd, 
J2,3 = 3.2 Hz, H-2), 3.65 (1H, m, H-5), 3.34 (1H, t, J3,4 = J4,5 = 9.6 Hz, H-4), 1.34 (3H, d, Jvic = 
6.4 Hz, CH3-6). 13C NMR (125 MHz, CDCl3) δ 138.5, 137.7 (aromatic C), 133.7 (CH=CH2), 
128.5-127.6 (aromatic CH), 117.2 (CH=CH2), 96.0 (C-1), 82.3, 78.6, 75.1, 73.0, 71.6, 67.7, 
67.2, 18.0. 1H NMR (CDCl3, 400 MHz) significant signals of the β-anomer at δ 4.50 (1H, s, 
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H-1), 3.84 (1H, d, J2,3 = 3.6 Hz, H-2), 3.62 (1H, dd, J3,4  = 8.8 Hz, H-3), 3.50-3.35 (2H, 
overlapped signals, H-4 and H-5), 1.39 (3H, d, Jvic = 6.0 Hz, CH3-6). Significant signals of 
acetylated 28Dα at δ 5.21 (1H, dd, J2,3 = 3.4 Hz,  J3,4 = 9.6 Hz, H-3), 1.96 (3H, s, -COCH3). 
MS (MALDI-TOF) calcd for (C23H28O5Na+) 407.19, found 407.4. 
 
2,4-Di-O-benzyl-L-rhamnopyranose (29D). (anomeric mixture α/β 
ca 2.5:1). 1H NMR (CDCl3, 400 MHz) δ 7.40-7.10 (aromatic H), 5.23 
(1H, d, J1,2 =1.2 Hz, H-1 α), 4.75 (1H, bs, H-1 β), 4.95-4.60 (-CH2Ph 
a and β), 4.01 (1H, dd, J2,3 = 3.6 Hz, J3,4 = 9.2 Hz, H-3 α), 3.90 (1H, 
dd, J = 6.0 and 10.0 Hz, H-5 α), 3.83 (1H, dd, J2,3 = 3.2 Hz, H-2 β), 
3.83 (1H, dd, J2,3 = 3.6 Hz, H-2 α), 3.73 (1H, m, H-5 β), 3.36 (2H, t, J = 9.6 Hz, H-4 α and β), 
1.38 (3H, d, J = 6.0 Hz, CH3-6 β), 1.33 (3H, d, J = 6.4 Hz, CH3-6 α). 13C NMR (50 MHz, 
CDCl3) δ 138.5, 138.2, 138.9, 137.8 (aromatic C), 93.8 (C-1 β), 91.9 (C-1 α), 82.2, 81.5, 
78.7, 75.7, 75.0, 74.7, 73.2, 71.5, 71.2, 67.4, 18.1. MS (MALDI-TOF) calcd for 
(C20H24O5Na+) 367.15, found 367.3.  
 
Acetyl 2,4-di-O-benzyl-β-L-rhamnopyranoside (30D). 1H NMR 
(CDCl3, 500 MHz) δ 7.40-7.10 (aromatic protons), 5.67 (1H, s, H-
1), 5.02-4.66 (4H, 2 x AB, 2 x –CH2Ph), 3.88 (1H, d, J2,3 = 3.5 Hz, 
H-2), 3.75 (1H, m, H-3), 3.46 (1H, m, H-5), 3.32 (1H, t, J3,4 = J4,5 = 
10.0 Hz, H-4), 2.33 (1H, d, J = 9.0 Hz, OH-3), 2.14 (3H, s, -COCH3), 1.39 (3H, d, J = 6.0 Hz, 
CH3-6). 13C NMR (50 MHz, CDCl3) δ 168.9 (-COCH3), 138.2 and 137.9 (aromatic C), 128.5-
127.7 (aromatic CH), 93.1 (C-1), 81.5, 77.5, 75.3, 75.1, 73.9, 72.4, 21.0, 17.9. MS (MALDI-
TOF) calcd for (C22H26O6Na+) 409.16, found 409.5.  
 
2,4-Di-O-benzyl-L-fucopyranose (32D). (anomeric mixture α:β 
ca 1.5). 1H NMR (CDCl3, 500 MHz) δ 7.40-7.10 (aromatic 
protons), 5.30 (1H, bs, H-1 α), 5.00-4.70 (-CH2Ph α and β), 4.63 
(1H, t, J = 7.2 Hz, H-1 β), 4.17 (1H, bq, Jvic  = 6.8 Hz, H-5 α), 
4.04 (1H, m, H-3), 3.77 (1H, dd, J1,2 = 3.6 Hz, J2,3 =  9.6 Hz, H-2), 
3.72-3.60 (H-4 α, H-3 and H-5 β), 3.59 (1H, bd, J3,4 = 3.2 Hz, H-4 β), 3.50 (1H, dd, J2,3 = 9.6 
Hz, H-2 β), 3.00 (1H, d, J1,OH = 7.2 Hz, OH-1 β), 2.76 (1H, d, J1,OH = 2.0 Hz, OH-1 α), 2.29 
(1H, d, J3,OH = 4.8 Hz, OH-3 β), 2.18 (1H, d, J3,OH = 5.6 Hz, OH-3 α), 1.26 (3H, d, J = 6.4 Hz, 
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CH3-6 β), 1.21 (3H, d, J = 6.8 Hz, CH3-6 α). 13C NMR (100 MHz, CDCl3) δ 138.3 and 137.8 
(aromatic C), 128.6-127.6 (aromatic CH), 97.6 (C-1 β), 91.1 (C-1 α), 80.8, 79.5, 78.5, 75.6, 
74.6, 74.3, 72.9, 71.0, 70.3, 66.5 16.9, 16.8. MS (MALDI-TOF) calcd for (C20H24O5Na+) 
367.15, found 367.2.  
 
Acetyl 2,4-di-O-benzyl-α,β-L-fucopyranoside (33D). 
(anomeric mixture α:β ca 1.0). 1H NMR (CDCl3, 500 MHz) δ 
6.41 (1H, d, J1,2  = 3.5 Hz, H-1 α), 5.53 (1H, d, J1,2  = 8.0 Hz, H-
1 β), 4.87-4.52 (-CH2Ph α and β), 4.03 (2H, m, H-3 and H-5 
α), 3.91 (1Η, dd, J2,3  = 10.4 Hz, H-2 α), 3.78-3.68 (4H, H-4 α, 
H-2, H-3 and H-5 β), 3.59 (1H, d, J3,4  = 3.6 Hz, H-4 β), 2.28 (1H, d, J3,OH = 4.0 Hz, OH-3 α), 
2.25 (1H, d, J3,OH = 5.0 Hz, OH-3 β), 2.10 and 2.06 (6H, 2 xs, –COCH3 α and β), 1.25 and 
1.19 (6H, 2 x d, J = 7.5 Hz, CH3-6 α and β). 13C NMR (50 MHz, CDCl3) δ 169.5 and 169.4 (-
COCH3 α and β), 138.3, 138.2, 138.1 and 137.6 (aromatic C), 128.6-127.4 (aromatic CH), 
94.2 (C-1 β), 90.1 (C-1 α), 79.0, 78.6, 78.5, 75.8, 75.6, 74.8, 74.4, 72.8, 71.7, 70.5, 69.0, 21.0 
(x2), 16.7 (x2). MS (MALDI-TOF) calcd for (C22H26O6Na+) 409.16, found 409.5. 
 
Acetyl 2,3,6-tri-O-benzyl-α,β-D-
glucopyranoside (35D) and Acetyl 
2,4,6-tri-O-benzyl-α,β-D-
glucopyranoside (36D). 
(regiosiomeric mixture 35D/36D ca 2.5). 1H NMR (CDCl3, 500 MHz) significant signals of 
35Dα at δ 6.39 (1H, d, J1,2  = 3.0 Hz, H-1), 5.03-4.56 (3 x -CH2Ph), 3.87 (1H, m, H-5), 3.81 
(1H, t, J2,3 = J3,4 = 9.0 Hz, H-3), 3.80-3.66 (4H), 2.60 (1H, bs, OH-4), 2.20 (3H, s, -COCH3). 
Significant signals of acetylated 35Dα at δ  6.34 (1H, d, J1,2  = 3.4 Hz, H-1), 5.12 (1H, t, J3,4 = 
J4,5 = 9.4 Hz, H-4), 2.17 and 1.84 (6H, 2 x s, 2 x -COCH3). 1H NMR (CDCl3, 500 MHz) 
significant signals of 36Dα at δ 6.41 (1H, d, J1,2  = 3.5 Hz, H-1), 4.08 (1H, bt, J2,3 = J3,4 = 9.0 
Hz, H-3), 3.58 (1H, dd, H-2), 2.25 (1H, bs, OH-3), 2.14 (3H, s, -COCH3). Significant signals 
of acetylated 36Dα at δ 6.36 (1H, d, J1,2  = 3.5 Hz, H-1), 5.46 (1H, t, J2,3 = J3,4 = 9.0 Hz, H-3), 
2.13 and 1.93 (6H, 2 x s, 2 x -COCH3). MS (MALDI-TOF) calcd for (C29H32O7Na+) 515.20, 
found 515.4. 
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Acetyl 2,6-di-O-benzyl-α,β-D-glucopyranoside (37D). 
(anomeric mixture α:β ca 5.0). 1H NMR (CDCl3, 500 MHz) 
signals of  the α anomer at δ 6.41 (1H, d, J1,2  = 3.5 Hz, H-1), 
4.73-4.54 (4H, 2 x AB, 2 x -CH2Ph), 3.90 (1H, t, J2,3 = J3,4 = 9.5 
Hz, H-3), 3.84 (1H, m, H-5), 3.76-3.65 (3H, overlapped signals, H-4 and CH2-6), 3.50 (1H, 
dd, J2,3  = 9.5 Hz, H-3), 2.13 (3H, s, -COCH3). Significant signals of acetylated 37Dα at δ 
6.35 (1H, d, J1,2  = 3.5 Hz, H-1), 5.37 (1H, t, J2,3 = J3,4 = 9.5 Hz, H-3), 5.12 (1H, t, J4,5 = 9.5 
Hz, H-4), 2.16, 2.00 and 1.90 (6H, 2 x s, 2 x -COCH3). MS (MALDI-TOF) calcd for 
(C22H26O7Na+) 425.16, found 425.3. 
 
Acetyl 2,3,6-tri-O-benzyl-α,β-D-galactopyranoside (40D). 
(anomeric mixture α:β ca 1.0). 1H NMR (CDCl3, 400 MHz) 
significant signals at δ 6.41 (1H, d, J1,2  = 2.8 Hz, H-1 α), 5.59 (1H, 
d, J1,2  = 8.0 Hz, H-1 β), 4.19 and 4.13 (2H, 2 x bs, H-4 α and β), 
2.14 and 2.07 (6H, 2 x s, 2 x –COCH3). 13C NMR (100 MHz, CDCl3) significant signals at δ 
94.1 (C-1 β), 90.4 (C-1 α), 80.9, 77.5, 77.2, 75.3, 74.6, 73.7, 73.6, 73.2, 72.6, 72.3, 70.9, 69.0, 
68.5, 67.5, 66.4, 21.0 (x2). Significant 1H NMR signals of acetylated 40D at δ 6.39 (1H, d, J1,2  
= 3.5 Hz, H-1), 5.72 and 5.67 (2H, 2 x bs, H-4 α and β), 5.63 (1H, d, J1,2  = 7.6 Hz, H-1 β), 
2.14, 2.11 and 2.08 (x2) (12H, 3 x s, 4 x –COCH3). MS (MALDI-TOF) calcd for 
(C29H32O7Na+) 515.20, found 515.1. 
 
Methyl 4-O-acetyl-3,6-di-O-benzyl-α-D-galactopyranoside (42D). 
1H NMR (CDCl3, 400 MHz) δ 7.40-7.15 (aromatic H), 5.61 (1H, bd, 
J3,4 = 3.2 Hz, H-4), 4.87 (1H, d, J1,2 = 3.6 Hz, H-1), 4.80-4.40 (4H, 2 x 
AB, 2 x –CH2Ph), 4.07 (1H, bt, J5,6a = J5,6b = 6.4 Hz, H-5), 3.94 (1H, 
bdd, J2,3 = 10.0 Hz, H-2), 3.72 (1H, dd, H-3), 3.55-3.45 (2H, m, CH2-
6), 3.43 (3H, s, -OCH3), 2.08 (3H, s, -COCH3). 13C NMR (CDCl3, 100 MHz) δ 170.3 (-
COCH3), 137.6 (x2) (aromatic C), 128.4-127.6 (aromatic CH), 99.4 (C-1), 76.4, 73.6, 71.5, 
68.3, 67.9, 67.2, 55.5, 20.8. Significant signals of acetylated 42D at δ 5.63 (1H, bd, J3,4 = 2.8 
Hz, H-4), 5.09 (1H, dd, J1,2 = 3.6 Hz,  J2,3 = 10.4 Hz, H-2), 2.09 and 2.08 (6H, 2 x s, 2 x –
COCH3). MS (MALDI-TOF) calcd for (C23H28O7Na+) 439.18, found 439.3. 
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Methyl 4-O-benzoyl-3,6-di-O-benzyl-α-D-galactopyranoside (44D). 
1H NMR (CDCl3, 400 MHz) δ 8.10-7.10 (aromatic H), 5.87 (1H, bd, 
J3,4 = 2.8 Hz, H-4), 5.00 (1H, d, J1,2 = 3.6 Hz, H-1), 4.90-4.43 (4H, 2 x 
AB, 2 x –CH2Ph), 4.19 (1H, bt, J5,6a = J5,6b = 6.4 Hz, H-5), 4.09 (1H, 
bdd, J2,3 = 10.0 Hz, H-2), 3.85 (1H, dd, H-3), 3.70-3.55 (2H, m, CH2-
6), 3.48 (3H, s, -OCH3). 13C NMR (CDCl3, 100 MHz) δ 165.7 (-COPh), 137.6 and 133.1 
(aromatic C), 129.9-127.6 (aromatic CH), 99.5 (C-1), 76.5, 73.6, 71.4, 68.6 (x2), 68.3, 67.7, 
55.5. Significant signals of acetylated 44D at δ 5.89 (1H, bd, J3,4 = 2.8 Hz, H-4), 5.20 (1H, dd, 
J1,2 = 3.6 Hz,  J2,3 = 10.4 Hz,  H-2), 2.04 (3H, s, –COCH3). MS (MALDI-TOF) calcd for 
(C28H30O7Na+) 501.20, found 501.4.  
 
Methyl 4-O-benzoyl-3-O-benzyl-6-O-triethylsilyl-α-D-
galactopyranoside (45D). 1H NMR (CDCl3, 400 MHz) δ 8.10-7.10 
(aromatic H), 5.85 (1H, bd, J3,4 = 2.8 Hz, H-4), 4.95 (1H, d, J1,2 = 3.6 
Hz, H-1), 4.91-4.49 (2H, AB, Jgem = 11.2 Hz,  –CH2Ph), 4.07 (1H, dd, 
J2,3 = 10.0 Hz, H-2), 4.03 (1H, bt, J5,6a = J5,6b = 6.4 Hz, H-5), 3.85 (1H, 
dd, H-3), 3.70 (2H, d, CH2-6), 3.48 (3H, s, -OCH3), 0.90 (9H, t, Jvic = 8.0 Hz,-Si(CH2CH3)3), 
0.55 (6H, q, Si(CH2CH3)3). 13C NMR (CDCl3, 100 MHz) δ 165.7 (-COPh), 133.1 (aromatic 
C), 130.0-127.6 (aromatic CH), 99.4 (C-1), 76.8, 71.5, 70.1, 68.7, 67.4, 61.5, 55.4, 6.62, 4.23. 
Significant signals of acetylated 45D at δ 5.86 (1H, bd, J3,4 = 2.8 Hz, H-4), 5.20 (1H, dd, J1,2 = 
3.6 Hz,  J2,3 = 10.4 Hz,  H-2), 2.09 (3H, s, –COCH3). MS (MALDI-TOF) calcd for 
(C27H38O7SiNa+) 525.24, found 525.4. 
 
Methyl 2,3,4,6-tetra-O-benzyl-α-D-
galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-
galactopyranoside (47D). 1H NMR (CDCl3, 400 MHz) 
δ 7.40-7.00 (aromatic protons), 5.01 (1H, J1,2 = 3.2 Hz, 
H-1′), 4.73 (1H, J1,2 = 3.2 Hz, H-1),  4.99-4.55 (12 H, 6 
x AB, 6 x –CH2Ph), 4.43 (1H, bdd, J = 5.6 and 9.2 Hz), 
4.24 (1H, s), 4.13 (1H, bs, 2H), 4.08 (1H, dd, J = 2.4 
and 9.2 Hz), 3.95-3.80 (4H), 3.60-3.45 (2H), 3.39 (3H, 
s, -OCH3), 3.24 (1H, dd, J = 4.8 and 8.4 Hz). 13C NMR (75 MHz, CDCl3) δ 138.98, 138.95, 
138.75, 138.67, 138.5, 138.2, 138.1  (6 x aromatic C), 128.3-127.2 (aromatic CH), 100.3 and 
98.7 (C-1 and C-1′), 79.5, 77.9, 77.2, 76.6, 75.1, 74.9, 74.6, 74.1, 73.3, 73.1, 72.9, 72.6, 72.2, 
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69.5, 69.3, 68.2, 67.8, 55.3. MS (MALDI-TOF) calcd for (C62H66O11)+ 1009.45, found 
1009.7. 
 
Allyl 2,3,4-tri-O-benzyl-α-L-
fucopyranosyl-(1→3)-2,3,4,6-tetra-O-
benzyl-β-D-galactopyranosyl-(1→4)-2,6-
di-O-benzyl-β-D-glucopyranoside (49D). 
1H NMR (CDCl3, 500 MHz) δ 7.42-7.00 
(aromatic protons), 5.92-5.81 (1H, m, -
CH=CH2), 5.65 (1H, d, J1,2 = 4.0 Hz, H-1 
Fuc), 5.26 (1H, dd, Jtrans = 17.0 Hz, Jgem = 1.5 Hz, -OCH2-CH=CHcisHtrans ), 5.14 (1H, dd, Jcis 
= 11.0 Hz, Jgem = 1.5 Hz, –OCH2-CH=CHcisHtrans), 5.08-4.34 (22 H, 9 x AB, 9 x –CH2Ph, H-5 
Fuc, 2 H-1 and –CHaCHbCH=CH2), 4.51 (1H, d, J1,2 = 7.0 Hz, H-1 Glc), 4.44 (1H, d, J1,2 = 
7.5 Hz, H-1 Gal), 4.15 (1H, t, J = 9.5 Hz, H-4 Glc), 4.08 (1H, bdd, Jgem = 13.0 Hz, Jvic = 6.0 
Hz, –OCHaHbCH=CH2), 4.02-3.94 (4H, m), 3.92 (1H, dd, J2,3 = 10.0 Hz, H-2 Fuc), 3.80 (1H, 
t, J = 9.0 Hz, H-5 Gal), 3.76-3.70 (2H, m, H-6), 3.67 (1H, bdd, J2,3 = 10.0 Hz, H-2 Gal), 3.60 
(1H, bdd, J2,3 = 9.0 Hz, H-2 Glc), 3.41 (1H, dd, J3,4 = 3.0 Hz, H-3 Gal), 3.39-3.35 (1H, m, H-5 
Glu), 3.34-3.30 (2H, m, H2-6 Glc), 1.14 (3H, d, J5,6 = 6.5 Hz, H3-6 Fuc). 13C NMR (125 MHz, 
CDCl3) δ 138.3, 139.2, 139.0, 138.9, 138.7, 138.5, 138.4 (x2), 137.9 (9 x aromatic C), 128.3-
127.2 (aromatic CH), 134.0 (CH=CH2), 128.7-126.3 (aromatic CH), 117.2 (CH=CH2), 102.9, 
102.2, and 97.6 (anomeric C), 82.8, 82.4, 80.1, 79.6, 78.8, 75.8, 75.5, 75.4, 75.3 (x2), 75.0, 
73.9, 73.3 (x3), 73.0, 72.9, 72.7, 72.4, 72.2, 70.2, 68.0, 67.8, 65.8; 16.8 (Fuc C-6). MS 
(MALDI-TOF) calcd for (C84H90O15)+ 1361.62, found 1361.4.  
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 Chapter E  
 
Sequential One-Pot Glycosidations Catalytically Promoted:  
an Unprecedented Strategy in Oligosaccharide Synthesis  
for the Straightforward Assemblage of the Antitumor  
PI-88 Pentasaccharide 
 
Introduction 
Over the last years the therapeutic impact of oligosaccharides has been widely recognized 
by the scientific community as demonstrated by the increasing number of biomedical 
applications1 (such as the investigation of the role of carbohydrates in a immune response, 
pathogenesis and for the generation of carbohydrate-based drugs). Unfortunately, isolation of 
oligosaccharides from natural sources is very tedious because they are generally present as 
complex micro-heterogeneous mixtures. Hence, chemical synthesis constitutes the only 
prospect for building strictly homogeneous oligosaccharides of suitable complexity in the 
required amounts. 
Oligosaccharide assembly can be achieved using both automated solid phase synthesis2 and 
solution synthesis. The latter approach traditionally requires building of oligosaccharides 
through the initial preparation of suitable saccharidic precursors properly functionalized and 
their subsequent assembly through an appropriate sequence of glycosidation reactions 
alternated to protection/deprotection steps. These latter intermediate steps make the 
oligosaccharide synthesis more time consuming and increase both the number of 
chromatographical purifications and the overall cost of the global procedure (Figure 1). 
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Figure 1 Example of a hypothetical linear oligosaccharidic synthesis. 
 
Towards this goal, in the last decade solution synthesis of oligosaccharide has reached a 
remarkable stage of maturity thanks to the development of sequential one-pot 
multiglycosidation strategies allowing the construction of more glycosidic bonds in a single 
synthetic operation3 (Figure 2). In this regard, several approaches have been usefully 
exploited. An option is represented by the use of the orthogonal strategy which exploits for 
each coupling the selective activation of one leaving group over another, the two groups being 
chemically different.4 Another opportunity is offered by a chemoselective approach, which 
takes advantage of the feasible reactivity tuning of donors bearing similar anomeric groups by 
exploiting the arming-disarming5 effect of the functional groups present on the saccharide 
scaffold. This latter concept has been broadly elaborated by Wong and co-workers who 
developed a computer-assisted protocol for choosing the best set of glycosyl donors to 
assemble a given target sequence.6,7 
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Figure 2 One-pot strategies of sequential multiple glycosydations. 
 
Very recently, a special case of the chemoselective scheme has been proposed. It is based on a 
pre-activation stage for every coupling in which a thioglycoside donor is converted to a highly 
reactive glycosylating species at low temperature upon exposure to a suitable stochiometric 
promoter. Subsequent addition of a thioglycoside acceptor yields a glycosidation product 
which can be “in situ” pre-activated for a further elongation with a further acceptor.8 This 
latter strategy is advantageous because it is independent of the relative reactivity of the 
employed donors (Figure 3). 
 
Figure 3 Sequential one-pot multiglycosidation strategy based on the preactivation. 
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A common drawback of all the one-pot sequential glycosidation procedures so far described is 
the required activation of glycosyl donors with stoichiometric or excess amounts of costly 
and/or sensitive reagents such as NIS, triflic anhydride, silver triflate, sterically encumbured 
pyridines.3 
Recently, my research group has communicated the first examples of catalytic procedures 
for the sequential construction of two glycosidic bonds in a one-pot approach.9 Such protocols 
were inspired by the recognition of the well differentiated activation conditions of similarly 
protected glycosyl- trichloroacetimidates10 and (N-phenyl)trifluoroacetimidates11 under the 
agency of catalytic ytterbium(III) triflate.12,13 More recently, my research group has also 
disclosed that bismuth(III) triflate is a novel activator of glycosyl trihaloacetimidates endowed 
of exceptional reactivity so that reactions can be performed under relevantly milder conditions 
in terms of temperature and catalyst loading than when using Yb(OTf)3.14 The capability of 
Bi(OTf)3 of promoting high yielding glycosidations in short times appeared well fitting with 
the attempts to develop ever more efficient catalytic multiglycosidation processes to achieve 
biologically useful oligosaccharides. 
In this chapter, it was reported a work on the sequential one-pot glycosidations performed 
exclusively under catalytic activation that is a very straightforward and flexible approach for 
preparing the pentasaccharide component of the anti-tumour agent PI-88 (Figure 4). This 
drug is currently in phase-II clinical trial15 and is constituted by a mixture of randomly 
sulfated tri-, tetra-, and penta-mannans bearing a phosphate functionality at the primary site of 
the non-reducing terminal residue. This phosphate can be replaced by a sulfate group without 
appreciable loss of biological activity.16,17 The drug is obtained by the yeast Pichia 
(Hansenula) holstii NRRL Y-2448 as a mixture of phosphorylated mannans that are 
subsequently randomly sulfated via a chemical approach.18 
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Figure 4 Components of PI-88. 
 
Anti-tumor properties of PI-88 are believed to be connected with its ability to act as 
inhibitor of both heparanases and angiogenic growth factors19 (Figure 5). 
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Figure 5 
 
The pentasaccharide fraction is the most abundant and is considered the most active 
component of the drug. To date, only two examples of chemical syntheses of this 
pentasaccharide have been reported, including a very recent paper by Ferro and co-
workers.17,20 Both these schemes are providing good overall yields, but a large number of 
synthetic steps render them rather laborious (Figure 6a and 6b).  
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Figure 6a Synthesis of a 6V-sulfated mannopentasaccharide analogue related to PI-88.  
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Figure 6b Synthesis and heparanase inhibitory activity of sulfated mannoligosaccharides 
related to the antiangiogenic agent PI-88. 
 
Here it was reported the straightforward assemblage of the p-
methoxyphenylpentamannoside of  PI-88 1E (Scheme 1) by an alternative strategy based on 
only three steps (two one-pot multi-glycosidations and a deallylation intermediate step), and 
entailing only three monosaccharide building-blocks for the whole task.   
 
Results and discussion 
The proposed strategy (Scheme 1) relies on the feasible “in-situ” generation of disaccharide 
2E as the precursor of both BC and DE fragments, whereas readily obtainable acceptor 3E 
represents the precursor of the reducing terminus A. Disaccharide 2E was expected to be 
accessible by the key chemoselective coupling of trichoroacetimidate donor 4E and the 
partially protected trifluoroacetimidate 5E acting as an acceptor at this stage. 
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Scheme 1 Retrosynthetic scheme of the PI-88 pentasaccharide.  
 
Acceptor 3E was efficiently obtained starting from penta-O-acetyl-D-mannose (Scheme 2) 
which was initially converted into methyl orthoester 6E through a rapid sequence of four 
reactions (anomeric iodination, 1,2-orthoesterification, de-O-acetylation and per-O-
benzylation) and without any chromatographical purification of intermediates (50-55 overall 
yield).21 Compound 6E was submitted to sequential acid-mediated cyclic orthoester opening 
and acetylation to yield almost quantitatively the di-acetylated intermediate 7E. This latter 
was in turn directly converted into the corresponding 4-O-methoxy phenyl glycoside 8E 
under the agency of BF3.OEt2 and then 2-O-deacetylated to yield the desired building block 
3E. 
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Scheme 2 
 
Compounds 4E and 5E were prepared through synthetic pathways sharing a large number 
of steps (Scheme 3). Methyl mannoside 9E was regioselectively 3-O-allylated via a 
stannylidene intermediate22 and the resulting triol 10E was then perbenzylated under standard 
conditions. Derivative 11E was hydrolyzed under acidic conditions to yield hemiacetal 12E 
which was the last common intermediate of the routes leading to 4E and 5E. The former was 
prepared in high yield (ca 90%) with only an additional standard 1-O-trichloroacetimidation 
step. Alternatively, 12E was deallylated with PdCl2 in methanol in 72% yield and the 
resulting diol 13E was then selectively converted into trifluoroacetimidate 5E (α:β ca 4:1) 
adopting Cs2CO313d as the base. 
During the course of this work, with the same sequence reported in Scheme 3, mannosyl 
donors 4E and 5E were synthesized starting from allyl α-D-mannopyranoside obtained by 
Fischer glycosidation of D-mannose under the agency of catalytic amounts (0.03 eq) of 
Sc(OT)3. After the stage of anomeric hydrolysis of the 1-O-allylated analogue of 11E, 
hemiacetal 12E was obtained in lower yield (48% and 78% conversion) than when starting 
from 11E thus methyl α-D-mannopyranoside was chosen instead of D-mannose as the starting 
material for the preparation of 4E and 5E. As it will be shown in Chapter F, commercially 
available 9E will be used also for the synthesis of the precursors of the reducing terminus of 
other oligosaccharide of biological interest.  
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Scheme 3  
 
As shown in the retrosynthetic scheme (Scheme 1), the successful assemblage of the target 
pentasaccharide is critically dependent on the coupling between the fully protected 
trichloroacetimidate 4E and the partially protected trifluoroacetimidate 5E. Indeed, this 
reaction should provide in high yield and stereocontrol the desired glycosidic bond while 
leaving intact the activatable trifluoroacetimidate functionality to allow the subsequent 
glycosidation. To optimize this delicate step, acceptor 5E and the model trichloroacetimidate 
14E, easier to obtain than 4E,10 were coupled under a variety conditions aimed at achieving 
exclusive activation of the trichloroacetimidate component (Scheme 4). The reactions were 
quenched at low temperature with pyridine to minimize any deterioration of the 
trifluoroacetimidate functionality. After a preliminary screening, a toluene/diethyl ether 
mixture was found as the best serving reaction solvent. Reactions conducted under Bi(OTf)3 
activation at very low temperature produced the desired disaccharide trifluoroacetimidate 
15Eα in a satisfying isolated yield (Table 1, entries 4 and 6) together with minor amounts of 
the anomer 15Eβ (equally useful for the purposes in the planned one-pot application). This 
latter could not be isolated pure being it co-eluted with the by-product 16E derived from 
rearrangement of the trichloroacetimidate 14E. To the best of our knowledge these are the 
first examples of isolated glycosylation products in which an anomeric (N-
phenyl)trifluoroacetimidate group is designed to act as a temporary protecting group. With the 
same amount of Bi(OTf)3 (0.05 eq), the reaction is influenced by variation of the eq ratio 
between 14E/5E. In fact, if it decreases then yields of 15Eα decrease dramatically (Table 1, 
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entry 8). Comparing entry 4 and 6, the yield of 15Eα is slightly influenced by variation of the 
eq ratio between 14E/5E and both the doubling of Bi(OTf)3 amounts and the slight increase of 
the reaction temperature don’t provide better results. 
 Interestingly, the milder promoter Yb(OTf)3 furnished 15Eα in a higher yield than 
Bi(OTf)3 although a remarkably higher temperature (-10 °C vs -60 °C) to accomplish the 
reactions was required within comparable times (Table 1, entry 9). 
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Scheme 4 Chemoselective coupling of 14E and 5E. 
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Table 1 
Entry 
 
Eq 14E/Eq 5E 
 
Promoter 
(eq) 
 
Solvent 
 
T (°C) 
 
Time (h) Yield 
(%) 
of 15Eαb
1  1.7 Bi(OTf)3 
(0.015) 
PhCH3/DME 
2:1 
-70→0 2.5 25 
2 1.5 Bi(OTf)3 
(0.015) 
PhCH3/Et2O 
4:1 
-70→0 3 28 
3 1.6 Bi(OTf)3 
(0.035) 
PhCH3/DME 
2:1 
-70→rt 16 21 
4 1.5 Bi(OTf)3 
(0.10) 
PhCH3/Et2O 
4:1 
-60→-55 0.5 42 
5 1.5 Bi(OTf)3 
(0.10) 
PhCH3/DME
2:1 
-60→-55 0.3 28 
6 1.7 Bi(OTf)3 
(0.05) 
PhCH3/Et2O 
4:1 
-70→-60 1 47 
7 1.4 Bi(OTf)3 
(0.05) 
PhCH3/Et2O 
4:1 
-60 1.2 27 
8 0.7 Bi(OTf)3 
(0.05) 
PhCH3/Et2O 
4:1 
-70→-55 1.7 n.r. 
9 1.4 Yb(OTf)3 
(0.03) 
PhCH3/Et2O 
4:1 
-10 0.5 58 
 
aGeneral conditions: 14E (0.7-1.7 eq), 5E (1 eq), PhCH3:Et2O 4/1 or PhCH3/DME 2:1, 
Yb(OTf)3 or Bi(OTf)3 (16-20 mg/mL in dioxane), 4Å AW MS. bCalculated with respect to the 
overall amount (α and β anomers) of 5E. 
 
The donor ability of disaccharide 15Eα under Bi(OTf)3 activation was then examined in the 
coupling with acceptor 3E, quickly providing in excellent yield the trisaccharide 17E 
(Scheme 5), which corresponds to the ABC fragment of the target pentasaccharide and is 
itself biologically interesting being related to an anti-allergenic sequence.23  
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Scheme 5 
Having established the optimized conditions for generating and activating the requisite 
mannose disaccharide trifluoroacetimidate, their application was targeted towards the 
assemblage of the desired pentasaccharide via sequences of one-pot double glycosidations. 
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Method A: 4E (1.3-1.5 eq), 5E (1 eq), PhCH3/Et2O 4:1, Bi(OTf)3 (0.05 eq) in dioxane, -70 
°C to -60 °C, 45 min; then 3E (1-1.3 eq), -60 °C to 0°C, 90 min, 43-46 %. Method B: 4E (1.2 
eq), 5E (1 eq), PhCH3/Et2O 4:1, Yb(OTf)3 (0.03 eq) in dioxane, -10 °C, 30 min; then 3E (0.8 
eq), Bi(OTf)3 (0.025 eq) in dioxane, -60 °C to 10 °C, 90 min, 60%.  
 
The extensible precursor 19E of the ABC fragment was prepared by initial coupling of 5E 
and the 3-O-allylated trichloroacetimidate 4E, the subsequent addition of acceptor 3E to the 
mixture, and the adjustment of the experimental conditions for activating the 
trifluroacetimidate leaving group (Scheme 6). The one-pot synthesis was examined by using 
either Bi(OTf)3 or Yb(OTf)3 for the initial coupling. In the former case (Scheme 6, Method 
A), the first glycosidation step occurred at a very low temperature (from -70 to -60 °C) and 
the second coupling was accomplished without any further amount of promoter by the simple 
addition of acceptor 3E and the spontaneous warming of the mixture. Alternatively (Scheme 
6, Method B), Yb(OTf)3 promoted the first coupling between 4E and 5E at -10 °C for 30 min 
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then, after cooling to -60°C, acceptor 3E and Bi(OTf)3 (0.03 eq) were sequentially added and 
the mixture was allowed to warm spontaneously. As expected from the results of preliminary 
experiments shown on Table 1, use of a different promoter for each glycosidation (Method B) 
provided an improved yield, the results being in any way quite satisfying by the means of 
both methods (yields in the range of 43-60 %). It’s worthy of note that in both cases a very 
low amount of promoter(s) was needed for accomplishing the sequential double 
glycosidation, and the whole process took less than three hours, with a sensible acceleration in 
comparison with the previously reported catalytic procedure based on the sole Yb(OTf)3.8 
Trisaccharide 19E was smoothly deallylated to yield 20E (Scheme 6), the requisite acceptor 
for the final one-pot sequence leading to pentasaccharide 21E. Following the procedure that 
best served for 19E (Method B, Scheme 6), 18E was transiently formed from 4E and 5E 
under the agency of Yb(OTf)3, and then coupled with 20E in the presence of Bi(OTf) 3 to give 
21E  in a gratifying yield of 56% (Scheme 7).  
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Scheme 7 
 
Despite the structural changes in the final acceptor (20E rather than 3E), the yield of this 
sequence was somewhat similar to that leading to trisaccharide 19E. Pentasaccharide 21E was 
deallylated and debenzylated under standard conditions to yield the free pentasaccharide 1E 
which can be submitted to the procedure of random sulfation. On the other hand, the presence 
in 21E of differentiated protecting groups (allyl, benzyls and an anomeric 4-methoxy-phenyl 
group) renders the obtained pentasaccharide amenable of further structural elaborations. 
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Conclusions 
In conclusion, in this chapter it has shown the notable applicative potential of one-pot 
glycosidation of oligosaccharides conducted under exclusively catalytic conditions of 
activation, the pentasaccharide component of the drug PI-88 being rapidly accessed through a 
reduced number of synthetic steps and resorting to only three easily obtained D-mannose 
building-blocks. Notably, inclusion of Bi(OTf)3 in the activation system allows the one-pot 
glycosidation sequences to be accomplished in short times and high yields. Additionally, very 
low amounts of shelf-stable promoter(s) (about 0.10 eq) are sufficient for the assemblage of 
the overall sequence, which entails the construction of four glycosidic bonds. It’s also worthy 
of note that some model coupling experiments have shown that the trifluoroacetimidate 
anomeric group can play the role of a temporary anomeric protecting group in sequential 
multiglycosidation steps. Feasible access to a biological important target establishes a 
conceptually novel strategy where the catalytic activation of all sequential glycosidation steps 
allows to overcome important drawbacks of the current strategies such as the use of costly 
and/or sensitive stoichiometric promoters and the production of higher amounts of side-
products.  
 
 
 
 
 
 
 
 
 
 
 
 
 147
Experimental section 
General methods  
1
H and 
13
C NMR spectra were recorded in CDCl
3 
(internal standard, for 
1
H: CHCl
3 
at δ 7.26; 
for 
13
C: CDCl
3 
at δ 77.0) or D
2
O (internal standard, for 
1
H: HDO at δ 4.80, for 
13
C CH
3 
of 
acetone at δ 31.5). 
1
H NMR assignments were based on homo-decoupling experiments. 
MALDI-MS spectra were recorded in the positive mode: compounds were dissolved in 
acetonitrile (or water for compound 1E) at a concentration of 0.1 mg/mL and one microliter 
of these solutions were mixed with one microliter of a 20 mg/mL solution of 2,5-
dihydroxybenzoic acid in 7:3 CH
3
CN/H
2
O or, in the case of trifluoroacetimidate derivatives, 
with a 10 mg/mL solution of trihyroxyacetophenone in 1:1 MeOH/H
2
O. Analytical thin layer 
chromatography (TLC) was performed on aluminium plates pre-coated with Silica Gel 60 F
254 
as the adsorbent. The plates were developed with 5% H
2
SO
4 
ethanolic solution and then 
heating to 130°C. Column chromatography was performed on silica gel (63-200 mesh). 
Glycosidations were performed with commercial anhydrous solvents. Ytterbium(III) and 
bismuth(III) triflate were coevaporated three times in toluene and dried under vacuum for 45-
60 minutes before use in glycosidations. 
 
3,4,6-Tri-O-benzyl-1,2-O-(1-methoxyethylidene)-β-D-
mannopyranose (exo-orthoester) (6E). 1H NMR (CDCl3, 200 
MHz) δ = 7.50-7.10 (aromatic protons), 5.33 (1H, d, J1,2 = 2.4 Hz, 
H-1), 4.92-4.56 (6H, 3 x AB, 3 x benzyl CH2), 4.39 (1H, dd, J2,3 = 
3.8 Hz, H-2), 3.93 (1H, t, J = 9.2 Hz, H-4), 3.82-3.62 (3H, m, H-3, H-6a, H-6b), 3.45-3.34 
(1H, m, H-5), 3.28 (3H, s, -OCH3), 1.74 (3H, s, -CH3). 13 C NMR (CDCl3, 50 MHz) δ 138.0, 
137.7, 136.4, 128.3, 128.2, 128.1, 127.8, 127.6, 127.3, 127.2, 126.7, 120.0, 97.4, 78.8, 75.0, 
74.0, 73.9, 73.1, 72.1, 68.8, 64.7, 49.5, 24.3.  
 
1,2-Di-O-acetyl-3,4,6-tri-O-benzyl-α,β-D-mannopyranoside 
(7E). Orthoester 6E (3.895 g, 7.9 mmol) was dissolved at rt in 
80% aq AcOH (20 mL). After 30 minutes, the mixture was 
diluted with DCM and the organic phase washed with water, 
and then with aq Na2CO3. The aq phases were then re-extracted with DCM and the collected 
organic phases dried and concentrated under vacuum. The residue was dissolved in pyridine 
BnO
BnO
AcO
BnO
O
OAc
BnO
BnO
O
BnO
O
O
OMe
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(5 mL) and acetic anhydride (2.5 mL). After 2.5 hours the mixture was treated with MeOH 
and diluted with DCM. The organic phase was washed with water, dried and concentrated to 
yield syrupy 7E in a satisfying purity (3.960 g, α/β ca 4, yield 96%) to be directly submitted 
to the following step. 1H NMR (CDCl3, 300 MHz) δ = 7.50-7.00 (aromatic protons), 6.15 
(1H, d, J1,2 = 2.1 Hz, H-1), 5.39 (1H, bd, H-2), 4.90-4.50 (6H, 3 x AB, 3 x benzyl CH2), 4.00 
(1H, bd, J3,4 = 9.3 Hz, H-3), 3.95-3.75 (3H, H-5, H-6a, H-6b), 3.72 (1H, t, J4,5 = 9.3 Hz, H-4), 
2.17, 2.08 (6H, 2 x s, 2 x –COCH3). 13C NMR (CDCl3, 50 MHz): δ = 170.8, 170.0, 138.1 
(x2), 137.6, 128.9-127.5, 91.3, 75.3, 73.7, 73.6, 73.5, 71.9, 68.5, 67.5, 20.9. Anal. Calcd. for 
C31H34O8: C, 69.65, H, 6.41. Found: C, 69.93; H, 6.52. 
 
p-Methoxyphenyl 3,4,6-tri-O-benzyl-α-D-mannopyranoside 
(3E). To a solution of compound 7E (1.234 g, 2.31 mmol), and p-
methoxyphenol (436 mg, 3.51 mmol) in dry DCM (7 mL) freshly 
activated 4Å molecular sieves and BF3.OEt2 (75 μL, 0.59 mmol) 
were added at 0°C under argon. After removing the ice-bath, the mixture was stirred at room 
temperature for 3 hours and then pyridine (6 drops) was added to quench the reaction. The 
mixture was concentrated in vacuo and the residue submitted to silica gel flash-
chromatography to yield 8E slightly contaminated with un-reacted p-methoxyphenol. To this 
impure material dissolved in methanol (4 mL), was added drop-wise a solution of MeONa 
(2M in MeOH) until completion of the reaction (TLC). The mixture was then diluted with 
DCM, and washed with 0.1 M aq NaOH and water. Aqueous phases were re-extracted with 
DCM and the collected organic phases were dried and concentrated. The residue was applied 
to a short silica gel column eluted with petroleum ether/acetone 6:4 to yield 3E as a yellow oil 
(556 mg, 43% over two steps). [α]25D + 86.4° (c 1.0, CHCl3). 1H NMR (CDCl3, 300 MHz) δ = 
7.44-6.70 (aromatic protons), 5.50 (1H, d, J1,2 = 1.8 Hz, H-1), 4.84-4.40 (6H, 3 x AB, 3 x 
benzyl CH2), 4.19 (1H, m, H-2), 4.06 (1H, dd, J2,3 = 3.3 Hz, H-3), 3.94 (1H, t, J3,4 = J4,5 = 9.9 
Hz, H-4), 3.91-3.84 (1H, m, H-5), 3.74 (1H, dd, J5,6a = 4.2 Hz, J6a,6b = 10.8 Hz, H-6a), 3.73 
(3H, s, -OCH3), 3.63 (1H, dd, J5,6b = 1.5 Hz, H-6b), 2.55 (1H, d, J2,OH = 2.4 Hz, 2-OH). 13C 
NMR (CDCl3, 50 MHz): δ = 154.9, 150.0, 138.3, 138.2, 137.8, 128.4-127.0, 117.7, 114.5, 
98.2, 79.9, 75.0, 74.1, 73.2, 72.0, 71.5, 68.8, 68.2, 55.4. MALDI-MS: [M + Na]+ calcd 
579.24, found 579.32. Anal. Calcd. for C34H36O7: C, 73.36, H, 6.52. Found: C, 73.25; H, 6.55. 
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Methyl 3-O-allyl-α-D-mannopyranoside (10E). Methyl α-
mannopyranoside 9E (3.118 g, 16.1 mmol) and Bu2SnO (4.402 g, 
17.7 mmol) were refluxed in MeOH (80 mL) for 2 hours. The 
obtained solution was evaporated under vacuum. To the residue 
suspended in toluene (100 mL), allyl bromide (14.0 mL, 165 mmol) and TBAI (5.94 g, 16.1 
mmol) were sequentially added. The mixture was kept under stirring at 65-70 °C for 20 hours, 
and concentrated. Silica-gel flash-chromatography of the residue (eluent: ethyl 
acetate/petroleum ether from 7:3 to 8:2) yielded 10E slightly contaminated with 
tetrabutylammonium salts (estimated yield 65-70 % on the base of NMR integrations). The 
product thus obtained was directly submitted to the subsequent step. 1H NMR (200 MHz, 
CDCl3): δ = 6.05-5.85 (1H, m, -CH=CH2), 5.29 (1H, dq, J = 1.4 and 18.8 Hz, -
CH=CHcisHtrans), 5.17 (1H, bd, J = 10.4 Hz, -CH=CHcisHtrans), 4.73 (1H, bs, H-1), 4.25-3.70 
(6H), 3.65-3.40 (2H), 3.31 (3H, s, -OCH3). 
 
Methyl 3-O-allyl-2,4,6-tri-O-benzyl-α-D-mannopyranoside 
(11E). To a solution of compound 10E (estimated mass ca 2.5 g, 
ca 11 mmol) in dry DMF (13 mL) were sequentially added at 0°C 
benzyl bromide (6.4 mL, 54 mmol) and sodium hydride (60% in 
oil, 1.75 g, 73 mmol). The mixture was allowed to warm to rt, and after 3 hours MeOH (ca 1 
mL) was added. The mixture was diluted with DCM and the organic phase washed with 
water. The aq phase was re-extracted with DCM and the collected organic phases were dried  
with anhydrous Na2SO4 and concentrated in vacuo to give a residue which was purified by 
silica gel flash-chromatography (eluent: petroleum ether/ethyl acetate 85:15) to yield 11E as 
an oil (5.465 g, 53% over two steps). [α]25D + 29.4° (c 1.0, CHCl3). 1H NMR (200 MHz, 
CDCl3): δ = 6.05-5.85 (1H, m, -CH2CH=CH2), 5.34 (1H, dq, J = 1.6 and 17.4 Hz, -
CH=CHcisHtrans), 5.17 (1H, dq, J = 10.2 Hz, -CH=CHcisHtrans), 4.78 (1H, bs, H-1), 4.93-4.50 
(6H, 3 x AB, benzyl CH2), 4.15-4.05 (2H, m, -OCH2CH=CH2), 4.00-3.85 (2H), 3.85-3.70 
(4H), 3.34 (3H, s, -OCH3). 13C NMR (50 MHz, CDCl3): δ = 138.5, 138.4 (x2), 134.9, 128.2-
127.5, 116.5, 99.0, 79.8, 75.0, 74.8, 74.5, 73.3, 72.5, 71.6, 71.0, 69.3, 54.7. MALDI-MS: [M 
+ Na]+ calcd 527.24, found 527.30. Anal. Calcd. for C31H36O6: C, 73.79, H, 7.19. Found: C, 
73.65; H, 7.23. 
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3-O-Allyl-2,4,6-tri-O-benzyl-D-mannopyranose (12E). A 
solution of 11E (446 mg, 0.88 mmol) in 7:1 AcOH/1M H2SO4 
(5.4 mL) was heated at 110 °C for 70 minutes. The mixture was 
then diluted with DCM, and the organic phase was washed with 
water. The aq phase was re-extracted with DCM. Collected organic phases were washed with 
aq sodium carbonate and concentrated. The residue was purified by silica gel flash 
chromatography (eluent: petroleum ether/ethyl acetate from 3:1 to 7:3) to yield 12E as a 
yellow oil (434 mg, α/β ca 7:1, 71%). 1H NMR (300 MHz, CDCl3): δ = 6.05-5.85 (1H, m, -
CH=CH2), 5.34 (1H, bd, J = 17.4 Hz, CH2CH=CHcisHtrans), 5.25 (1H, bs, H-1), 5.19 (1H, bd, J 
= 10.2 Hz, CH=CHcisHtrans), 4.91-4.48 (6H, 3 x AB, benzyl CH2), 4.15-4.00 (3H), 3.95-3.60 
(5H), 3.24 (bs, 1-OH). 13C NMR (50 MHz, CDCl3): δ = 138.3 (x2), 137.8, 134.8, 128.2-
127.5, 116.4, 92.4, 79.3, 75.0, 74.9, 73.0, 72.4, 71.2, 70.9, 70.8, 69.5. MALDI-MS: [M + Na]+ 
calcd 513.23, found 513.18. Anal. Calcd. for C30H34O6: C, 73.45, H, 6.99. Found: C, 73.28; 
H, 7.04. 
 
Trichloroacetimidoyl 3-O-allyl-2,4,6-tri-O-benzyl-α-D-
mannopyranoside (4E). To a solution of 12E (488 mg, 
0.99 mmol) in DCM (5 mL) were sequentially added at 0°C 
trichloroacetonitrile (400 μL, 4 mmol) and sodium hydride 
(60% in oil, 10 mg, 0.25 mmol). The mixture was allowed 
to warm to rt and concentrated after 40 minutes. The 
residue was chromatographed on neutral alumina (Brockman grade 2, eluent: petroleum 
ether/ethyl acetate 9:1 with two drops of pyridine for every 100 mL of eluent) to yield 4E as 
an oil (560 mg, yield 89%). 1H NMR (CDCl3, 300 MHz) δ = 8.69 (1H, s, -NH), 7.53-7.20 
(aromatic protons), 6.52 (1H, s, H-1), 6.04-5.91 (1H, m, -OCH2-CH=CH2), 5.37 (1H, dd, J = 
1.2 and 17.4 Hz, CH=CHcisHtrans), 5.24 (1H, dd, J = 10.5 Hz, –OCH2-CH=CHcisHtrans), 4.99-
4.57 (6H, 3 x AB, 3 x benzyl CH2), 4.23 (1H, t, J = 9.6 Hz, H-4), 4.19-4.07 (3H, m, H-5 and -
OCH2CH=CH2), 4.06 (1H, dd, J1,2 = 1.8 Hz, J2,3 = 2.7 Hz, H-2), 3.97 (1H, dd, H-3), 3.91 (1H, 
dd, J5,6a = 4.5 Hz, J6a,6b = 11.4 Hz, H-6a), 3.81 (1H, bd, H-6b). 13 C NMR (CDCl3, 75 MHz) δ 
= 160.0, 138.0 (x2), 137.6, 134.4, 128.1-127.1, 116.8, 95.9, 90.7, 78.7, 74.9, 74.5, 73.7, 73.0 
(x2), 72.3, 70.8, 68.4. Anal. Calcd. for C32H34Cl3NO6: C, 60.53, H, 5.40. Found: C, 60.41; H, 
5.46. 
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2,4,6-Tri-O-benzyl-D-mannopyranose (13E). To a solution 
of 12E (307 mg, 0.63 mmol) in methanol (2 mL) was added at rt 
palladium chloride (15 mg, 0.085 mmol). The mixture was 
stirred overnight and then concentrated under vacuum. The 
residue was then filtered through a short plug of silica gel (eluent DCM/MeOH 95:5), 
concentrated, and purified by silica-gel flash chromatography (eluent: petroleum ether/ ethyl 
acetate from 7:3 to 6:4) to provide diol 13E as an oil (α:β ca 9:1, 205 mg, yield 72%). 1H 
NMR (CDCl3, 300 MHz) δ = 7.5-7.10 (aromatic protons), 5.31 (1H, s, H-1), 4.89-4.51 (6H, 3 
x AB, 3 x benzyl CH2), 4.10-4.00 (2H, m, H-3, H-5), 3.84-3.64 (3H, m, H-2, H-6a, H-6b), 
3.60 (1H, t, J3,4 = J4,5 = 9.6 Hz, H-4), 2.92 (1-OH). 13 C NMR (CDCl3, 75 MHz) 138.5, 137.9 
(x2), 128.4-127.6, 91.5, 79.0, 78.6, 74.8, 73.4, 72.9, 71.5, 70.6, 69.7. Anal. Calcd. for 
C27H30O6: C, 71.98, H, 6.71. Found: C, 71.85; H, 6.77. 
 
(N-Phenyl)trifluoroacetimidoyl 2,4,6-tri-O-benzyl-
α,β-D-mannopyranoside (5E). To a solution of diol 13E 
(399 mg, 0.89 mmol) in acetone (3 mL) were 
sequentially added at 0 °C Cs2CO3 (324 mg, 0.99 mmol) 
and (N-phenyl)trifluoroacetimidoyl chloride (220 μL, 1.8 mmol). The mixture was allowed to 
warm to rt and after two hours concentrated under vacuum. The residue was purified by 
chromatography on neutral alumina (Brockman grade 2, eluent: petroleum ether/ethyl acetate 
9:1 with two drops of pyridine for every 100 mL of eluent) to yield 5E as a yellow oil 
(anomeric mixture α/β ca 4:1, 492 mg, yield 89%). 1H NMR (CDCl3, 300 MHz) δ = 7.50-
6.81 (aromatic protons), 6.42 (1H, bs, H-1), 4.92-4.56 (6H, 3 x AB, 3 x benzyl CH2), 4.08 
(1H, m, H-3), 4.03-3.77 (5H), 2.75 (1H, d, J3,OH = 8.4 Hz, 3-OH). 13C NMR (CDCl3, 75 MHz) 
δ = 143.3, 138.0 (x2), 137.0, 129.0-127.7, 127.4, 124.3, 119.3, 94.5, 75.9, 75.5, 74.9, 73.8, 
73.3, 72.7, 71.2, 68.5. Anal. Calcd. for C35H34F3NO6: C, 67.62, H, 5.51. Found: C, 67.50; H, 
5.59.  
 
(N-Phenyl)trifluoroacetimidoyl 2,3,4,6-
tetra-O-benzyl-α-D-mannopyranosyl-
(1→3)-2,4,6-tri-O-benzyl-α-D-
mannopyranoside (15Eα). 
Trichloroacetimidate 14E (26 mg, 0.038 
mmol) and trifluoroacetimidate 5E (17 mg, 
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0.027 mmol) were coevaporated three times with toluene (3 x 0.5 mL) and dried under 
vacuum. After adding 4Å AW 300 MS, the mixture was dissolved with 4:1 toluene/Et2O (1 
mL) and cooled to -10 °C. After stirring for ca 15 min, a solution of Yb(OTf)3 in dioxane (20 
mg/mL, 25 μL, 8.1 μmol) was added and after 30 min the reaction was quenched at the same 
temperature with pyridine. The mixture was filtered on a short plug of neutral alumina and 
concentrated. The residue was chromatographed on neutral alumina (Brockman grade 2, 
eluent: petroleum ether/ethyl acetate 85:15 with two drops of pyridine for every 100 mL) to 
yield 15Eα as an oil (18 mg, yield 58%). 1H NMR (CDCl3, 300 MHz) δ = 7.60-6.75 
(aromatic protons), 6.25 (1H, bs, H-1), 5.25 (1H, s, H-1′), 4.90-4.46 (14H, 7 x AB, 7 x benzyl 
CH2), 4.15 (1H, dd, H-3), 3.94 (1H, d, J2,3 = 3.3 Hz, H-2), 3.77 (1H, bd, H-2′), 4.20-3.60 (9H). 
13 C NMR (CDCl3, 75 MHz) δ = 143.4, 138.7, 138.4, 138.2, 138.1, 138.0, 137.5, 129.3-119.4, 
100.1, 94.7, 79.7, 75.8, 75.5, 74.9, 74.7, 74.5, 74.1, 73.39, 73.38, 72.7, 72.4, 72.2, 69.3, 68.6. 
MALDI-MS: [M + Na]+ calcd 1166.46, found 1166.70. Anal. Calcd. for C69H68F3NO11: C, 
72.42, H, 5.99. Found: C, 72.40; H, 6.07. 
 
p-Methoxyphenyl 2,3,4,6-tetra-O-
benzyl-α-D-mannopyranosyl-(1→3)-2,4,6-
tri-O-benzyl-α-D-mannopyl-(1→2)-3,4,6-
tri-O-benzyl-α-D-mannopyranoside (17E). 
Disaccharide donor 15Eα (25 mg, 0.022 
mmol) and acceptor 3E (9 mg, 0.017 mmol) 
were co-evaporated three times with toluene 
(3 x 0.5 mL) and dried under vacuum. After 
adding 4Å AW 300 MS, the mixture was dissolved under argon with 4:1 toluene/Et2O (0.7 
mL), cooled to -60 °C, and stirred for 15 min. A solution of Bi(OTf)3 in dioxane (20 mg/mL, 
17 μL, 0.5 μmol) was then added, and after stirring for 20 min at -60 °C, the temperature was 
allowed to raise up to -20 °C over 60 minutes. Pyridine was added to quench the reaction and 
the mixture was filtered on a short plug of silica gel, concentrated and purified by silica gel 
flash chromatography (eluent: petroleum ether/ethyl acetate from 8:2 to 7:3) to yield 17E as 
an oil (22 mg, 84% yield). 1H NMR (CDCl3, 400 MHz) δ = 7.40-7.00 (benzyl protons), 6.98 
and 6.72 (4H, 2 x d, Jortho = 9.2 Hz, aromatic p-methoxyphenyl protons), 5.57 (1H, d, J = 1.6 
Hz, H-1), 5.23 (1H, bs, anomeric proton), 5.22 (1H, d, J = 1.6 Hz, anomeric proton), 4.90-
4.33 (20H, 10 x AB, 10 x benzyl CH2), 4.26 (1H, t, H-2), 4.21 (1H, dd, J = 3.0 and 8.4 Hz), 
4.13-4.06 (2H), 4.00-3.80 (7H), 3.73 (3H, s, -OCH3), 3.77-3.62 (6H), 3.56 (1H, bd, J = 10.0 
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Hz). 13 C NMR (CDCl3, 50 MHz) 154.8, 150.1, 138.8, 138.5-138.2, 128.2-127.0, 117.9, 
114.5, 99.6, 99.5, 98.0, 80.0, 79.6, 75.5, 75.1, 75.0, 74.7, 74.2, 73.3, 73.2, 72.5, 72.3, 72.2, 
72.1, 69.2, 68.9, and 55.6. MALDI-MS: [M + Na]+ calculd 1533.67, found 1533.56. Anal. 
Calcd. for C95H98O17: C, 75.47, H, 6.53. Found: C, 75.28; H, 6.62. 
 
p-Methoxyphenyl 3-O-allyl-2,4,6-tri-O-
benzyl-α-D-mannopyranosyl-(1→3)-2,4,6-
tri-O-benzyl-α-D-mannopyl-(1→2)-3,4,6-tri-
O-benzyl-α-D-mannopyranoside (19E). 
Trichloroacetimidate 4E (123 mg, 0.194 
mmol) and trifluoroacetimidate 5E (106 mg, 
0.170 mmol) were coevaporated three times 
with anhydrous toluene (3 x 1 mL) and dried 
under vacuum for 1 hour. The residue was dissolved under argon with 4:1 toluene/Et2O (4.7 
mL) in the presence of freshly activated 4Å AW300 MS. The mixture was then cooled to -10 
°C and stirred for 15 minutes. A solution of Yb(OTf)3 in dioxane (25 mg/mL, 125 μL, 0.005 
mmol) was added at that temperature, the mixture was stirred for 30 min and then cooled to –
60°C. Acceptor 3E (75 mg, 0.135 mmol) in 4:1 toluene/Et2O (0.9 mL) and a solution of 
Bi(OTf)3 in dioxane (16.6 mg/mL, 160 μL, 0.004 mmol) were subsequently added, and the 
temperature was allowed to warm up to 10 °C over 90 minutes. The reaction was quenched 
with some drops of pyridine and the mixture was filtered on a short plug of silica gel (eluent: 
DCM/MeOH/acetonitrile 85:10:5), concentrated, and purified by silica-gel flash-
chromatography (eluent: petroleum ether/ethyl acetate from 9:1 to 8:2) to yield trisaccharide 
19E as a yellow oil (118 mg, 60 % overall yield). [α]25D + 29.7° (c 1.0, CHCl3). 1H NMR 
(CDCl3, 400 MHz) δ = 7.50-7.10 (aromatic benzyl protons), 7.10 and 6.93 (4H, 2 x d, Jortho = 
9.2 Hz, aromatic p-methoxyphenyl protons), 5.80-5.95 (1H, m, OCH2-CH=CH2), 5.58 (1H, d, 
J1,2 = 1.6 Hz, H-1), 5.26 (1H, dd, Jtrans = 1.2 and 16.8 Hz, -OCH2-CH=CHcisHtrans), 5.24 (2H, 
bs, H-1′ and H-1′′), 5.26 (1H, dd, Jcis = 10.4 Hz, -OCH2-CH=CHcisHtrans), 4.90-4.30 (18H, 9 x 
AB, 9 x benzyl CH2), 4.27 (1H, t, H-2), 4.23 (1H, dd, J = 3.2 and 8.4 Hz), 4.15-4.10 (2H), 
3.74 (3H, s, -OCH3), 4.15-3.65 (16 H), 3.56 (1H, bd, J = 9.6 Hz). 13 C NMR (CDCl3, 75 MHz) 
154.9, 150.1, 138.6-138.2, 135.0, 128.3-127.0, 116.4, 118.0, 114.5, 99.5 (x2), 98.0 (C-1), 
79.7, 79.6, 75.3, 75.2, 75.1, 74.8, 74.6, 73.2, 73.1, 71.0, 69.2, 68,8, 55.6. MALDI-MS [M + 
Na]+ calcld 1483.65, found 1483.85. Anal. Calcd. for C91H96O17: C, 74.77, H, 6.62. Found: C, 
74.60; H, 6.69. 
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p-Methoxyphenyl 2,4,6-tri-O-benzyl-α-
D-mannopyranosyl-(1→3)-2,4,6-tri-O-
benzyl-α-D-mannopyl-(1→2)-3,4,6-tri-O-
benzyl-α-D-mannopyranoside (20E). PdCl2 
(2 mg, 0.011 mmol) was added to a solution 
of trisaccharide 19E (110 mg, 0.075 mmol) 
in MeOH/DCM 9:1 (6 mL). After three 
hours under stirring the mixture was concentrated under vacuum, resuspended with 
DCM/MeOH 95:5, filtered on a short plug of silica-gel, concentrated and purified by silica-
gel flash chromatography (eluent: toluene/acetone 96:4) to yield 20E as an oil (98 mg, yield 
92%). [α]25D + 35.2° (c 1.0, CHCl3). 1H NMR (CDCl3, 400 MHz) δ = 7.50-7.10 (benzyl 
aromatic protons), 6.99 and 6.73 (4H, 2 x d, Jortho = 9.2 Hz, p-methoxyphenyl protons), 5.60 
(1H, d, J = 1.6 Hz, H-1), 5.27 (1H, bs, anomeric proton), 5.23 (1H, d, J = 1.6 Hz, anomeric 
proton), 4.85-4.30 (18 H, 9 x AB, 9 x benzyl CH2), 4.28 (1H, t, H-2), 4.25 (1H, dd, J = 3.2 
Hz, 9.6 Hz), 4.20-4.10 (2H), 3.74 (3H, s, -OCH3), 4.05-3.60 (14 H, m), 3.52 (1H, bd, J = 11.6 
Hz). 13C NMR (CDCl3, 100 MHz) δ = 154.9, 150.2, 138.7, 138.3, 138.2 (x6), 137.7, 128.5-
126.9, 117.9, 114.5, 99.6, 98.5, 98.0, 79.6, 78.7, 77.5, 75.1 (x2), 74.9, 74.7, 74.5, 74.2, 73.3, 
73.2, 73.1, 72.4, 72.3, 72.1, 72.0, 71.7, 71.6, 69.2, 68.7, 55.6 (-OCH3). MALDI-MS [M + 
Na]+ calcld 1443.62, found 1443.78. Anal. Calcd. for C88H92O17: C, 74.35, H, 6.52. Found: C, 
74.18; H, 6.61. 
 
 
 
 
BnO
O
BnO
BnO
O
BnO
HO
BnO
BnO
O
BnO
BnO
O
BnO
O
OMP
 155
O
BnO
AllO
BnO
BnO
OBnO
BnO
OBnO
BnO
OBnO
BnO
O
BnO
O
BnO
OMP
BnO
BnO
BnO
O
O
BnO
O
 
p-Methoxyphenyl 3-O-allyl-2,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→3)-2,4,6-tri-O-
benzyl-α-D-mannopyranosyl-(1→3)-2,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→3)-
2,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→2)-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
(21E). Trichloroacetimidate 4E (44 mg, 0.069 mmol) and trifluoroacetimidate 5E (29 mg, 
0.047 mmmol) were coevaporated three times with anhydrous toluene (3 x 1 mL) and dried 
under vacuum for 45 minutes. The residue was dissolved under argon with 4:1 toluene/Et2O 
(1.5 mL) in the presence of freshly activated 4Å AW300 MS and the resulting mixture was 
cooled to -10 °C and stirred for 15 minutes. A solution of Yb(OTf)3 in dioxane (22.5 mg/mL, 
40 μL, 1.4 μmol) was added at that temperature, the mixture was stirred for 30 min and then 
cooled to – 60°C. Acceptor 20E (44 mg, 0.031 mmol) in 4:1 toluene/Et2O (0.4 mL) and a 
solution of Bi(OTf)3 in dioxane (16.6 mg/mL, 49 μL, 1.2 μmol) were subsequently added, and 
the temperature was allowed to raise up to rt over 2 hours. The reaction was quenched with 
some drops of pyridine and the mixture was filtered on a short plug of silica gel (eluent: 
DCM/MeOH/acetonitrile 85:10:5), concentrated, and purified by silica-gel flash-
chromatography (eluent: petroleum ether/ethyl acetate from 9:1 to 8:2) to yield 
pentasaccharide 21E as an oil (40 mg, yield 56 %). [α]25D + 25.3° (c 0.8, CHCl3). 1H NMR 
(CDCl3, 400 MHz) δ = 7.40-7.00 (benzyl protons), 6.98 and 6.73 (4H, 2 x d, Jortho = 9.2 Hz, 
aromatic p-methoxyphenyl protons), 6.00-5.90 (1H, m, -OCH2-CH=CH2), 5.60 (1H, bs, H-1), 
5.28 (3H, bs, 3x anomeric protons), 5.25 (1H, bs, anomeric proton), 5.23 (1H, bd, Jtrans = 17.6 
Hz, -CH=CHcisHtrans), 5.08 (1H, bd, J = 10.4 Hz, -CH=CHcisHtrans), 4.75-4.25 (30H, 15 x AB, 
15 x benzyl CH2), 4.30-4.20 (3H), 4.15-4.10 (2H), 4.05-3.68 (16H), 3.74 (3H, s, -OCH3), 
3.65-3.60 (2H), 3.60-3.55 (3H), 3.55-3.45 (3H), 3.38 (1H, bd, J = 10.4 Hz). 13C NMR (CDCl3, 
100 MHz) 154.9, 150.2, 139.0, 138.7, 138.4 (x4), 138.3 (x4), 138.2 (x4), 138.1, 135.0, 128.5-
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126.8, 118.0, 116.4, 114.5, 99.9, 99.6, 99.4, 99.3, 98.0, 76.7, 76.6, 78.9, 78.4, 77.8, 77.3, 77.2, 
76.9, 76.8, 75.7, 75.2, 75.1, 75.0, 74.7, 74.5, 74.3, 73.3, 73.2, 73.1, 72.7, 72.6, 72.5, 72.3, 
72.2, 72.0, 71.9, 71.0, 69.4, 69.3, 69.2, 69.0, 68.8, 55.6. MALDI-MS [M + Na]+ calcld 
2349.05, found 2348.93. Anal. Calcd. for C145H152O27: C, 74.85, H, 6.58. Found: C, 74.63; H, 
6.66. 
 
 
 
p-Methoxyphenyl α-D-mannopyranosyl-(1→3)-α-D-mannopyranosyl-(1→3)-α-D-
mannopyranosyl-(1→3)-α-D-mannopyranosyl-(1→2)-α-D-mannopyranoside (1E). PdCl2 
(2 mg, 0.011 mmol) was added to a solution of pentasaccharide 21E (37 mg, 0.014 mmol) in 
MeOH/DCM 9:1 (3 mL). After ca 60 minutes under stirring the mixture was concentrated 
under vacuum, resuspended with DCM/MeOH 95:5, filtered on a short plug of silica-gel and 
concentrated. The residue was dissolved with several aliquots of MeOH/formic acid 9:1 (total 
volume 4 mL) and added under argon to palladium on charcoal (10 %, 50 mg) previously wet 
with tha same solution. The mixture was ultra-sonicated for two hours and then filtered on a 
plug of celite and concentrated under vacuum. The residue was eluted with water and 
methanol on a short column of mixed-bed ion exchange resin and concentrated to yield 
pentasaccharide 1E as a white amorphous solid (9 mg, 70% over two steps). [α]25D + 43.3° (c 
0.6, H2O). 1H NMR (D2O, 400 MHz) δ = 7.08 and 6.93 (4H, 2 x d, Jortho = 10.2 Hz, p-
methoxyphenyl protons), 5.71 (1H, d, J1,2 = 1.6 Hz, H-1), 5.09 (2H, bs, 2 x anomeric protons), 
5.07 (1H, d, J1,2 = 1.2 Hz, anomeric proton), 5.01 (1H, d, J1,2 = 1.8 Hz, anomeric proton), 4.21 
(1H, dd, J = 1.8 and 3.0 Hz), 4.18-4.16 (2H), 4.13 (1H, dd, J = 1.8 and 3.4 Hz, H-2), 4.08 (1H, 
dd, J = 3.0 and 8.8 Hz), 4.03-4.01 (2H), 3.98 (1H, m), 3.96 (1H, m), 3.76 (3H, s, -OCH3), 
3.92-3.60 (21H). 13C NMR (D2O, 50 MHz) 155.9, 151.0, 120.1, 116.3, 103.6 (x2), 103.5, 
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103.4, 99.1, 80.3, 80.2, 79.3, 74.8, 74.7, 74.6, 71.6, 71.3, 70.9, 68.1, 68.0, 67.5, 67.4, 62.3, 
61.9, 57.0. MALDI-MS: [M + Na]+ calculd 957.31, found 957.45. Anal. Calcd. for C37H58O27: 
C, 47.54, H, 6.25. Found: C, 47.38; H, 6.30. 
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Chapter F 
One-pot catalytic glycosidation-Fmoc removal: an iterable 
sequence  for straightforward assembly of oligosaccharides 
related to HIV gp120. 
 
Introduction 
As it was widely discussed in Chapter E, standard strategies of sequential glycosidations 
contemplate the elongation of the oligomer starting from the non-reducing terminus of the 
target. However, with the exception of the previously mentioned preactivation strategy, the 
success of the elongation is critically dependent on the availability of a set of glycosyl donors 
displaying well differentiated reactivities. Here it was reported the less common approach of 
sequential glycosidations featuring the opposite elongation direction.1 In general terms, this 
can be pursued by first coupling a glycosyl donor with a glycosyl acceptor and then removing 
in the same reaction vessel a transient protecting group from the in situ generated di- or 
oligosaccharide. In this way, after a single purification process a potential glycosyl acceptor, 
ready for a further glycosidation step, is directly obtained. Apart from the reduced overall 
number of synthetic operations, this strategy is advantageous because it is independent of the 
anomeric reactivity of the involved components since in each glycosidation step there is no 
competition between two potential glycosyl donors. So far a few sparse examples of this tactic 
have been reported.2 Almost all of them exploit the acidic conditions required in the 
glycosidation step for performing, upon adjustment of the experimental conditions, the 
subsequent removal of the transient protecting group (Figure 1). 
 
Figure 1 
A much less exploited synthetic route is instead the removal of a base labile protecting 
group immediately after an acid promoted glycosidation. In this regard, Fmoc was recently 
applied as a transient protecting group3 in the synthesis of β-(1→6) gluco oligosaccharides 
conducted in microreactors4 (Figure 2). 
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Figure 2 
The group survived the acid activation (with 2-3 eq of TMSOTf) of glycosyl phosphate 
donors and was removed by simple excess addition of a mild base (piperidine/DMF 1:4) to 
the glycosidation medium. The excess of promoter caused partial trimehtyl silylation of the 
liberated alcohol, a process which required the addition of desilylation agents in the 
deprotection mixture. By a similar approach, Fmoc was removed in situ from oligosaccharide 
intermediates just generated by electrochemical glycosidations.5 
In this chapter it was described the effective application of Fmoc as a transient group in an 
iterable sequence for solution oligosaccharide synthesis based on the Bi(OTf)3 catalyzed 
activation6,7 of glycosyl trihaloacetimidates. The devised strategy has been targeted to the 
rapid assembly of two biologically relevant targets, the protected mannose tetrasaccharide 1F 
and the branched pentasaccharide 2F, both corresponding to moieties incorporated into HIV 
glycoprotein gp120 (Figure 3).  
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Figure 3 Structures of the gp120 glycan and the synthetic targets of the present work. 
In particular, tetrasaccharide 1F represents the partially protected so-called D1 arm of the 
highly mannosylated ensemble, whereas compound 2F embodies both partially protected D2 
and D3 arms. Either sequence was found to exhibit high affinity towards human antibody 
2G128 (Figure 4, 5 and 6) so to be currently investigated for immunogenic applications.9 
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Figure 4 Chemical structures of oligomannosides 2-6 and their inhibition (%) of 2G12 to 
gp120. Man9 = Man9GlcNAc2 (1). 
 
 
Figure 5 Crystal structure of Fab 2G12 with Man4. (A) 2Fo _ Fc electron density map of the 
Man4 sugar (shown in ball-and-stick) contoured at 1.8σ. Mannose residues are labeled in red. 
The light and heavy chains of Fab 2G12 are shown in cyan and purple. (B) Overlap of the 
Man4 sugar (shown in blue) with a previous Fab 2G12 structure10 bound to Man9GlcNAc2 
(shown in green). The Man4 clearly adopts a conformation similar to the D1 arm of 
Man9GlcNAc2. (C) Additional H bonds between Fab 2G12 and mannose 4 of Man4. Two of 
the H bonds are water mediated (water molecules shown as gray spheres). These interactions 
may explain in the preference for D1 arm binding in the context of the full Man9GlcNAc2 
moiety. Figures were made by using MOLSCRIPT11, BOBSCRIPT12, and RASTER3D13. 
 
In the crystal structure of Fab 2G12 in complex with Man4 (oligomannose 3), the Man4 sugar 
is located in the combining site of the Ab and has extremely well defined electron density 
(Fig. 5A). As expected, the Manα1–2Man terminus of the sugar (consisting of mannoses D1 
and C) binds end-on in a cleft in the binding site. An overlay with a previous structure of Fab 
2G12 plus Man9GlcNAc210 shows that Man4 binds with a similar geometry to the D1 arm of 
Man9GlcNAc2 (Fig. 5B) that correlates with the biochemical data that indicate Man4 binds as 
well as the entire Man9GlcNAc2 moiety8. The crystal structure of the Fab 2G12–Man4 
complex is of higher resolution and allows better characterization of the interactions between 
Fab and sugar ligand. A total of 51 van der Waals interactions and 15 H bonds are formed on 
complex formation; 292 Å2 of molecular surface is buried on Fab 2G12 and 294 Å2 is buried 
on the sugar in the complex. Although the bulk of the interactions are with Manα1–2Man 
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(mannoses D1 and C), three H bonds are made between 2G12 and mannose 4, two of which 
are water-mediated (Fig. 5C). TyrL94 H bonds to the O-3 oxygen of mannose 4, whereas water 
molecules coordinate between the O-5 of mannose D1 and the O-3 of mannose 4, and 
between TyrH56 and the O-4 of mannose 4. 
Man5 (oligomannose 4) is instead the structural equivalent of the D2 and D3 arms of 
Man9GlcNAc2. 2G12 binds to Man5 with similar apparent affinity as Man4 and 
Man9GlcNAc28. The Manα1–2Man moieties (mannoses D3 and B), which correspond to the 
D3 arm of Man9GlcNAc2, are well ordered in the primary combining site (Fig. 6). The other 
Manα1–2Man (mannoses D2 and A) branch, which corresponds to the D2 arm of 
Man9GlcNAc2, points away from the binding site, confirming biochemical studies that 
suggest 2G12 recognizes the D3 arm in preference to D2. 302 Å2 of molecular surface is 
buried on Fab 2G12 and 307 Å2 is buried on Man5 upon complex formation. Unlike Man4 (D1 
arm) binding, no additional H bonds are made to sugars other than with the terminal Manα1–
2Man. 
 
Figure 6 
 
Results and discussion 
Before developing the sequential one-pot scheme of Bi(OTf)3 catalyzed multiglicosidation 
followed by the removal of one or more base labile Fmoc temporary protecting group by 
simple addition of TEA to the reaction vessel, it was hoped to perform the elaboration of  the 
D1, D2 and D3 arms of the gp120 of the HIV-1 with a sequential one-pot scheme analogous 
to the straightforward assemblage of the fully protected p-methoxyphenyl pentamannoside 
21E of PI-88 as described in Chapter E. Both these elaborations potentially would require 
three building blocks where one of the three is a (N-phenyl)trifluoroacetimidate mannosyl 
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donor deprotected at O-2 and also bearing acyl or benzyl groups on the other positions 
(Scheme 1 and 2). 
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After many experiments of regioselective anomeric trifluoroacetimidoylation of diol 3F by 
using different bases (Cs2CO3, Cs2CO3/TBAI, NaH/TBAI) or by producing in situ an 
anomeric tri-nbutylstannyl ether (Scheme 3), at the moment I can assert that it is currently 
impossible to synthesize a 2-OH (N-phenyl)trifluoroacetimidate mannosyl donor 3,4,6-tri-O-
benzylated. 
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a) MeOH/MeONa 2M, from 0°C to rt
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Additionally, it was also tried the synthesis of a a 2-OH (N-phenyl)trifluoroacetimidate 
mannosyl donor 3,4,6-tri-O-benzoylated as it has showed in Scheme 4. After a standard 
sequence of reactions it was obtained 6F that was subsequently deallylated to provide diol 8F. 
With this building block, it was hoped that its treatment, with (N-phenyl)trifluoroacetimidoyl 
chloride (2 eq) and a base such as Cs2CO3 or K2CO3 (1.1 eq) in acetone starting from 0°C and 
then raising the temperature to rt, would afford the desired mannosyl donor deprotected at O-
2. Indeed with these experimental conditions and after chromatographic purification of the 
crude mixture, it was observed the regioselective trifluoroacetimidoylation of the anomeric 
carbionl but also the simultaneous undesired intramolecular transbenzoylation that afforded a 
mixture of mannosyl donors deprotected either at O-2 or O-3. This result was deduced from 
the 1H NMR spectrum which displayed the presence of these significant signals: two broad 
singlets at δ 6.48 and 6.42 indicating two α-anomers, two triplets at δ 6.06 and 5.78, a double 
doublet and a broad doublet in the range of δ 5.74-5.63 denoting the presence of protons 
(respectively 2x 4-H, 3-H and 2-H) attached to benzoylated carbinols. The heterogeneous 
sample so obtained was unuseful for the desired synthetic purposes.    
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After these frustrating results, the attention was turned to the syntesis of a 2-OH (N-
phenyl)trifluoroacetimidate mannosyl donor equipped with acetyl groups on the other 
carbinol positions. In this case it was supposed that access to this kind of mannosyl donor 
would be possible through an original potential pathway based on the hypotesis of the feasible 
removal under mild basic conditions of a Fmoc carbonate in the presence of a 
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trifluoroacetimidate anomeric group. This application would have expand the concept of 
temporary anomeric protection for this group that was also stated in Chapter E in the context 
of sequential multiglycosidation steps. To verify the validity of this strategy, it was introduced 
a Fmoc group on the O-2 of the previously described allyl mannoside 3,4,6-tri-O-acetylated 
18B but in the here reported conditions a mixture of  two fully protected building blocks was 
obtained (Scheme 5). Despite this initial unsatisfactory result, the subsequent synthetic steps 
of deallylation and imidoylation were accomplished and finally it was demonstrated that 
excess amounts of TEA remove a Fmoc carbonate in the presence of a trifluoroacetimidate 
anomeric group. This is a very interesting result but once again it was currently impossible to 
obtain a 2-OH (N-phenyl)trifluoroacetimidate mannosyl donor equipped with acyl groups on 
the other carbinol positions.      
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With these poor results in hand, the attention was turned to a different sequential one-pot 
scheme allowing the synthesis of mannose oligomers starting from the reducing terminus to 
avoid potential problems associated with the opposite elongation sense such as both 
availability and use of a set of glycosyl donors featuring a well differentiated decreasing 
reactivity. As detailed below, catalytic amounts of easy to handle Bi(OTf)3 activate 
trihaloacetimidate mannosyl donors, equipped with a Fmoc temporary protecting group, to 
perform one or more glycosidation reactions. The subsequent addition to the reaction vessel 
of a mild base such as TEA  allows both quenching of the promotion system and removal of 
one or more transient Fmoc groups from the oligosaccharide generated in situ. In this way, 
after a chromatographic purification an oligosaccharide acceptor is directly obtained and, if 
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necessary, it is ready for a further elongation step. As it will be widely shown in this chapter, 
this approach is an especially effective sequential one-pot iterable scheme for constructing the 
target compounds. 
For the target 1F14 was planned the following retrosynthetic analysis (Figure 7) entailing 
the availability of only two mannose building blocks, 9F and 10F, the latter being the 
precursor of the reducing terminal residue. 
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Figure 7 Retrosynthesis of 1F. 
Acceptor 10F was synthesized (Scheme 6) starting from commercially available methyl α-
D-mannopyranoside. This was initially allylated at O-3 and per-O-benzylated to give 11E as 
previously reported in Chapter E.6 Deallylation of 11E smoothly afforded acceptor 10F 
(Scheme 6). 
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Scheme 6 Synthesis of acceptor 10F. 
Many experiments were performed to obtain mannosyl donor 9F with a high yielding 
approach also requiring a limitated number of purification processes. The synthesis of 9F 
generally requires the introduction of the versatile allyl group on the anomeric position 
followed by the 2-O-deacylation step using a 1,2-orthoester or a 1,2-di-O-acylated 
mannosides as precursors. Experiments conducted on methyl orthoester 6E and 7E, both 
previously described in Chapter E, in allyl alchol and in the presence of AllocCl (generating 
HCl in situ) afforded intermediate 12F in similar yields (about 60%, Schemes 7 and 8).  
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So it was necessary the use of a different promotion system, providing a limitated number of 
by-products during the first step of the synthesis of 9F, and the attention was turned to  
substoichiometric amounts of BF3 . Et2O. When a global one-pot synthesis of 9F was tried 
using 6E as the precursor (Scheme 9), the isolated yield of the desired donor was not 
excellent although a single purification process was performed.  
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1) DCM, AllOH (5 eq), BF3 
. Et2O in DCM (0.20 eq), 0°C, MS 4 Å;
    then filtration on silica.  
2) MeOH/DCM 2:1, MeONa/MeOH 2M, from 0°C to rt;
    then quenching with Amberlist 15.
3) DCM, FmocCl (1.3 eq), Py (10.3 eq), rt; then extraction.
Scheme 9 
During the first one-pot sequence of the synthesis of 9F (Scheme 10), Methyl 3,4,6-tri-O-
benzyl-2-O-fluorenylmethoxycarbonyl-α-D-mannopyranoside was isolated after 
chromatographic purification. It derives from the intramolecular rearrangement of the 
methoxy group belonging to orthoester 6E and to prevent the production of this by-prodouct, 
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allyl 1,2-orthoester 14F was then used. Hence compound 9F was prepared from intermediate 
14F (Scheme 11) obtained via a previously described one-pot sequence.6,15 Orthoester 14F 
was submitted to acid promoted rearrangement in the presence of allyl alcohol to give 11Fα 
which was directly submitted to 2-O-deacetylation and Fmoc protection to give 13Fα in 76% 
yield over three steps. Sequential anomeric deallylation and installation of the 
trifluoroacetimidate16 leaving group completed the preparation of 9F (90% yield over the two 
steps). Additionally improvements of the isolated yield of 9F were also obtained by changing 
both work-up (filtration on a plug of celite instead of solvent removing under vacuum) and 
chromatographic purification (silica can be used instead of alumina and drops of pyridine 
aren’t necessary in the appropriate eluent of the purification) in the imidoylation step. 
O
BnO
BnO
O
BnO
O
OMe
6E
O
BnO
BnO
OFmoc
BnO
13Fα
62%
over the three steps
1) MeOH/DCM 1.6:1,
    PdCl2 (0.10 eq), rt
2) acetone, Cl(PhN=)CCF3 (2.7 eq),
    Cs2CO3 (1.1 eq), from 0°C to rt
O
BnO
BnO
OFmoc
BnO
9F
90% over the two steps
O
CF3
PhN
9F was synthesized in 56% overall yield over 5 steps and by performing 2 chromatographic purifications
OAll
O
BnO
BnO
OFmoc
BnO
OMe22%
+
1) DCM, AllOH (5 eq), 0°C, MS 4 Å,
    BF3 
. Et2O in DCM (0.20 eq);
2) MeOH/DCM 1.8:1.4, 
    MeONa/MeOH 2M, from 0°C to rt;
3) DCM, FmocCl (1.3 eq), Py (10.3 eq).
α/β ca 7.6
Scheme 10 
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13Fα
76%
over the three steps
1) MeOH/DCM 1.6:1,
    PdCl2 (0.10 eq), rt
2) acetone, Cl(PhN=)CCF3 (2.7 eq),
    Cs2CO3 (1.1 eq), from 0°C to rt
O
BnO
BnO
OFmoc
BnO
9F
90% over the two steps
O
CF3
PhN
9F was synthesized in 68% overall yield over 5 steps and by performing 2 chromatographic purifications
OAll
1) DCM, AllOH (5 eq), 0°C, MS 4 Å,
    BF3 
. Et2O in DCM (0.20 eq);
2) MeOH/DCM 1.8:1.4, 
    MeONa/MeOH 2M, from 0°C to rt;
3) DCM, FmocCl (1.3 eq), Py (10.3 eq).
α/β ca 7.6
Scheme 11 
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Before to proceed with the rapid assemblage of the partially protected tetramannoside D1 1F 
of gp120, a significative number of experiments were performed both to understand the 
reactivity of mannosyl donor 9F towards a set of glycosyl acceptors in glycosidation reactions 
promoted by catalytic amounts of Bi(OTf)3 and to find out the optimized conditions for the 
glycosidations to occur (Scheme 12, Table 1). Fmoc in 2-O-Fmoc trihaloacetimidate donors  
is expected to behave initially as a participating group to guarantee α-selectivity and then as a 
transient group removable by simple addition of excess TEA.  
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4 Å AW MS9F
 
Scheme 12 
Table 1 Optimization of catalytic α-mannosylations with trifluoroacetimidate donor 9F. 
Entry R-OH Solvent Products and yield 
O
OMe
OBn
OBn
OBnO
O
HO
BnO
BnO
BnO
O
HO
BnO
BnO
BnO
SEt
OOOPh
OMeHO
BnO O
OFmoc
BnO
BnO
BnO
O
HO
BnO
BnO
BnO
OMP
O
OFmoc
BnO
BnO
BnO
O
O
BnO
BnO
BnO
SEt
O
OFmoc
BnO
BnO
BnO
O
O
BnO
BnO
BnO
OMP
O
OMe
OBn
OBn
BnO
HO
15F
16F63% (α/β 1.7)
17F92% (α/β 5.1)
18F85% (α/β 2.0)
19F
87%
18F 82% (α/β 2.5)
sluggish reaction
18F 85% (α only)
1
2
3
4
5
6
7
32B
3E
3E
3E
3E
10F
DCE
DCE
DCE
DCM/Et2O 4:1
PhCH3/DME 2:1
PhCH3/Et2O 4:1
PhCH3/Et2O 4:1
MP: p-methoxyphenyl
 
General conditions: 9F (1.3-1.6 eq), acceptor, solvent, Bi(OTf)3 (0.10 eq) added as a solution 
in dioxane, -30 °C to rt, 15-180 minutes. For the final solvent composition see experimental 
section. In entry 7, 0.08 eq of Bi(OTf)3 were used and TEA was added to the glycosidation 
vessel just after accomplishment of the coupling (see experimental section for details). 
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The shown results indicate that the reaction outcome was strongly dependent on the solvent 
mixture. Although Fmoc was expected to act as a reliable participating group, in a 
DCE/dioxane solvent mixture the reaction provided not negligible amounts of beta-
mannosides with different acceptors (entries 1-3), and in the case of the thioglycosyl acceptor 
15F (entry 1) the partial aglycon transfer (with formation of thioethyl 2-O-Fmoc mannoside) 
was also observed as an additional undesired event. To the best of our knowledge, in the 
literature are lacking examples of glycosidations where Fmoc group fails to act as a 
participant functionality.17 
Further experimentation was devoted to the screening of alternative solvent mixtures. Use of a 
1,2-dimethoxyethane (DME) containing solvent mixture (entry 5), previously found to be 
highly α-selective with perbenzylated donors,18 gave disappointing results due to the sluggish 
activation of the more disarmed 2-O-Fmoc donor. This behaviour might be rationalized by 
considering the ability of 1,2-dimethoxyethane to chelate the Lewis acid. A mixture of 
DCM/diethyl ether gave 18F in high yield (entry 4) but the stereoselectivity was still poor. 
More rewarding results were eventually gained by using a toluene/diethyl ether/dioxane 
solvent mixture (entries 6-7), which in previous studies had been applied only to carry out α-
selective glycosidations with donors devoid of 2-O-participating groups.6,19,20 Under these 
conditions, no β-mannosides could be detected in the reaction mixtures. In entry 7 the result 
refers to the glycosidation reaction/Fmoc removal sequence conducted by simple addition of 
TEA21 on completion of the coupling. As anticipated, the desired base-promoted deprotection 
occurred uneventfully. The deprotected disaccharide 19F obtained in entry 7, represents the 
reducing disaccharide terminus of the target sequence 1F and it was obtained, after 
chromatographic purification, in very good 87% overall yield in less than two hours. 
Once established the best glycosidation solvent, elongation of the acceptor disaccharide 19F 
was attempted through the glycosidation of the sterically encumbered axial 2-OH (Scheme 
13). Slight modifications of the optimized protocol gave acceptor trisaccharide 20F in an 
excellent overall yield (90 %), comparable with that of the previous one-pot sequence (Table 
1, entry 7). Further coupling of this latter with donor 9F under analogous conditions gave 
tetrasaccharide 1F in a rewarding, albeit lower overall yield (64 %). The whole sequence of 
the three synthetic operations gave the D1 tetrasaccharide 1F in about 50% overall yield for 
six steps, corresponding to almost 90% average yield for each step, and required only three 
chromatographic purifications. Comparison of NMR data with those reported in for a 
differently synthesized tetrasaccharide 1F14a confirms the identity of the obtained product, 
with the anomeric linkages all being alpha-configured.  
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O
HO
OBn
BnO
O
OMe
OBn
OBnO
O
O
BnO
BnO
BnO
BnO
BnO
O
OMe
OBn
OBn
OBnO
O
OH
BnO
BnO
BnO
20F  90%
9F (1.7 equiv.), Bi(OTf)3 (0.10 equiv.) in dioxane,
toluene/Et2O 4:1, –30 to –5 °C, 75 min; 
then TEA, r.t., 1 h.
1F  64%
19F
9F (1.7 eq), Bi(OTf)3 (0.10 equiv.) in dioxane, 
toluene/Et2O 4:1, –30 to rt, 150 min; 
then TEA, r.t., 1 h.
 
Scheme 13 Assembly of tetrasaccharide 1F. 
The here proposed strategy was then applied to the more demanding target mannan 
pentasaccharide 2F (Figure 3). This sequence requires an efficient access to diol 21F that was 
the reducing terminus precursor of 2F. For this purpose the synthetic scheme described by 
Ogawa was applied (Scheme 14),22 but the initial 3,6-di-O-allylation via stannylidene 
chemistry was found too sluggish and not satisfying in terms of yield (ca 30%) due to the 
prevalent formation of the mono 3-O-allylated derivative. Thus the attention turned to an 
alternative scheme, such as that described by Huang a coworkers on a mannosyl derivative 
bearing a propylazido aglycon. This entails (Scheme 14) regioselective 3,6-di-O-silylation 
with TBSCl of methyl α-D-mannopyranoside affording 22F, its subsequent 2,4-di-O-
benzylation and final removal of TBS.23 The overall sequence proceeded smoothly but 
afforded the desired diol in 42% overall yield.  
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d
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Scheme 14 Attempted three-steps routes to diol 21F. Reaction conditions: a) Bu2SnO (2.2 
eq), MeOH reflux, 3 hours; solvent removal then toluene, TBAI (2 eq), AllBr (20 eq), 70 °C, 
72 h; b) TBSCl, DMF, imidazole, 66% yield; c) NaH, BnBr, DMF; d) excess Pyr.HF, 64% 
yield over two steps. 
 
After having tested known three steps procedures, a more convenient access to the target was 
attempted by resorting to an original two-steps approach (Scheme 15). 
HO
HO
OH
O
OMe
OH
O
OMe
OH
OBn
HO
BnOO
OMe
O
O
Ph
O
O
Ph
61%73% (endo/exo 1.2)
23F 21F
a b
 
Scheme 15 A two-steps route to diol 21F. Reaction conditions: a) PhCH(OMe)2, DMF, CSA, 
70 °C, 250 mbar; b) BH3.THF, Cu(OTf)2, 0 °C to rt. 
 
In the first step methyl mannopyranoside was submitted to a double benzylidenation by 
slightly modifying a previously reported procedure described by Liptak and coworkers.24 
Product 23F was obtained after chromatographic purification as an almost equimolar 
diasteroisomeric mixture (endo/exo 1.2:1). It’s well established by several precedents25,26 that 
the reductive opening of five-membered benzylidenes displays complementary 
regioselectivity according to the configuration of the starting material. However, I have 
observed that when the exo/endo mixture of 23F was directly submitted to reductive opening 
conditions reported by Hung and co-workers (excess BH3.THF and 0.3 eq of copper(II) 
triflate)27 the desired 3,6-diol 21F largely prevailed (Scheme 15 and Table 2, entry 1). Minor 
amounts (ca 10 %) of the unexpected 3,4-diol 24F were also isolated and characterized in its 
 178
acetylated form (Table 2, entry 1). Other experiments displayed that the outcome of the 
benzylidene reductive opening was critically dependent on the experimental procedure. As 
shown on Table 2, the reaction was much more sluggish and much less regioselective when it 
was conducted in the presence of molecular sieves (entries 2 and 3). Preliminary 
coevaporation of copper(II) triflate in toluene also strongly influenced the final composition 
of the reaction mixture (compare entry 2 and 3). 
 
Table 2. Optimization of double reductive opening of 23F. 
Entry Conditions Time (h) Products and yields 
O
OMe
OH
OBn
HOBnO
O
OMe
OBn
OBn
HOHO
O
OMe
OH
OBn
HOBnO
O
OMe
OH
OH
BnOBnO
O
OMe
OH
OBn
HO
BnO
O O
OMe
OBn
HOO
Ph
OMe
OH
O
BnO
O
O
Ph
A
B
C
21F 24F
61% 9%
47% 30%21F 25F
21F 26F 27F7% 43% 26%
1
2
3
1.7
48
48
 
General conditions: 23F, BH3.THF (1M in THF, 10 eq), then Cu(OTf)2 (sol in THF, 0.3 eq), 0 
°C to rt. Condition A: neither use of molecular sieves, nor coevaporation in toluene of 
Cu(OTf)2 prior to its use. Condition B: use of 4Å molecular sieves and coevaporation in 
toluene of Cu(OTf)2 prior to its use. Condition C: use of 4Å molecular sieves and no 
coevaporation in toluene of Cu(OTf)2 prior to its use. 
 
Having established a straightforward access to the reducing terminus precursor of 2F, its 
direct double glycosidation was attempted. Simultaneous attachment of two mannose residues 
to acceptor diol 21F is not a trivial task (Scheme 16). As a matter of fact in some cases the 
assembly of this trisaccharide structure entails long sequences in which the mannose residues 
are added to the branching unit at different stages.28 Additionally, a literature survey29 reveals 
that the removal of poorly accessible 2-O-transient protecting groups from the inserted 
mannoses not frequently proceeds in yields higher than 90%. After a preliminary screening, 
for this application (Scheme 16) trichloroacetimidate 28F30 proved more efficient than the 
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trifluoro counterpart (9F) at providing trisaccharide 29F. Indeed, with the latter donor higher 
amounts of intermediate dimannosides were detected; with donor 28F the sequence of bis-
glycosylation and bis-deprotection was instead satisfyingly carried out under very mild 
conditions, in short times, and in a very high overall yield (72% for four synthetic steps, 
Scheme 16). Trisaccharide diol 29F was then exposed to trichloroacetimidate 28F under 
Bi(OTf)3 activation to afford pentasaccharide 2F in 63 % overall yield. The whole synthesis 
was performed in only two synthetic operations and the overall yield (ca 45%) of its eight 
synthetic steps corresponded once again to a ca 90% average yield for each step. 
O
HO
O
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O
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O
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O
O
BnO
BnO
BnO
O
HO
BnO
BnO
BnO
O
HO
BnO
BnO
BnO
28F 3.2 eq 21F
29F 72%
+
2F 63%
Bi(OTf)3 (0.10 eq uiv.) in dioxane, 
toluene/Et2O 4:1, –30 to –10 °C, 45 min; 
then TEA, r.t., 1 h.
28F (4.3 equiv.), Bi(OTf)3 (0.20 equiv.) in dioxane,
toluene/Et2O 4:1, –30 to 5 °C, 1 h;
 then TEA, r.t., 1 h.
 
Scheme 16 Assembly of pentasaccharide 2F. 
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Comparison of NMR data of the obtained pentasaccharide with those of close analogues of 
2F (differentiated exclusively for the aglycon)23,25  confirm the identity of the structure and 
the lack of β-mannosidic linkages.23 It’s noteworthy that oligosaccharides 1F and 2F were 
obtained in a partially protected form which can be exploited for further elaborations. 
Conclusions 
In conclusion, in this chapter it was shown that Fmoc protecting group can be simply 
removed in the same vessel where a Bi(OTf)3 promoted glycosidation is conducted. Despite 
the expected participating effect of Fmoc group, it was found that the nature of the solvent is 
decisive for obtaining highly selective α-mannosylations. Iteration of this one-pot sequence 
leads to biologically useful mannose oligosaccharides related to HIV gp120 by performing a 
smaller number of synthetic operations than in other reported procedures towards similar 
sequences. As to yields, the effectiveness of the present approach often compares favourably 
with most of the synthetic schemes so far described,8,9a,14,22,23,28,29 with exceptions being found 
in a few examples of especially high-yielding synthetic routes.25,29h,29p-r Anyway the actual 
merit of the strategy resides in the combination, rather unusual in other schemes, of 
simultaneous advantages such as the reduced experimental work (also because of the minimal 
number of required precursors), the attainment of high yields, and the exclusive use of a 
catalytic and moisture stable glycosidation promoter. Furthermore, the present iterable one-
pot scheme is anticipated to be of broad applicability, thus adding a further useful 
complement to the recent strategical advances in oligosaccharide synthesis. As an additional 
result, it was disclosed a rapid approach for accessing a mannose building-block to be 
incorporated in branched structures that relies on a regioselective double reductive opening of 
a di-O-benzylidene mannose intermediate. 
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Experimental Section 
 
General methods and Material 
Proton (1H NMR) and carbon (13C NMR) nuclear magnetic resonance spectra were recorded 
in CDCl3 (internal standard, for 1H: CHCl3 at δ 7.26; for 13C: CDCl3 at δ 77.0) on Varian 
spectrometers at 200 or 500 MHz and 50 or 125 MHz, respectively, or on a Bruker Avance 
400 spectrometer at 400 MHz. The chemical shifts are given in parts per million (ppm) on the 
delta (δ) scale. 1H NMR assignments were based on homo-decoupling experiments. MALDI-
MS spectra were recorded in the positive mode: compounds were dissolved in acetonitrile at a 
concentration of 0.1 mg/mL and one microliter of these solutions were mixed with one 
microliter of a 20 mg/mL solution of 2,5-dihydroxybenzoic acid in 7:3 CH3CN/H2O or, in the 
case of trifluoroacetimidate derivatives, with a 10 mg/mL solution of trihyroxyacetophenone 
in 1:1 MeOH/H2O. Analytical thin layer chromatography (TLC) was performed on aluminium 
plates precoated with Silica Gel 60 F254 as the adsorbent. The plates were developed with 5% 
H2SO4 ethanolic solution and then heating to 130°C. Column chromatography was performed 
on Kieselgel 60 (63-200 mesh). When specified, anhydrous solvents stored over molecular 
sieves (purchased from Aldrich) were used. Bismuth(III) triflate was coevaporated three times 
in toluene and dried under vacuum for 30-45 minutes before being dissolved in the presence 
of freshly activated 4Å in dioxane. 
 
General procedure of glycosidation with donor 9F. A mixture of donor 9F (0.13-0.16 
mmol) and an acceptor (0.10 mmol) was coevaporated three times with anhydrous toluene (3 
x 2 mL), and then dried in vacuo for 30 minutes. After adding 4Å AW 300 MS, the mixture 
was dissolved under argon with 4:1 toluene/Et2O (4.1 mL), cooled to -30 °C, and stirred for 
15 minutes. A solution of Bi(OTf)3 in dioxane (14.5 mg/mL, 10 μmol, 0.45 mL) was then 
added, and the temperature was allowed to slowly raise to room temperature. On completion 
of the glycosidation (TLC analysis, 15-180 minutes for entries in Table 1), a few drops of 
pyridine were added and the reaction mixture was filtered on a short plug of silica gel 
repeatedly washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, and 
the residue purified by silica-gel flash-chromatography (eluent: n-hexane/ethyl acetate or 
toluene/ethyl acetate). 
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Allyl α,β-D-mannopyranoside (4F). D-(+)-mannose (560 mg, 3.1 
mmol) was suspended in allyl alcohol (2 mL) and then Sc(OTf)3 (4 
mg, 0.09 mol) was added. The reaction mixture was heated to 
reflux for 6 h and after the disappearance of the starting material 
(TLC 85:15 CH2Cl2/MeOH), a few frops of pyridine were added at room temperature. The 
reaction mixture was concentrated to dryness and flushed through a silica gel column under 
reduced pressure (9:1 CH2Cl2/MeOH), to yield allyl mannopyranoside 4F (560 mg, 82%, α/β 
ca 8:1). Data for the α-anomer, 1H NMR (D2O, 300 MHz) δ 6.30-6.10 (1H, m, -
OCH2CH=CH2), 5.58 (1H, dq, Jtrans = 17.1 Hz, Jgem = 1.8 Hz, -OCH2CH=CHcisHtrans), 5.49 
(1H, dq, Jcis = 10.2 Hz, -OCH2CH=CHcisHtrans), 5.14 (1H, d, J1,2 = 1.8 Hz, H-1), 4.44 (1H, m, 
Jgem = 12.3 Hz, -OCHaHbCH=CH2), 4.29 (1H, m, -OCHaHb-CH=CH2), 4.18 (1H, dd, J2,3 = 3.6 
Hz, H-2), 4.09 (1H, dd, J5,6a = 0.9 Hz, J6a,6b = 11.7 Hz, H-6a), 4.05-3.95 (2H, m, H-5 e H-6b), 
3.89 (1H, t, J3,4 = J4,5 = 9.6 Hz, H-4).  13C NMR (D2O, 75 MHz) δ 133.0 (-OCH2CH=CH2),, 
118.3 (-OCH2CH=CH2), 98.5 (C-1), 72.1, 70.0, 69.5, 67.8, 66.2, 60.4. 
 
Allyl 3-O-allyl-α-D-mannopyranoside (5F). Allyl α,β-
mannopyranoside 4F (328 mg, 1.5 mmol) and Bu2SnO (410 mg, 1.6 
mmol) were refluxed in MeOH (7.4 mL) for 2 hours. The obtained 
solution was evaporated under vacuum. To the residue suspended in 
toluene (9 mL), allyl bromide (1.26 mL, 15 mmol) and TBAI (557 mg, 1.5 mmol) were 
sequentially added. The mixture was kept under stirring at 65-70 °C for 20 hours, and 
concentrated. Silica-gel flash-chromatography of the residue (eluent: ethyl acetate/petroleum 
ether from 7:3 to AcOEt) yielded 5F slightly contaminated with tetrabutylammonium salts 
(estimated yield 64 % on the base of NMR integrations). The product thus obtained was 
directly submitted to the subsequent step. 1H NMR (CDCl3, 200 MHz) significative signals δ 
6.05-5.70 (2H, m, 2x -OCH2CH=CH2), 5.34-5.11 (4H, m, 2x –OCH2CH=CH2), 4.86 (1H, s, 
H-1). 13 C NMR (CDCl3, 50 MHz) δ 134.3, 133.5 (2x -OCH2CH=CH2), 117.9, 117.2 (2x -
OCH2CH=CH2), 98.8 (C-1), 79.0, 72.3, 70.8, 67.9, 67.8, 64.7, 60.9. 
 
Allyl 3-O-allyl-2,4,6-tri-O-benzoyl-α-D-mannopyranoside (6F). 
To a solution of compound 5F (estimated mass ca 248 mg, ca 0.9 
mmol) in dry pyridine (4.4 mL) was added at 0°C benzoyl chloride 
(442 µL, 4 mmol). The mixture was allowed to warm to rt, and after 
2 hours a few drops of MeOH (ca 1 mL) were added. The mixture was diluted with DCM and 
HO
HO
HO
HO
O
OAll
HO
AllO
HO
HO
O
OAll
BzO
AllO
BzO
BzO
O
OAll
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the organic phase washed with water. The aq phase was re-extracted with DCM and the 
collected organic phases were dried  with anhydrous Na2SO4 and concentrated in vacuo to 
give a residue which was purified by silica gel flash-chromatography (eluent: petroleum 
ether/ethyl acetate from 9:1 to 8:2) to yield 6F as an oil (421 mg, 77%). 1H NMR (CDCl3, 300 
MHz) δ 8.30-7.10 (Ar), 6.08-5.92 (1H, m, -OCH2CH=CH2), 5.89 (1H, t, 4-H, J = 9.9 Hz), 
5.80-5.65 (1H, m, -OCH2CH=CH2), 5.64 (1H, dd, J1,2 = 2.1 Hz, J2,3 = 3.0 Hz, 2-H), 5.33 (1H, 
dd, Jtrans = 17.1 Hz, Jgem = 1.5 Hz, -OCH2CH=CHcisHtrans), 5.24 (1H, dd, Jcis = 10.5 Hz, Jgem = 
1.5 Hz, -OCH2CH=CHcisHtrans), 5.17 (1H, dd, Jtrans = 17.1 Hz, Jgem = 1.5 Hz, -
OCH2CH=CHcisHtrans), 5.09 (1H, d, 1-H), 5.04 (1H, dd, Jcis = 10.5 Hz, Jgem = 1.2 Hz, -OCH2-
CH=CHcisHtrans), 4.70 (1H, dd, J5,6a = 2.5 Hz, H-6a), 4.45 (1H, dd, J5,6b = 4.3 Hz, J6a,6b = 12.3 
Hz, H-6b), 4.35-4.26 (2H, m, 5-H, –OCH2CH=CH2), 4.21 (1H, dd, 3-H), 4.16-3.98 (3H, m, 3x 
–OCH2CH=CH2). 13 C NMR (CDCl3, 75 MHz) δ 165.9, 165.4, 165.2 (3x -COPh), 134.0, 
133.1 (x3), 133.0, 132.8, (aromatic C e 2x -OCH2CH=CH2), 129.7-129.4, 128.2 (aromatic 
CH), 118.0, 117.2 (2x -OCH2CH=CH2), 96.8 (C-1), 74.3, 70.5, 69.0, 68.8, 68.5, 68.2, 62.9 
(C-6).  
 
Allyl 2,4,6-tri-O-benzoyl-α-D-mannopyranoside (7F). Compuond 
6F (421 mg, 0.73 mmol) was dissolved in the solvent mixture 
MeOH/DCM 3.7:1 (4.7 mL) and then to the solution was added at rt 
palladium chloride (14 mg, 0.079 mmol). The mixture was stirred 
overnight and after the disappearance of  6F (TLC petroleum ether/ethyl acetate 4:6) we 
observed two products with different chromatographic mobility, one with Rf = 0.77 and the 
other with Rf = 0.43. The reaction mixture was then concentrated under vacuum, the obtained 
residue was then filtered through a short plug of silica gel (eluent DCM/MeOH 95:5), 
concentrated, and purified by silica-gel flash chromatography (eluent: petroleum ether/ ethyl 
acetate 7:3) to provide 7F as an oil (49 mg, yield 12%, Rf = 0.77) and diol 8F as an oil (286 
mg, yield 79%, Rf = 0.43). Compound 7F was subsequently deallylated under analogous 
conditions to provide 8F in 92% combined yield. 1H NMR (CDCl3, 300 MHz) δ 8.10-7.27 
(Ar), 6.04-5.89 (1H, m, -OCH2CH=CH2), 5.72 (1H, t, J = 9.9 Hz, 4-H), 5.45 (1H, dd, J2,3 = 
3.6 Hz, 2-H), 5.34 (1H, dd, Jtrans = 17.1 Hz, Jgem = 1.5 Hz, -OCH2CH=CHcisHtrans), 5.26 (1H, 
dd, Jcis = 10.5 Hz, Jgem = 1.5 Hz, -OCH2CH=CHcisHtrans), 5.11 (1H, d, J1,2 = 1.5 Hz, 1-H), 4.68 
(1H, dd, J5,6a = 2.4 Hz, J6a,6b = 12.0 Hz, H-6a), 4.50-4.43 (2H, m, 3-H and H-6b), 4.36-4.25 
(2H, m, 5-H and -OCHaHbCH=CH2), 4.15-4.08 (1H, m, -OCHaHbCH=CH2). 13 C NMR 
(CDCl3, 75 MHz) δ 166.7, 166.1, 165.8 (3x COPh), 133.5, 133.4 (x2), 133.1 (aromatic C and 
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-OCH2CH=CH2), 129.9-128.3 (aromatic CH), 118.1 (-OCH2CH=CH2), 96.6 (C-1), 72.8, 70.3, 
69.0, 68.8, 68.5, 63.0. 
 
2,4,6-Tri-O-benzoyl-α-D-mannopyranose (8F). 1H NMR (CDCl3, 
200 MHz) δ 8.20-7.10 (Ar), 5.75 (1H, t, J = 10.0 Hz, 4-H), 5.49-5.32 
(2H, m, 1-H and 2-H), 4.68 (1H, dd, J5,6a = 2.2 Hz, J6a,6b = 12.0 Hz, 
H-6a), 4.53-4.42 (2H, m, 3-H and 5-H), 4.36 (1H, dd, J5,6b = 3.4 Hz, 
H-6b), 3.34 (1H, d, J = 2.2 Hz), 3.00 (1H, bs). 13 C NMR (CDCl3, 50 MHz) δ 166.6, 166.4, 
166.1 (3x COPh), 133.4, 133.3, 133.0 (aromatic C), 129.8-128.3 (aromatic CH), 91.9 (C-1), 
73.4, 70.2, 68.2 (x2), 62.9.  
 
Methyl 2,4,6-tri-O-benzyl-α-D-mannopyranoside (10F). To a 
solution of 11E6 (260 mg, 0.515 mmol) in 2.5:1 MeOH/DCM (3.5 
mL) was added at rt palladium chloride (10 mg, 0.056 mmol). The 
mixture was stirred overnight and then concentrated under vacuum. 
The residue was then filtered through a short plug of silica gel (eluent: DCM/MeOH 95:5), 
concentrated and purified by silica-gel flash chromatography (eluent: petroleum ether/ethyl 
acetate from 8:2 to 7:3) to provide 10F as an oil (215 mg, 90%); [α]D29 +15.6 (c 1.0 in 
CHCl3), (lit.,31 [α]29D +14.5 (c 1.0, CHCl3));1H NMR (400 MHz; CDCl3): δ = 7.40−7.15 (Ar), 
4.87 (bs, 1 H, 1-H), 4.90-4.50 (3x AB, 6 H, 3x –CH2Ph), 4.05-3.95 (m, 1 H, 5-H), 3.85-3.70 
(overlapped signals, 4 H, 2-H, 4-H and 6-H2), 3.37 (s, 3 H, 1-OCH3), 2.50 (br s, 1 H, 3-OH) 
ppm. 13 C NMR (50 MHz; CDCl3): δ = 138.3, 138.1, 137.6 (aromatic C), 128.4-127.4 
(aromatic CH), 97.7 (C-1), 78.1, 76.4, 74.6, 73.2, 72.6, 71.6, 70.6, 69.0, 54.7 ppm. MALDI-
TOF MS: calcd. for [M+Na]+ 487.21; found 487.45. Calcd. for C28H32O6 (487.21): C, 72.39; 
H, 6.94; found: C, 72.20; H, 6.85. 
 
3,4,6-Tri-O-benzyl-1,2-O-(1-allyloxyethylidene)-β-D-
mannopyranose (exo-orthoester) (14F). Allyl orthoester 14F was 
syntesized, starting from D-mannose in 55% overall yield, with the 
same protocol affording methyl orthoester 6E15 by using AllOH 
rather MeOH in the 1,2-orthoesterification step. 1H NMR (CDCl3, 500 MHz) δ = 7.43-7.20 
(aromatic protons), 6.00-5.90 (1H, m, -CH=CH2), 5.35 (1H, d, J1,2 = 2.5 Hz, H-1), 5.30 (1H, 
dd, Jtrans = 17.5 Hz, Jgem = 1.5 Hz,-CH2CH=CHcisHtrans), 5.18 (1H, dd, Jcis = 11.0 Hz, -
CH2CH=CHcisHtrans), 4.95-4.53 (6H, 3 x AB, 3 x benzyl CH2), 4.40 (1H, dd, J2,3 = 4.0 Hz, H-
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2), 4.10-4.00 (2H, m, -CH2CH=CH2),  3.92 (1H, t, J = 9.5 Hz, H-4), 3.80-3.68 (3H, m, H-3, 
H-6a, H-6b), 3.47-3.40 (1H, m, H-5), 1.77 (3H, s, -CH3). 13 C NMR (CDCl3, 50 MHz) δ 138.2 
(x2), 137.8 (aromatic C), 134.4 (-CH=CH2), 128.5, 128.4, 128.3, 128.0, 127.7, 127.6, 127.5, 
126.9 (aromatic CH), 123.8 (quaternary orthoester C), 116.5 (-CH=CH2), 97.4 (C-1), 78.9, 
76.9, 75.2, 74.1 (x2), 73.3, 72.3, 68.9, 63.6, 24.8 (orthoester -CH3).  
 
Allyl 3,4,6-tri-O-benzyl-2-O-fluorenylmethoxycarbonyl-α-D-
mannopyranoside (13Fα). Allyl orthoester 14F (3.69 g, 6.93 mmol) 
was coevaporated three times with toluene (3 x 5 mL) and dried 
under vacuum. After adding freshly activated 4Å molecular sieves, 
14F was dissolved at rt in dry DCM (47 mL) and allyl alcohol (2.36 
μL, 34.6 mmol) was subsequently added. The mixture was then cooled to 0 °C and stirred for 
ca 10 minutes. A solution of BF3.OEt2 (0.3 M in DCM, 4.7 mL, 1.41 mmol) was then added at 
0°C under argon. The mixture was allowed to warm to rt, stirred overnight and then was 
quenched at rt with pyridine (112 µl) after the disappearance of 14F (TLC toluene/ethyl 
acetate 10:1). The mixture was filtered through a short plug of silica gel (eluent: 
DCM/MeOH/acetonitrile 85:10:5) and concentrated in vacuo to obtain crude 11Fα  as an oil 
that was directly submitted to the following step. 1H NMR (200 MHz; CDCl3) : δ =  7.60−7.15 
(Ar), 6.05-5.90 (m, 1 H, -CH=CH2), 5.50 (br s, 1 H, 2-H), 5.36 (br d, 1 H, Jtrans = 17.4, -
CH2CH=CHcisHtrans), 5.28 (br d, Jcis = 10.2 Hz, 1 H, -CH2CH=CHcisHtrans), 5.00 (br s, 1 H, 1-
H), 4.98-4.55 (6 H, 3x –CH2Ph), 4.26 (m, 1 H, -CHaHbCH=CH2), 4.15-3.98 (3 H), 3.95-3.79 
(3 H), 2.23 (3 H, s, -COCH3) ppm. 13C NMR (75 MHz; CDCl3): δ = 170.1 (-COCH3), 138.2, 
138.0, 137.8 (aromatic C), 133.2 (-CH=CH2); 128.2-127.4 (aromatic CH), 117.5 (-CH=CH2), 
96.7 (C-1), 78.0, 74.9, 74.2, 73.2, 71.6, 71.3, 68.7, 68.6, 67.9 ppm. Crude 11Fα was dissolved 
in 4:1 MeOH/DCM (10 mL) and the mixture was then cooled to 0 °C. At this temperature 
some drops of a solution of MeONa (2M in MeOH) were added, the mixture was allowed to 
warm to rt and stirred overnight. After adding Amberlist 15, the supernatant was removed and 
concentrated in vacuo to obtain an oil in a satisfying purity to be directly submitted to the last 
step of this one-pot sequence. Spectroscopic data of the 2-O-deacetylated intermediate 
12Fα:29m 1H NMR (400 MHz; CDCl3): δ = 7.40−7.10 (Ar), 6.00-5.80 (m, 1 H, -CH=CH2), 
5.30-5.15 (2 H, -CH=CH2), 5.02 (d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.90-4.45 (6 H, 3x –CH2Ph), 
4.25-4.10 (m, 1 H, -CHaHbCH=CH2), 4.08-3.95 (2 H, -CHaHbCH=CH2 and H-2), 3.90-3.65 (4 
H, 3-H, 4-H, 5-H and 6-H2), 2.44 (d, J2,OH = 2.2 Hz, 1 H, 2-OH) ppm.  
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The product from the previous step was dissolved at rt in dry DCM (68 mL) and pyridine 
(5.75 mL, 71.5 mmol) and FmocCl (2.33 g, 9.0 mmol) were sequentially added under argon to 
the solution. The mixture was stirred for 25 minutes and was then diluted with EtOAc, 
washed three times with an aqueous saturated solution of CuSO4 and the organic phase was 
dried with anhydrous Na2SO4 and concentrated in vacuo to give a residue which was purified 
by silica gel flash-chromatography (eluent: petroleum ether/ethyl acetate from 9:1 to 85:15) to 
yield 13Fα as a yellow oil (3.73 mg, 76% over three steps). [α]D29 +19.9 (c 0.6 in CHCl3);  1H 
NMR (200 MHz; CDCl3): δ 7.80−7.10 (Ar), 6.00-5.80 (m, 1 H, -CH=CH2), 5.35-5.18 (3 H, -
CH=CH2 and 2-H), 5.02 (d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.95-4.25 (9 H, 3x –CH2Ph and Fmoc –
OCH2CH-), 4.25-4.15 (1 H, m, -CHaHbCH=CH2), 4.10-3.70 (6H, -CHaHbCH=CH2, 3-H, 4-H, 
5-H, 6-H2) ppm. 13C NMR (50 MHz; CDCl3): δ 154.5 (Fmoc-CO2), 143.2, 142.9, 141.0, 
140.9, 138.0, 137.9, 137.7 (aromatic C), 133.1 (-CH=CH2); 128.0-126.9, 122.1, 124.9, 119.7 
(aromatic CH), 117.5 (-CH=CH2), 96.3 (C-1), 78.0, 75.0, 74.1, 73.1, 72.4, 71.5, 71.3, 69.9, 
68.6, 67.8, 46.3 ppm. MALDI-TOF MS: calcd. for [M + Na]+ 735.30, found 735.25. Calcd. 
for C45H44O8 (712.84): C, 75.82; H, 6.22. Found: C, 75.53; H, 6.15. 
 
 3,4,6-Tri-O-benzyl-2-O-fluorenylmethoxycarbonyl-
α,β-D-mannopyranosyl  
(N-phenyl)trifluoroacetimidate (9F). To a solution of 
13Fα (474 mg, 0.67 mmol) in 1.6:1 MeOH/DCM (6.7 
mL) was added at rt palladium chloride (12 mg, 0.068 mmol). The mixture was stirred 
overnight and then concentrated under vacuum. The residue was then filtered through a short 
plug of silica gel (eluent DCM/MeOH 95:5) and concentrated to yield the hemiacetal 
intermediate in a satisfying purity to be directly submitted to the following step. 
Spectroscopic data:  1H NMR (200 MHz; CDCl3): significant signals at δ = 7.90−7.20 (Ar), 
5.41 (br s, 1 H, 1-H), 5.30 (br d, 1 H, 2-H), 4.14 (dd, J2,3 = 2.4 Hz, J3,4 = 9.0 Hz, 1 H, 3-H), 
3.90-3.70 (m, 2 H, 6-H2) ppm. 13C NMR (50 MHz; CDCl3): δ = 154.6 (Fmoc-CO2), 143.3, 
143.1, 141.0, 138.1, 137.8, 137.6 (aromatic C), 128.2-127.0, 125.2, 125.0, 119.8 (aromatic 
CH), 91.9 (C-1), 77.6, 74.9, 74.5, 73.2, 73.0, 71.6, 70.7, 70.0, 69.4 ppm. To a solution of the 
hemiacetal in acetone (6 mL) were sequentially added at 0 °C Cs2CO3 (239 mg, 0.733 mmol) 
and (N-phenyl)trifluoroacetimidoyl chloride (230 μL, 1.82 mmol). The mixture was allowed 
to warm to rt and after three hours was diluted with DCM, filtered through Celite (eluent: 
ethyl acetate) and concentrated under vacuum. The residue was purified by silica gel flash-
chromatography (eluent: petroleum ether/ethyl acetate from 9:1 to 8.5:1.5) to yield 9F as a 
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yellow oil (anomeric mixture α/β ca 7.6:1, 506 mg, 90% over two steps). 1H NMR (400 MHz; 
CDCl3): signals of α-anomer at δ = 7.90−7.00 (Ar), 6.61 (br s, 1 H, 1-H), 5.55 (bs, 1 H, 2-H), 
5.12-4.70 (6 H, 3x –CH2Ph), 4.63-4.48 (3 H, Fmoc –OCH2CH-), 4.42-4.10 (3 H, 3-H, 4-H 
and 5-H), 4.05-3.90 (2 H, 6 H2) ppm. 13C NMR (50 MHz; CDCl3): δ = 154.3 (Fmoc-CO2), 
143.1, 142.9, 142.8, 141.3, 141.0, 137.8 (x2), 137.3 (aromatic C); 128.8-125.7, 120.4, 119.8, 
119.1 (aromatic CH), 93.9 (C-1), 77.3, 75.2, 74.0, 73.4, 73.2, 72.1, 71.1, 70.2, 68.3 ppm. 
MALDI-TOF MS: calcd. for [M + Na]+ 866.30, found 866.15. Calcd. for C50H44F3NO8 
(866.30): C, 71.16; H, 5.26. Found: C, 71.00; H, 5.35. 
 
Ethyl 3,4,6-tri-O-benzyl-2-O-fluorenylmethoxycarbonyl-α-
D-mannopyranosyl-(1→2)-3,4,6-tri-O-benzyl-1-thio-α-D-
mannopyranoside (16α). 1H NMR (300 MHz, CDCl3) δ 7.91-
7.00 (Ar), 5.45 (s, 1H, H-1), 5.40 (bd, 1H, H-2'), 5.21 (s, 1H, H-
1'), 5.00-4.41 (m, 6 x AB, 12H, 6 x -CH2Ph), 4.40-4.23 (m, 3H, 
-CH2O and H-9 Fmoc), 4.20-4.01 (m, 4H, H-2, H-5, H-3' and 
H-5'), 4.00-3.78 (m, 6H), 3.72 (d, J 6a, 6b = 11.1 Hz, 1H, H-6b), 2.64-2.49 (m, 2H, -SCH2CH3), 
1.24 (t, 3H, J 7.2 Hz, -SCH2CH3). 13C NMR (50 MHz, CDCl3) δ 154.7 (-OCO2-), 143.7, 
143.4, 141.3, 141.2 (Fmoc aromatic C), 138.6 (x 2), 138.5, 138.4, 138.2, 138.1 (aromatic C), 
128.3-120.0 (aromatic CH), 99.4 (C-1'), 80.2 (C-1), 78.2, 75.9, 75.6, 75.2, 75.1, 75.0, 74.6, 
73.4, 73.3, 72.8, 72.3 (x 3), 72.0, 70.3, 69.3 (x 2), 46.7 (Fmoc -CHCH2), 25.5 (-SCH2CH3), 
15.0 (-SCH2CH3). MALDI-TOF MS: calcd. for [M + Na]+ 1171.47. found 1171.4. Calcd. for 
C71H72O12S: C, 74.19; H, 6.31. Found: C, 74.45; H, 6.25. 
 
Ethyl 3,4,6-tri-O-benzyl-2-O-
fluorenylmethoxycarbonyl-β-D-mannopyranosyl-
(1→2)-3,4,6-tri-O-benzyl-1-thio-α-D-
mannopyranoside (16β). 1H NMR (300 MHz, CDCl3) 
δ 7.80-6.90 (Ar), 5.57 (d, J 1,2 = 2.7 Hz, 1H, H-1), 5.43 
(d, J 2,3 = 1.5 Hz, 1H, H-2'), 5.07-4.77 (m, 4H, -CH2Ph 
and H-1'), 4.76-4.43 (m, 4 x AB, 8H, 4 x -CH2Ph), 4.42-4.19 (m, 4H), 4.18-4.05 (m, 2H), 3.94 
(t, J = 9.4 Hz, 1H), 3.93-3.58 (m, 7H), 3.57-3.48 (m, 1H, H-5'), 2.77-2.43 (m, 2H, -
SCH2CH3), 1.26 (t, 3H, J 7.5 Hz, -SCH2CH3). 13C NMR (50 MHz, CDCl3) δ 155.1 (-OCO2-), 
143.9, 143.4, 141.2, 141.1 (Fmoc aromatic C), 138.6, 138.5, 138.4, 138.3 (x 2), 137.6 
(aromatic C), 128.4-119.8 (aromatic CH), 95.8 (C-1'), 81.1 (C-1), 80.1, 78.2, 75.9, 75.2, 75.1, 
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74.5, 74.4, 73.6, 73.4, 73.1, 72.3, 71.8, 71.4, 70.6, 70.3, 69.6, 69.4, 46.8 (Fmoc -CHCH2), 
25.5 (-SCH2CH3), 15.0 (-SCH2CH3). MALDI-TOF MS: calcd. for [M + Na]+ 1171.47. found 
1171.7. Calcd. for C71H72O12S: C, 74.19; H, 6.31. Found: C, 74.40; H, 6.20. 
Methyl 3,4,6-tri-O-benzyl-2-O-
fluorenylmethoxycarbonyl-α-D-mannopyranosyl-(1→2)-
3-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside 
(17α). 1H NMR (400 MHz, CDCl3) δ 7.87-7.03 (m, Ar), 5.58 
(s, 1H, benzylidene -CHPh), 5.37 (br d, 1H, H-2'), 5.17 (s, 
1H, H-1'), 4.96 (d, J 1,2 = 3.2, 1H, H-1), 5.00-4.38 (m, 4 x 
AB, 8H, 4 x -CH2Ph), 4.50-4.45 (m, 1H, Fmoc –CHCH2O-), 4.40 (d, J = 12.0 Hz,1H, Fmoc -
CHCHaHbO-), 4.35-4.28 (m, 3H, H-6a, and Fmoc –CHCH2O-), 4.25-4.20 (m, 1H, H-5'), 4.14 
(dd, J 2,3 = 2.8 Hz, J 3,4 = 9.6 Hz, 1H, H-3'), 4.07 (t, J 3,4 = 9.6 Hz, 1H, H-4'), 4.00-3.95 (m, 2H, 
H-2 and H-3), 3.88 (td, J5, 6a = 4.6 Hz, J5, 6b = 9.8 Hz, 1H, H-5), 3.76 (t, J 5,6b = J 6a,6b = 10.0 
Hz ,1H, H-6b), 3.73 (dd, J 5, 6b = 4.0 Hz, J 6a, 6b = 10.2 Hz, 1H, H-6'a), 3.67-3.57 (m, 2H, H-4 
and H-6'b), 3.49 (s, 3H, -OMe). 13C NMR (50 MHz, CDCl3) δ 154.8 (-OCO2-), 143.5, 143.1, 
141.25, 141.20 (Fmoc aromatic C), 138.6, 138.3, 137.9, 137.8, 137.3 (aromatic C), 129.0-
119.9 (aromatic CH), 101.2 (benzylidene -CHPh), 97.0, 94.3 (anomeric CH), 82.1, 79.1, 78.0, 
75.6, 75.2, 74.1, 73.6, 73.0, 72.7, 71.8, 71.2, 70.2, 68.9, 68.5, 62.2, 55.4 (-OMe), 46.5 (Fmoc -
CHCH2). MALDI-TOF MS: calcd. for [M + Na]+ 1049.41. found 1049.3. Calcd. for 
C63H62O13: C, 73.67; H, 6.08. Found: C, 73.45; H, 6.15. 
 
Methyl 3,4,6-tri-O-benzyl-2-O-fluorenylmethoxycarbonyl-
β-D-mannopyranosyl-(1→2)-3-O-benzyl-4,6-O-
benzylidene-α-D-glucopyranoside (17β). 1H NMR (400 
MHz, CDCl3) δ 7.87-7.06 (Ar), 5.59 (s, 1H, benzylidene H), 
5.35 (d, 1H, J 2,3 = 2.8 Hz, H-2'), 5.01-4.37 (4 x -CH2Ph, 8H), 
4.94 (d, 1H, J 1,2 = 3.9 Hz, H-1), 4.78 (s, 1H, H-1'), 4.50-4.35 
(m, 2H, Fmoc -CHCH2O-), 4.36-4.28 (m, 2H, H-6a and Fmoc -CHCH2O-), 4.08 (t, J 2,3 = J 3,4 
= 9.6 Hz 1H, H-3), 3.91-3.71 (m, 6H), 3.64 (t, J 4,5 = 9.6 Hz, 1H, H-4), 3.49 (dd, 1H, J3,4 = 9.2 
Hz, H-3'), 3.47-3.43 (m, 1H, H-5'), 3.30 (s, 3H, -OMe). 13C NMR (50 MHz, CDCl3) δ 155.0 (-
OCO2-), 143.6, 143.5, 141.2, 141.1 (Fmoc aromatic C), 138.8, 138.2, 138.0, 137.5, 137.3 
(aromatic C), 128.9-119.9 (aromatic CH), 101.3 (benzylidene CH), 100.2, 100.1 (anomeric 
CH), 82.4, 80.5, 79.5, 78.5, 75.5, 75.3, 74.1, 73.5, 72.1, 71.5, 70.2, 69.3, 69.1, 67.0, 62.3, 55.3 
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(-OMe), 46.7 (Fmoc -CHCH2). [M + Na]+ 1049.41. found 1049.3. Calcd. for C63H62O13: C, 
73.67; H, 6.08. Found: C, 73.50; H, 6.15. 
 
p-Methoxyphenyl 3,4,6-tri-O-benzyl-2-O-
fluorenylmethoxycarbonyl-α-D-mannopyranosyl-(1→2)-
3,4,6-tri-O-benzyl-α-D-mannopyranoside (18α). 1H NMR 
(400 MHz, CDCl3) δ 7.90-7.12 (Ar), 6.97 (d, J = 9.1 Hz, 2H, 
Ar-HPMP), 6.74 (d, J = 9.1 Hz, 2H, Ar-HPMP), 5.59 (d, J 1,2 = 
2.0 Hz, 1H, H-1), 5.41 (dd, J 2,3 = 3.0 Hz, H-2'), 5.25 (d, J 1,2 = 
1.6 Hz,1H, H-1'), 4.97-4.43 (m, 6 x AB, 12H, 6 x -CH2Ph), 4.32 (d, J = 8.0 Hz, 1H, Fmoc -
CHCHaCHaO-), 4.30 (d, J = 7.9 Hz, 1H, - Fmoc -CHCHaCHbO-), 4.25 (t, 1H, Fmoc -
CHCHaCHbO-), 4.21 (t, J 2,3 = 2.5 Hz, 1H, H-2), 4.14 (dd, 1H, J 2,3 = 3.0 Hz, J 3,4 = 8.8 Hz, H-
3), 4.11-4.02 (m, 2H, H-5' and H-3'), 3.97 (t, 1H, J = 9.3 Hz), 3.94-3.86 (m, 2H), 3.84-3.72 
(m, 3H), 3.74 (s, 3H, -OMe), 3.69 (dd, J 5, 6 = 1.6 Hz, J 6a, 6b = 11.2 Hz, 1H, H-6). 13C NMR 
(50 MHz, CDCl3) δ 155.0 (p-methoxyphenyl aromatic C), 154.7 (-OCO2), 150.1 (p-
methoxyphenyl aromatic C), 143.6, 143.3, 141.3, 141.2 (Fmoc aromatic C), 138.5, 138.4, 
138.3(3), 138.3(0), 138.2, 138.0 (aromatic C), 128.4-120.0 (aromatic CH), 117.9, 114.6 (p-
methoxyphenyl aromatic CH), 99.3, 97.7 (C-1' and C-1), 79.5, 78.2, 75.24, 75.20, 75.0, 74.6, 
74.5, 73.3, 73.2, 72.7, 72.5, 72.4, 72.2, 72.0, 70.2, 69.2 (x 2), 55.6 (-OMe), 46.7 (Fmoc -
CHCH2). [M + Na]+ 1233.50. found 1233.6. Calcd. for C76H74O14: C, 75.35; H, 6.16. Found: 
C, 75.20; H, 6.05. 
 
p-Methoxyphenyl 3,4,6-tri-O-benzyl-2-O-
fluorenylmethoxycarbonyl-β-D-mannopyranosyl-
(1→2)-3,4,6-tri-O-benzyl-α-D-mannopyranoside 
(18β). 1H NMR (400 MHz, CDCl3) δ 7.94-6.94 (Ar), 
6.77 (d, J = 9.1 Hz, 2H, Ar-HPMP), 5.57 (d, J2,3 = 3.0 
Hz, 1H, H-2'), 5.54 (d, J 1,2 = 2.4 Hz, 1H, H-1), 4.84 
(s, 1H, H-1'), 4.52 (t, J 2,3 = 2.4 Hz, 1H, H-2), 4.94-4.46 (m, 12H, 6x -CH2Ph), 4.34 (d, J = 8.0 
Hz, 2H, Fmoc -CHCH2O-), 4.24 (t, 1H, Fmoc -CHCH2O-), 4.17-4.07 (m, 2H, H-3 and H-4'), 
3.96-3.88 (m, 2H, H-4 and H-5), 3.85-3.70 (m, 3H, H-6a', H-6b', H-3'), 3.74 (s, 3H, -OMe), 
3.66 (dd, J5, 6b = 5.1 Hz, J6a, 6b = 10.9 Hz, 1H, H-6b), 3.62 (dd, J5, 6a = 2.3 Hz, 1H, H-6a), 3.58-
3.61 (m, J5, 6a = 1.7 Hz, J5, 6b = 4.8 Hz, J4,5 = 9.7 Hz, 1H, H-5'). 13C NMR (50 MHz, CDCl3) δ 
155.0 (p-methoxyphenyl aromatic C and –OCO2-), 150.5 (p-mMethoxyphenyl aromatic C), 
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143.8, 143.4, 141.2, 141.1 (Fmoc aromatic C), 138.8, 138.4 (x 2), 138.2 (x 2), 137.6 (aromatic 
C), 128.4-119.8 (aromatic CH), 118.0, 114.6 (p-methoxyphenyl aromatic CH), 96.8, 96.7 
(anomeric CH), 80.1, 78.5, 75.8, 75.3, 74.9, 74.5, 74.2, 73.6, 73.1, 72.4, 72.2, 72.1, 71.4, 71.0, 
70.3, 69.6, 69.3, 55.6 (-OMe), 46.7 (Fmoc -CHCH2). [M + Na]+ 1233.50. found 1233.5. 
Calcd. for C76H74O14: C, 75.35; H, 6.16. Found: C, 75.15; H, 6.10.  
  
Methyl 3,4,6-tri-O-benzyl-α-D-mannopyranosyl-
(1→3)-2,4,6-tri-O-benzyl-α-D-mannopyranoside 
(19F). A mixture of donor 9F (147 mg, 0.174 
mmol) and acceptor 10F (49 mg, 0.105 mmol) was 
coevaporated three times with anhydrous toluene (3 
x 2 mL), and then dried in vacuo for 30 minutes. After adding 4Å AW 300 MS, the mixture 
was dissolved under argon with 4:1 toluene/Et2O (3.3 mL), cooled to -30 °C, and stirred for 
15 minutes. A solution of Bi(OTf)3 in dioxane (14.5 mg/mL, 0.38 mL, 8.4 μmol) was then 
added, and the temperature was allowed to slowly raise. After 50 minutes (temperature at -20 
°C), having realized the completion of the glycosidation step (TLC analysis, eluent: n-
hexane/ethyl acetate 7:3), TEA (0.8 mL) was added and the reaction vessel was immediately 
warmed to rt. After one hour the reaction mixture was filtered on a short plug of silica gel 
repeatedly washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, and 
the residue purified by silica-gel flash-chromatography (eluent: n-hexane/ethyl acetate from 
3:1 to 2:1) to yield disaccharide 19F as an oil (84 mg, 87% overall yield); [α]D 28 +29.1 (c 1.0 
in CHCl3); 1H NMR (400 MHz; CDCl3) δ = 7.40−7.10 (Ar), 5.22 (d, J1,2 = 1.2 Hz, 1 H, 1′-H), 
4.72 (d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.85-4.46 (12 H, 6x-CH2Ph), 4.13 (dd, J = 3.2 and 10.6 Hz, 1 
H), 4.02-3.60 (11 H), 3.29 (s, 3 H, -OCH3), 2.31 (d, = 2.4 Hz, 1 H, OH-2) ppm. 13C NMR (50 
MHz; CDCl3): δ = 138.6, 138.3 (x3), 138.1, 137.9 (aromatic C); 128.5-127.5 (aromatic CH); 
101.2 and 98.2 (anomeric CH), 80.0, 78.4, 75.2, 75.0, 74.9, 74.4, 72.1, 72.0, 71.9, 71.7, 69.2, 
69.0, 68.6, 54.8 ppm. MALDI-TOF MS: calcd. for [M + Na]+ 919.40, found 919.27. Calcd. 
for C55H60O11 (919.40): C, 73.64; H, 6.74. Found: C, 73.50; H, 6.65.  
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Methyl 3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→2)-3,4,6-tri-O-
benzyl-α-D-mannopyranosyl-(1→3)-
2,4,6-tri-O-benzyl-α-D-
mannopyranoside (20F). A mixture of 
donor 9F (74 mg, 88 µmol) and acceptor 
19F (45 mg, 49 µmol) was coevaporated 
three times with anhydrous toluene (3 x 1 
mL), and then dried in vacuo for 30 minutes. After adding 4Å AW 300 MS, the mixture was 
dissolved under argon with 4:1 toluene/Et2O (3.3 mL), cooled to -30 °C, and stirred for 15 
minutes. A solution of Bi(OTf)3 in dioxane 14.5 mg/mL, 0.22 mL, 4.9 µmol) was then added, 
and the temperature was allowed to raise up to -5 °C over 75 minutes. Having realized the 
completion of the glycosidation step (TLC analysis, eluent n-hexane/ethyl acetate 7:3), TEA 
(0.83 mL) was added and the reaction vessel was immediately warmed to rt. After one hour 
the reaction mixture was filtered through a short plug of silica gel repeatedly washed with 
DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, and the residue purified by 
silica-gel flash-chromatography (eluent: n-hexane/ethyl acetate from 3:1 to 2:1) to yield 
trisaccharide 20F as an oil (59 mg, 90 % overall yield); [α]D28 +34.2 (c 1.3 in CHCl3); 1H 
NMR (400 MHz; CDCl3): δ = 7.45−7.10 (Ar), 5.31 (J1,2 = 1.6 Hz, 1 H, d, 1′′-H), 5.13 (d, J1,2 = 
1.6 Hz, 1 H, 1′-H), 4.85 (d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.92-4.41 (18 H, 9 x-CH2Ph), 4.18-4.12 
(2 H), 4.10-3.80 (9 H), 3.80-3.65 (6 H), 3.55 (bd, J = 10.0 Hz, 1 H,), 3.33 (s, 3 H, -OCH3), 
2.48 (bs, 1 H, 2.OH) ppm. 13C NMR (100 MHz; CDCl3): δ = 138.8, 138.6, 138.55, 138.48 
(x2), 138.41 (x2), 138.2, 138.1 (aromatic C); 128.5-127.3 (aromatic CH); 101.0 (x2), 98.2 
(anomeric CH), 79.9, 79.5, 77.7, 75.4, 75.0, 74.9, 74.7, 74.3, 73.4, 73.3, 73.2, 72.7, 72.2, 72.1, 
72.0, 71.8, 69.7, 69.3, 68.6, 68.5 54.8 ppm. MALDI-TOF MS: calcd. for [M + Na]+ 1351.60, 
found 1351.48. Calcd. for C82H88O16 (1351.60): C, 74.18; H, 6.67. Found: C, 73.95; H, 6.71.  
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Methyl 3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→2)-3,4,6-tri-O-
benzyl-α-D-mannopyranosyl-(1→2)-
3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→3)-2,4,6-tri-O-
benzyl-α-D-mannopyranoside (1F). 
A mixture of donor 9F (11 mg, 13 
μmol) and acceptor 20F (10 mg, 7.5 
μmol) was coevaporated three times 
with anhydrous toluene (3 x 1 mL), 
and then dried in vacuo for 30 minutes. After adding 4Å AW 300 MS, the mixture was 
dissolved under argon with 4:1 toluene/Et2O (0.51 mL), cooled to -30 °C, and stirred for 15 
minutes. A solution of Bi(OTf)3 in dioxane (14.3 mg/mL, 34 μL, 0. 75 μmol) was then added, 
and the temperature was allowed to raise up to rt over 2.5 hours. Having realized the 
completion of the glycosidation step (TLC analysis, eluent: n-hexane/ethyl acetate 7:3), TEA 
(0.13 mL) was added. After one hour from the addition, the reaction mixture was filtered on a 
short plug of silica gel repeatedly washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate 
was concentrated, and the residue purified by silica-gel flash-chromatography (eluent: 
toluene/ethyl acetate from 100:0 to 85:15) to yield tetrasaccharide 1F as an oil (8 mg, 64 % 
overall yield); [α]28D +28.5 (c 0.8 in CHCl3); 1H NMR (500 MHz; CDCl3): δ  
= 7.40−7.05 (Ar), 5.25 (1 H, br s, 1′′′-H), 5.18 (1 H, br s, 1′′-H), 5.14 (1 H, bs, 1′-H), 4.70 (1 
H, d, J1,2 = 1.5 Hz, 1-H), 4.85-4.22 (24 H, 12 x-CH2Ph), 4.12-4.08 (2 H), 4.00 (1 H, J = 1.5 
Hz), 3.98-3.60 (18 H), 3.55 (1H, dd, J = 3.0 and 11.5), 3.47 (1H, bd, J = 11.5), 3.43 (1H, bd, J 
= 10.0), 3.26 (3 H, s, -OCH3), 2.39 (1 H, br s, 2-OH) ppm. 13C NMR (100 MHz; CDCl3): δ 
= 138.8−138.1 (aromatic C); 128.5-127.2 (aromatic CH); 101.0, 100.9, 100.8 and 98.2 
(anomeric CH), 80.0, 79.6, 79.4, 79.2, 79.0, 77.6, 77.2, 75.6, 75.1, 74.9, 74.7, 74.2, 73.4, 73.3, 
73.0, 72.6, 72.5, 72.4, 72.1, 72.0, 71.9, 71.7, 71.6, 69.7, 69.3, 69.0, 68.7, 68.5, 54.7 ppm. 
MALDI-TOF MS: calcd. for [M + Na]+ 1784.79, found 1784.45. Calc. for C109H116O21 
(1784.79): C, 74.30; H, 6.64. Found: C, 73.95; H, 6.50. 
 
Methyl 3,6-di-O-tert-butyldimethylsilyl-α-D-mannopyranoside 
(22F). Compound 22F was prepared and elaborated to diol 21F by 
reproducing the procedures described in reference23. 1H NMR (300 
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MHz, CDCl3) δ 4.69 (d, J 1,2 = 0.9 Hz, 1H, H-1), 3.83 (d, 2H, H-6a and H-6b), 3.80 (dd, 1H, 
H-3), 3.72 (br d, J 2,3 = 3.6 Hz, 1H, H-2), 3.66 (td, J 3,4 = 9.1 Hz, 1H, H-4), 3.52 (dt, J 5, 6a = 
4.5 Hz, J 5, 6b = 5.2 Hz, 1H, H-5), 3.33 (s, 3H, -OMe), 2.78 (d, J 4,OH = 2.1 Hz, 1H, 4-OH), 
2.59 (br s, 1H, 2-OH), 0.88 (s, 9H, -C(CH3)3), 0.87 (s, 9H, -C(CH3)3), 0.12 (s, 3H, -Si(CH3)2), 
0.10 (s, 3H, -Si(CH3)2), 0.06 (s, 6H, -Si(CH3)2). 13C NMR (75 MHz, CDCl3) δ 100.1 
(anomeric CH), 73.0, 71.0, 70.6, 70.3, 64.8, 54.6 (-OMe), 25.8 and 25.7 (2 x -C(CH3)3), 18.2, 
18.0 (2 x -C(CH3)3), -5.3, -4.6 (2 x -Si(CH3)2), -4.3 (2 x -Si(CH3)2). 
 
Methyl 2,4-di-O-benzyl-α-D-mannopyranoside (21F). Compound 
23F24,26a (endo/exo 1.2:1, 55 mg, 0.15 mmol) was dissolved at 0 °C 
under argon with 1 M BH3 in THF (1.5 mL, 1.5 mmol). To the 
resulting solution was added at 0 °C a solution of copper(II) triflate 
in THF (0. 069 M prepared dissolving the salt under argon in the presence of 4Å MS, 0.65 
mL, 0.045 mmol). After 30 minutes, the ice-bath was removed and the reaction vessel was 
allowed to warm to rt. After a few minutes a black precipitate appeared. After 1 hour and 40 
minutes from the start, the reaction was quenched with TEA (25 μL) and MeOH (0.2 mL). 
The mixture was concentrated in vacuo and the residue was purified by silica-gel flash 
chromatography (eluent: n-hexane/ethyl acetate from 32:18 to 55:45) to yield diol 21F as a 
colourless oil (34 mg, 61% yield). Acetylation of a sample confirmed the presence of free 
hydroxyls at O-3 and O-6 as indicated by 1H NMR (200 MHz; CDCl3): signals at δ  5.16 (dd, 
J 2,3 = 3.3 Hz, J3,4 = 9.0 Hz, 1H, 3-H), 4.30 (dd, J5,6a = 3.0 Hz, J6a,6b = 12.4 Hz, 1H, 6a-H), 
4.22 (dd, J5,6b = 4.2 Hz, 1H, 6b-H). Compound 21F: [α]D28 +21.5 (c 1.1 in CHCl3), lit.:24 [α]D 
+23.5 (c 0.77 in CHCl3); 1H NMR (400 MHz; CDCl3) δ  7.40−7.25 (Ar), 4.75 (d, J 1,2 = 1.6 
Hz, 1H, anomeric proton), 4.92-4.59 (4H, 2x-CH2Ph), 3.99 (dd, J 2,3 = 3.2 Hz, J 3,4 = 9.6 Hz, 
1H, 3-H), 3.86 (dd, J 5,6a = 3.2 Hz, J 6a,6b = 11.6 Hz, 1H, 6a-H), 3.77 (dd, J 5,6b = 4.4 Hz, 1H, 
6b-H), 3.73 (dd, 1H, 2-H), 3.68 (t, J4,5 = 9.6 Hz, 1H, 4-H), 3.60-3.55 (m, 1H, 5-H), 3.32 (s, 3 
H, -OCH3). 13C NMR (50 MHz; CDCl3) δ  138.3, 137.6 (aromatic C); 128.6-127.8 (aromatic 
CH); 98.1 (C-1), 78.3, 74.8, 73.1, 71.7, 71.1, 62.3, 54.8 (-OCH3). MALDI-TOF MS: calcd. 
for [M + Na]+ 397.17, found 397.25. Calcd. for C21H26O6: C, 67.36; H, 7.00. Found: C, 67.05; 
H, 7.10.  
 
Other reductive opening procedures (conditions B and C of Table 2). The reductive 
openings were essentially accomplished as illustrated above for preparation of 21F (condition 
A of Table 2). Only differences were the addition of molecular sieves to the reaction vessel 
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and coevaporation of Cu(OTf)2 with toluene prior to be dissolved in THF, according to the 
indications on Table 2 (conditions B and C). Listed below are the NMR data of all products 
obtained from the reductive openings. In several cases acetylation was exploited for structural 
confirmation. 
 
Methyl 3,4-di-O-acetyl-2,6-di-O-benzyl-α-D-mannopyranoside 
(acetylated 24F). 1H NMR (400 MHz, CDCl3) δ 7.42-7.29 (m, 
10H, ArH), 5.39 (t, J 3,4 = J 4,5 = 9.9 Hz, 1H, H-4), 5.21 (dd, 1H, J2,3 
= 3.4 Hz, H-3), 4.75 (d, J 1,2 = 1.7 Hz, 1H, H-1), 4.66-4.54 (2x AB, 
4H, 2x -CH2Ph), 3.88 (ddd, 1H, J 5, 6a = 2.3 Hz, J 5, 6b = 3.5 Hz, H-5), 3.82 (dd, 1H, H-2), 3.61 
(dd, 1H, H-6a), 3.56 (dd, 1H, J6a, 6b 10.9 Hz, H-6b), 3.38 (s, 3H, -OMe), 1.98 and 1.91 (2xs, 
6H, 2x -COCH3). 
 
Methyl 3,4-di-O-benzyl-α-D-mannopyranoside (25F). 1H NMR 
(200 MHz, CDCl3) δ 7.49-7.28 (Ar), 4.94-4.60 (m, 5H, 2 x -CH2Ph 
and H-1), 4.06-4.00 (br d, 1H, H-2), 3.94-3.72 (m, 4H, H-3, H-4, H-
6a and H-6b), 3.70-3.60 (m, 1H, H-5), 3.36 (s, 3H, -OMe). 13C 
NMR (50 MHz, CDCl3) δ 138.3, 137.8 (aromatic C), 128.5-127.8 (aromatic CH), 100.2 
(anomeric CH), 80.0, 75.1, 74.1, 72.1, 71.3, 68.3, 62.1, 54.9 (-OMe).  
 
Methyl 2,6-di-O-acetyl-3,4-di-O-benzyl-α-D-mannopyranoside 
(acetylated 25F). 1H NMR (300 MHz, CDCl3) δ 7.43-7.28 (m, 
10H, ArH), 5.37 (dd, 1H, J1,2 = 1.8 Hz, J2,3 = 3.3 Hz, H-2), 4.92-
4.50 (m, 5H, 2 x -CH2Ph and H-1), 4.38-4.32 (d, 2H, H-6a and H-
6b), 4.00 (dd, J 4,5 = 9.9 Hz, 1H, H-3), 3.84 (dt, 1H, J 5,6a = 2.7 Hz, J 5,6b = 3.6 Hz, H-5), 3.74 
(t, 1H, H-4), 3.36 (s, 3H, -OMe), 2.16 and 2.08 (2x s, 6H, 2x -COCH3).  
 
Methyl 2-O-benzyl-4,6-O-benzylidene-α-D-
mannopyranoside (26F). 1H NMR (500 MHz, CDCl3) δ 
7.53-7.28 (Ar), 5.54 (s, 1H, benzylidene PhCH), 4.72 (s, 1H, 
H-1), 4.71 (d, 1H, Jgem = 11.5 Hz, -CHaHbPh), 4.67 (d, 1H, -
CHaHbPh), 4.23 (dd, 1H, J 5, 6a = 4.2 Hz, J 6a, 6b = 9.7 Hz, H-6a), 4.05 (dd, 1H, J 2,3 = 3.7 Hz, J 
3,4 = 9.7 Hz, H-3), 3.88 (t, 1H, H-4), 3.84-3.70 (m, 3H, H-2, H-5 and H-6b), 3.33 (s, 3H, -
OMe), 2.43 (br s, 1H, 3-OH). 
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Methyl 3-O-benzyl-4,6-O-benzylidene-α-D-
mannopyranoside (27F). 1H NMR (500 MHz, CDCl3) δ 
7.53-7.28 (Ar), 5.61 (s, 1H, benzylidene PhCH), 4.84 (d, 1H, 
Jgem = 12.0 Hz, -CHaHbPh), 4.76 (d, J 1,2 = 1.0 Hz, 1H, H-1), 
4.70 (d, 1H, Jgem = 12.0 Hz, -CHaHbPh), 4.27 (dd, 1H, J 5, 6a = 
4.2 Hz, J 6a, 6b = 9.7 Hz, H-6a), 4.09 (t, 1H, H-4), 4.04 (dd, 1H, H-2), 3.90 (dd, 1H, J 2,3 = 3.7 
Hz, J 3,4 = 9.7 Hz, H-3), 3.88-3.77 (m, 2H, H-5 and H-6b), 3.37 (s, 3H, -OMe). 13C NMR (75 
MHz, CDCl3) δ 170.7, 170.2 (2 x -COCH3), 138.1, 137.8 (aromatic C), 128.4-127.8 (aromatic 
CH), 98.8 (anomeric CH), 78.1, 75.1, 74.1, 71.7, 69.6, 68.5, 63.4, 54.9 (-OMe), 21.0, 20.8 (2 
x -COCH3). 
 
3,4,6-Tri-O-benzyl-2-O-fluorenylmethoxycarbonyl-
α,β-D-mannopyranosyl trichloracetimidate (28F). To a 
solution of 13Fα (318 mg, 0.447 mmol) in 1.6:1 
MeOH/DCM (4.5 mL) was added at rt palladium chloride 
(8 mg, 0.045 mmol). The mixture was stirred overnight and then concentrated under vacuum. 
The residue was then filtered through a short plug of silica gel (eluent DCM/MeOH 95:5) and 
concentrated to yield the hemiacetal as a foam. The obtained hemiacetal was dissolved in 
trichloroacetonitrile (6.7 mL) and the solution was added drop-wise to a reaction vessel 
containing sodium hydride (60% in oil, 1.9 mg) at 0°C under magnetic stirring. After 15 min 
at the same temperature the mixture was neutralized by portion-wise addition of silica gel and 
the residue was purified by silica gel flash-chromatography (eluent: toluene/acetone 20:1) to 
yield 28F as a foam (anomeric mixture α/β ca 8.3:1, 348 mg, 95% over two steps). 1H NMR 
(400 MHz; CDCl3) : signals of α anomer at δ = 8.83 (s, 1 Η,  −ΝΗ), 8.00−7.15 (Ar), 6.57 (d, 
J1,2 = 1.6 Hz, 1 H, 1-H), 5.47 (t, J2,3 = 1.6 Hz, 1 H, 2-H), 4.55-4.35 (3 H, Fmoc –CHCH2O), 
4.26 (t, J3,4 = J4,5 = 9.6 Hz,1 H, 4-H), 4.20 (dd, 1 H, 3-H), 4.20-4.13 (m, 1 H, 5-H), 3.98 (dd, 
J5,6a = 4.4, J6a,6b = 11.2 Hz, 1 H, 6a-H), 3.87 (dd, J5,6b = 1.6 Hz, 1H, 6b-H) ppm. Significant 
signals of the β-anomer at δ =  8.78 (1Η, s, −ΝΗ),  6.05 (1H, s, H-1) ppm. 13C NMR (100 
MHz; CDCl3): signals of α anomer at δ = 160.0 (C=NH), 154.6 (-OCO2-); 143.4, 143.2, 141.3 
(x2) (Fmoc aromatic C), 138.1, 137.9, 137.4 (benzyl aromatic C); 128.4-127.3, 125.4, 125.3, 
120.1 (aromatic CH), 95.3 (C-1), 77.5, 75.6, 74.6, 73.8, 73.5, 72.2, 71.4, 70.6, 68.6, 46.6 ppm.  
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Methyl (3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→3))-(3,4,6-tri-O-benzyl-α-
D-mannopyranosyl-(1→6))-2,4-di-O-benzyl-α-
D-mannopyranoside (29F). A  mixture of donor 
28F (78 mg, 95 µmol) and diol 21F (12 mg,  29 
µmol) was coevaporated three times with 
anhydrous toluene (3 x 2 mL), and then dried in 
vacuo for 30 minutes. After adding 4Å AW 300 
MS, the mixture was dissolved under argon with 4:1 toluene/Et2O (2.8 mL), cooled to -30 °C, 
and stirred for 15 minutes. A solution of Bi(OTf)3 in dioxane (14.5 mg/mL, 135 µL, 0.29 
µmol)  was then added, and the temperature was allowed to raise up to – 10 °C over 45 
minutes. Having realized the completion of the glycosidation step (TLC analysis, eluent: 
petroleum ether/ethyl acetate 7:3), TEA (0.70 mL) was added and the reaction vessel was 
immediately warmed to rt. After one hour the reaction mixture was filtered through a short 
plug of silica gel repeatedly washed with DCM/MeOH/acetonitrile 85:10:5. The filtrate was 
concentrated, and the residue purified by silica-gel flash-chromatography (eluent: n-
hexane/acetone/dichloromethane from 3:1:0.5 to 2:1:0.5) to yield trisaccharide 29F as an oil 
(26 mg, 72 % overall yield). [α]D26 +25.9 (c 0.77 in CHCl3); 1H NMR (400 MHz; CDCl3):  δ  
= 7.40−7.10  (Ar), 5.23 (d, J1,2 = 1.2 Hz, 1 H, 1′3-H), 5.09 (d, J1,2 = 1.2 Hz, 1 H, 1′6-H), 4.66 
(d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.87-4.46 (16 H, 8x-CH2Ph), 4.15-4.10 (2 H), 4.05-3.95 (2 H), 
3.95-3.80 (8 H), 3.80-3.60 (6H), 3.25 (3 H, s, -OCH3) ppm. 13C NMR (100 MHz; CDCl3): δ = 
138.5, 138.4, 138.3 (x2), 138.2, 138.1, 137.9 (x2) (aromatic C); 128.6-127.5 (aromatic CH); 
101.4, 98.7, and 98.2 (anomeric CH), 80.1, 79.5, 78.9, 77.7, 75.0, 74.9, 74.8, 74.4, 74.2, 73.6, 
73.3, 72.3, 72.0, 71.9, 71.4, 71.1, 69.4, 68.8, 68.7, 68.0, 66.1, 54.7 ppm. MALDI-TOF MS: 
calcd. for [M + Na]+ 1261.55. found 1261.15. Calcd. for C75H82O16 (1261.55): C, 72.68; H, 
6.67. Found: C, 72.35; H, 6.50.  
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Methyl (3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→2)-3,4,6-tri-O-
benzyl-α- D-mannopyranosyl-
(1→3))-(3,4,6-tri-O-benzyl-α-D-
mannopyranosyl-(1→2)-3,4,6-tri-O-
benzyl-α-D-mannopyranosyl-
(1→6))-2,4-di-O-benzyl-α-D-
mannopyranoside (2F). A mixture of 
donor 28F (40 mg, 49 μmol) and diol 
29F (14 mg, 11 μmol) was coevaporated three times with anhydrous toluene (3 x 1 mL), and 
then dried in vacuo for 30 minutes. After adding 4Å AW 300 MS, the mixture was dissolved 
under argon with 4:1 toluene/Et2O (2.1 mL), cooled to -30 °C, and stirred for 15 minutes. A 
solution of Bi(OTf)3 in dioxane (14.5 mg/mL, 100 μL, 2.2 μmol) was then added, and the 
temperature was allowed to raise up to + 5 °C over one hour. Having realized the completion 
of the glycosidation step (TLC analysis, eluent petroleum ether/ethyl acetate 7:3), TEA (0.35 
mL) was added and the reaction mixture immediately warmed to rt. The reaction mixture was 
then filtered through a short plug of silica gel repeatedly washed with 
DCM/MeOH/acetonitrile 85:10:5. The filtrate was concentrated, and the residue purified by 
silica-gel flash-chromatography (eluent: n-hexane/acetone/dichloromethane 3:1:0.5) to yield 
pentasaccharide 2F as an oil (15 mg, 63% overall yield); [α]D28 +34.7 (c 0.7 in CHCl3); 1H 
NMR (400 MHz; CDCl3): δ  = 7.40−7.10 (Ar), 5.25, 5.11 and 5.05 (3 x d, J1,2 = 1.6 Hz, 3 H, 2 
x 1′′-H and 1′3-H), 4.97 (d, J1,2 = 1.6 Hz, 1 H, 1′6-H), 4.64 (d, J1,2 = 1.6 Hz, 1 H, 1-H), 4.98-
4.30 (28 H, 14 x-CH2Ph), 4.15-4.05 (4 H), 4.05-3.95 (3 H), 3.95-3.75 (13 H), 3.75-3.63 (6 H), 
3.60-3.40 (4 H), 3.16 (s, 3 H, -OCH3) ppm. 13C NMR (100 MHz; CDCl3): δ = 138.7-138.0 
(aromatic C); 128.6-127.0 (aromatic CH); 101.1 (x3), 99.1, and 97.9 (anomeric CH), 80.3, 
80.0, 79.9, 79.6, 78.9, 77.8, 75.3, 75.0, 74.9, 74.8, 74.7, 74.6, 74.5, 74.3, 74.2, 73.4, 73.3, 
72.7, 72.1, 72.0, 71.8, 71.6, 71.5, 71.0, 69.7, 69.1, 68.9, 68.6, 68.5, 66.5, 54.6 ppm. MALDI-
TOF MS: calcd. for [M + Na]+  2126.94, found 2126.11. Calcd. for C129H138O26 (2126.94): C, 
73.62; H, 6.61. Found: C, 73.35; H, 6.70. 
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